data_2kd0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kd0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.951 0.405 . . . . 62.310000000000002 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.150000000000006 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.399999999999999 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.540000000000006 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.209999999999994 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.310000000000002 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.409999999999997 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CZ ' HG22 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.319999999999993 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.210000000000001 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.150000000000006 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.239999999999995 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 74.120000000000005 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.200000000000003 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.439999999999998 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 111.602 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 64.519999999999996 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 74.129999999999995 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.450000000000003 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.540000000000006 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 63.340000000000003 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HB ' HD13 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.010000000000005 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.239999999999995 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 73.030000000000001 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.099999999999994 111.593 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.129999999999995 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.109999999999999 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.510000000000005 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.340000000000003 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.531 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.310000000000002 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.439999999999998 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG11 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.140000000000001 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 44.310000000000002 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.430000000000007 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.129999999999995 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.450000000000003 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.109999999999999 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.130000000000003 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.129999999999995 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.329999999999998 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 37.700000000000003 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.329999999999998 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 62.009999999999998 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.219999999999999 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.450000000000003 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 74.030000000000001 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.099999999999994 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.420000000000002 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.310000000000002 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.319999999999993 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.200000000000003 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.120000000000005 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.420000000000002 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 74.129999999999995 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.439999999999998 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.724 ' HZ1' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.450000000000003 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.319999999999993 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.319999999999993 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.535 HD13 HD21 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.420000000000002 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.544 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.540000000000006 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.557 -176.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.329999999999998 112.179 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.310000000000002 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.530000000000001 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.299999999999997 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.019999999999996 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.299999999999997 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.329999999999998 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.229999999999997 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.340000000000003 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 72.239999999999995 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.409999999999997 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.120000000000005 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 74.530000000000001 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.230000000000004 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.230000000000004 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 54.399999999999999 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.120000000000005 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.129999999999995 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.040000000000006 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 74.519999999999996 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.439999999999998 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.129999999999995 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.510000000000005 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 74.049999999999997 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.430000000000007 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.9 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.130000000000003 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 74.439999999999998 112.303 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.140000000000001 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.130000000000003 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.329999999999998 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.040000000000006 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.520000000000003 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 72.120000000000005 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.129999999999995 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 75.129999999999995 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.140000000000001 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.140000000000001 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.229999999999997 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.549999999999997 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.439999999999998 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.120000000000005 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.510000000000005 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.299999999999997 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.439999999999998 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.430000000000007 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.109999999999999 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.530000000000001 111.835 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.129999999999995 111.036 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.420000000000002 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.150000000000006 111.911 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.340000000000003 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.420000000000002 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.109999999999999 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 70.109999999999999 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.430000000000007 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 73.049999999999997 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.549999999999997 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.240000000000002 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.030000000000001 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.219999999999999 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.329999999999998 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 63.329999999999998 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.510000000000005 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.230000000000004 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.310000000000002 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.409999999999997 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 64.200000000000003 111.4 -178.393 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.100000000000001 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HD22 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.439999999999998 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.149999999999999 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.219999999999999 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HZ1' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.310000000000002 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.259 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.430000000000007 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.239999999999995 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.549999999999997 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.439999999999998 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.530000000000001 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.510000000000005 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.140000000000001 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.010000000000005 111.472 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.430000000000007 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.349999999999994 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.310000000000002 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.230000000000004 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.100000000000001 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.409999999999997 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.239999999999995 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.230000000000004 111.508 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 71.319999999999993 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.310000000000002 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.299999999999997 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.428 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.149999999999999 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 62.25 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.200000000000003 113.244 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.239999999999995 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.340000000000003 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.420000000000002 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.340000000000003 111.238 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.209999999999994 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.448 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.519999999999996 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.487 HD11 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.009999999999998 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.549999999999997 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.450000000000003 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.329999999999998 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.319999999999993 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.420000000000002 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.010000000000005 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 HD21 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.439999999999998 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.239999999999995 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.150000000000006 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 73.25 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.420000000000002 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.230000000000004 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.319999999999993 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.3 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.540000000000006 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.140000000000001 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.120000000000005 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.510000000000005 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.409999999999997 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.439999999999998 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.510000000000005 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.030000000000001 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.200000000000003 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.520000000000003 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.239999999999995 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.040000000000006 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.509 ' HB3' HG11 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 63.130000000000003 112.442 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 75.150000000000006 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.230000000000004 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.745 ' HZ2' ' HB3' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD21 HG23 ' A' ' 28' ' ' VAL . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.299999999999997 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.219999999999999 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 64.319999999999993 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 73.239999999999995 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.400000000000006 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.549999999999997 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.340000000000003 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.340000000000003 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.239999999999995 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 54.340000000000003 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.420000000000002 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 51.119999999999997 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 72.519999999999996 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 HD21 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.340000000000003 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.530000000000001 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.430000000000007 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.299999999999997 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 75.230000000000004 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.329999999999998 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' HB ' HD13 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.209999999999994 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 HD23 ' NE2' ' A' ' 40' ' ' GLN . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.200000000000003 111.425 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.540000000000006 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.230000000000004 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.404 ' NE2' HD23 ' A' ' 37' ' ' LEU . 25.7 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 74.5 111.793 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.349999999999994 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.219999999999999 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.530000000000001 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.400000000000006 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.554 ' OG1' HG13 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.319999999999993 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.519999999999996 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.150000000000006 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 75.340000000000003 113.406 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.019999999999996 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.040000000000006 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.485 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 50.2 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.140000000000001 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.430000000000007 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.47 HD13 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.409999999999997 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.540000000000006 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 71.329999999999998 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.430000000000007 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.549999999999997 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.319999999999993 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 75.25 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.099999999999994 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.219999999999999 111.167 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 73.409999999999997 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.140000000000001 112.361 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.349999999999994 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.219999999999999 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 74.340000000000003 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.409999999999997 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.349999999999994 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.209999999999994 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.409999999999997 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.219999999999999 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.6 ' HB3' ' HZ2' ' A' ' 77' ' ' LYS . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.400000000000006 111.679 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.129999999999995 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.030000000000001 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.239999999999995 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.591 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.420000000000002 111.436 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.027 0.441 . . . . 73.200000000000003 112.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.540000000000006 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.150000000000006 112.065 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.010000000000005 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.230000000000004 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.219999999999999 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.540000000000006 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.040000000000006 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.409999999999997 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.439999999999998 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.450000000000003 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.549999999999997 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.049999999999997 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 63.240000000000002 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.540000000000006 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.129999999999995 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.149999999999999 111.817 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.489 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 74.209999999999994 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.109999999999999 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 72.209999999999994 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.409999999999997 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.349999999999994 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.129999999999995 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.510000000000005 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.513 HD22 ' NE2' ' A' ' 40' ' ' GLN . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 74.239999999999995 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HZ2' ' CD ' ' A' ' 63' ' ' GLU . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.140000000000001 110.576 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.120000000000005 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.513 ' NE2' HD22 ' A' ' 37' ' ' LEU . 24.4 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.430000000000007 111.751 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.340000000000003 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.129999999999995 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.299999999999997 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.200000000000003 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.450000000000003 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.229999999999997 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.329999999999998 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.349999999999994 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.310000000000002 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.140000000000001 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 38.560000000000002 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.109999999999999 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.120000000000005 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 74.019999999999996 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.230000000000004 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.510000000000005 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.040000000000006 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.239999999999995 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.420000000000002 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.409999999999997 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.530000000000001 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.109999999999999 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.040000000000006 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.140000000000001 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.240000000000002 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.430000000000007 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.709 HD13 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.340000000000003 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.319999999999993 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.439999999999998 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.209999999999994 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 54.539999999999999 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.520000000000003 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 72.120000000000005 111.526 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.310000000000002 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.009999999999998 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.430000000000007 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.209999999999994 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.349999999999994 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 63.520000000000003 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.519 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.219999999999999 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 112.25 -175.642 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 75.239999999999995 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 74.319999999999993 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.519999999999996 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 74.219999999999999 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.540000000000006 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.450000000000003 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.120000000000005 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.219999999999999 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.219999999999999 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.230000000000004 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.519999999999996 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.140000000000001 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 72.120000000000005 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 73.209999999999994 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.329999999999998 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.519999999999996 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 73.010000000000005 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.140000000000001 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.129999999999995 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.540000000000006 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.209999999999994 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.120000000000005 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.109999999999999 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.539999999999999 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.239999999999995 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 73.430000000000007 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 72.140000000000001 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 75.209999999999994 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.020000000000003 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.219999999999999 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.200000000000003 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.319999999999993 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.120000000000005 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.120000000000005 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.120000000000005 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.230000000000004 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 65.25 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 72.129999999999995 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.409999999999997 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.239999999999995 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.439999999999998 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.859 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.310000000000002 110.554 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 34' ' ' VAL . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 111.363 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.310000000000002 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.210000000000001 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.561 HD13 HD12 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.430000000000007 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.239999999999995 111.936 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 72.230000000000004 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.420000000000002 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.510000000000005 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.230000000000004 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.409999999999997 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.200000000000003 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.039999999999999 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.461 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.129999999999995 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.230000000000004 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.340000000000003 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.319999999999993 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.329999999999998 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.540000000000006 111.402 -178.656 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 74.040000000000006 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.010000000000005 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.099999999999994 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.129999999999995 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.099999999999994 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.239999999999995 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.120000000000005 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.409999999999997 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.340000000000003 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 61.450000000000003 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.109999999999999 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.329999999999998 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.420000000000002 112.694 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.319999999999993 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.450000000000003 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.209999999999994 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.140000000000001 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 53.229999999999997 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 54' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.049999999999997 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.430000000000007 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.530000000000001 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.657 HD12 HD22 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.530000000000001 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.450000000000003 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.040000000000006 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.219999999999999 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.009999999999998 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.409999999999997 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.030000000000001 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.299999999999997 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.532 ' OG1' HG11 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.230000000000004 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.430000000000007 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG11 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 63.240000000000002 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 72.329999999999998 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.439999999999998 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.239999999999995 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.439999999999998 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.450000000000003 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 70.120000000000005 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.526 HD11 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 74.219999999999999 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.329999999999998 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 72.209999999999994 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.349999999999994 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.509999999999998 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.439999999999998 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 75.299999999999997 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.219999999999999 110.506 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.219999999999999 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.409999999999997 112.375 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.129999999999995 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 HD12 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.400000000000006 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.109999999999999 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.240000000000002 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.040000000000006 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.120000000000005 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.340000000000003 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.240000000000002 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.099999999999994 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.329999999999998 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.420000000000002 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.409999999999997 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 111.299 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.409999999999997 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.040000000000006 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.010000000000005 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.040000000000006 111.504 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.033 0.444 . . . . 62.030000000000001 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.019999999999996 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.540000000000006 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.439999999999998 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 62.520000000000003 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 73.319999999999993 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 39.280000000000001 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.230000000000004 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.329999999999998 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.010000000000005 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.030000000000001 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.120000000000005 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.546 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.340000000000003 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.519999999999996 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 HD12 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 73.430000000000007 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.757 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.129999999999995 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 72.310000000000002 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.335 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.439999999999998 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.420000000000002 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.598 HD23 ' NE2' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 70.200000000000003 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.219999999999999 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 61.009999999999998 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.598 ' NE2' HD23 ' A' ' 37' ' ' LEU . 26.8 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.340000000000003 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.519999999999996 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.530000000000001 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.120000000000005 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.400000000000006 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.209999999999994 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.340000000000003 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.409999999999997 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.420000000000002 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.230000000000004 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.230000000000004 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB2' ' NZ ' ' A' ' 53' ' ' LYS . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.400000000000006 111.381 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.240000000000002 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.209999999999994 111.382 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.219999999999999 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.219999999999999 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.539999999999999 111.712 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 64.519999999999996 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 54.340000000000003 112.085 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 73.219999999999999 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.420000000000002 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 74.450000000000003 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.049999999999997 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.219999999999999 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' HD21 ' A' ' 15' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.049999999999997 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.120000000000005 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.099999999999994 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.519999999999996 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 63.409999999999997 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.439999999999998 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.140000000000001 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.510000000000005 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.319999999999993 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.450000000000003 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.349999999999994 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.310000000000002 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.140000000000001 112.021 -178.149 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.791 0.329 . . . . 73.400000000000006 111.683 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.230000000000004 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.310000000000002 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.219999999999999 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 71.0 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 73.329999999999998 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.400000000000006 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.329999999999998 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.219999999999999 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.319999999999993 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 74.510000000000005 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.519999999999996 112.182 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.310000000000002 112.624 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.445 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.219999999999999 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.229999999999997 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.209999999999994 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.109999999999999 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.019999999999996 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.530000000000001 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.310000000000002 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.430000000000007 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.450000000000003 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.140000000000001 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.340000000000003 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 23.1 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.200000000000003 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 55.130000000000003 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.409999999999997 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.340000000000003 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.319999999999993 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.456 HG22 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 65.450000000000003 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG11 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.040000000000006 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.130000000000003 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.420000000000002 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.100000000000001 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.520000000000003 111.902 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.340000000000003 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 80' ' ' LEU . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 74.120000000000005 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.319999999999993 111.957 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.119999999999997 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.310000000000002 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.340000000000003 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 110.991 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.310000000000002 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.954 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.120000000000005 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 74.230000000000004 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.513 ' HG ' HD12 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.310000000000002 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.229999999999997 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.140000000000001 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.319999999999993 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.200000000000003 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 72.430000000000007 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.539999999999999 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.140000000000001 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.420000000000002 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.299999999999997 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.506 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.239999999999995 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.129999999999995 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.450000000000003 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.120000000000005 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.329999999999998 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.329999999999998 111.172 179.622 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.796 0.332 . . . . 43.240000000000002 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.510000000000005 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.686 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.200000000000003 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 74.25 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.540000000000006 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.299999999999997 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.420000000000002 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.539999999999999 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.439999999999998 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.450000000000003 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 74.209999999999994 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.519999999999996 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 HD23 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.420000000000002 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.319999999999993 111.593 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.209999999999994 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.540000000000006 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.350000000000001 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.219999999999999 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.400000000000006 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.200000000000003 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.219999999999999 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.450000000000003 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.109999999999999 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.049999999999997 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.510000000000005 110.559 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.340000000000003 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 63.6 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.319999999999993 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.239999999999995 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.350000000000001 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.349999999999994 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.439999999999998 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.519999999999996 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.120000000000005 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.099999999999994 113.405 -176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.209999999999994 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.466 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.109999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HD2' ' SD ' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.420000000000002 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 72.200000000000003 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.519999999999996 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 73.530000000000001 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.299999999999997 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.329999999999998 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.340000000000003 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.319999999999993 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.109999999999999 110.921 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.019999999999996 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.040000000000006 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 63.43 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.409999999999997 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.439999999999998 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.209999999999994 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.299999999999997 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 76' ' ' ALA . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.040000000000006 111.233 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.420000000000002 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.109999999999999 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.210000000000001 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 71.409999999999997 111.707 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.140000000000001 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 74.450000000000003 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.559 ' SD ' ' HD2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB3' HG12 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.774 0.321 . . . . 71.030000000000001 111.676 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.349999999999994 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.329999999999998 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.310000000000002 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.329999999999998 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.340000000000003 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.439999999999998 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.200000000000003 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.539999999999999 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.049999999999997 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.019999999999996 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.420000000000002 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.450000000000003 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.329999999999998 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.230000000000004 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.319999999999993 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.340000000000003 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 63.399999999999999 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.539999999999999 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.340000000000003 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.510000000000005 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.420000000000002 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.549999999999997 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.439999999999998 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.430000000000007 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.120000000000005 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.439999999999998 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.409999999999997 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.340000000000003 112.393 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.439999999999998 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.019999999999996 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.430000000000007 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.310000000000002 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.540000000000006 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.099999999999994 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 74.109999999999999 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.310000000000002 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 63.109999999999999 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.530000000000001 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' HG3' HG21 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.119999999999997 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.129999999999995 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 74.099999999999994 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.150000000000006 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.239999999999995 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.329999999999998 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 62.340000000000003 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.010000000000005 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' N ' HD23 ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.319999999999993 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.239999999999995 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.439999999999998 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.239999999999995 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 71.310000000000002 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.219999999999999 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.340000000000003 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.200000000000003 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.129999999999995 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.530000000000001 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.239999999999995 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.109999999999999 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.530000000000001 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 73.010000000000005 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 HD12 HD21 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.319999999999993 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.409999999999997 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.140000000000001 110.824 179.08 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.24 0.543 . . . . 61.43 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.439999999999998 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.319999999999993 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.219999999999999 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.120000000000005 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.209999999999994 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.329999999999998 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.549999999999997 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.420000000000002 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.409999999999997 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.129999999999995 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.219999999999999 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.219999999999999 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.030000000000001 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.100000000000001 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.310000000000002 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 64.109999999999999 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 72.129999999999995 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.209999999999994 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.350000000000001 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.439999999999998 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 38' ' ' LYS . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 75.439999999999998 111.36 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.329999999999998 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.120000000000005 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.219999999999999 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.329999999999998 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.340000000000003 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.129999999999995 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.429 HG23 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.520000000000003 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 62.240000000000002 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.509999999999998 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 73.340000000000003 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.349999999999994 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.040000000000006 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.209999999999994 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.099999999999994 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 71.450000000000003 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.319999999999993 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.430000000000007 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.219999999999999 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.299999999999997 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.430000000000007 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 72.530000000000001 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.019999999999996 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.030000000000001 110.92 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.439999999999998 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 60.420000000000002 112.389 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.340000000000003 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.219999999999999 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.030000000000001 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.230000000000004 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.519999999999996 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.450000000000003 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.530000000000001 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 53.399999999999999 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.219999999999999 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.219999999999999 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.049999999999997 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.219999999999999 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.109999999999999 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.340000000000003 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.420000000000002 111.541 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.530000000000001 112.733 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.120000000000005 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.129999999999995 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.209999999999994 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.140000000000001 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.219999999999999 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.340000000000003 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 74.049999999999997 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.310000000000002 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.329999999999998 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.129999999999995 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.409999999999997 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.109999999999999 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.019999999999996 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.32 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG21 HD22 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 71.030000000000001 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 73.439999999999998 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.409999999999997 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 74.530000000000001 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 51.520000000000003 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.230000000000004 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 75.140000000000001 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.349999999999994 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.461 HD22 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.219999999999999 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.200000000000003 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 73.310000000000002 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.109999999999999 112.558 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.109999999999999 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.350000000000001 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.129999999999995 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 72.209999999999994 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.120000000000005 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.109999999999999 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 71.25 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.329999999999998 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.420000000000002 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.310000000000002 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 74.329999999999998 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.099999999999994 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.019999999999996 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.439999999999998 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.329999999999998 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.519999999999996 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.439999999999998 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 70.310000000000002 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 74.400000000000006 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.430000000000007 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.400000000000006 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.549999999999997 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.450000000000003 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.439999999999998 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.319999999999993 110.505 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.430000000000007 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.420000000000002 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 73.129999999999995 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.430000000000007 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.409999999999997 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.210000000000001 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.329999999999998 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.209999999999994 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.120000000000005 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.450000000000003 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.566 HD11 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.430000000000007 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.239999999999995 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.219999999999999 112.704 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.209999999999994 111.18 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HD23 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.129999999999995 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.230000000000004 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 71.409999999999997 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 75.120000000000005 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.150000000000006 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.494 ' HZ ' HG23 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 61.509999999999998 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.229999999999997 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.229999999999997 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.319999999999993 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 72.310000000000002 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.049999999999997 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 65.109999999999999 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.209999999999994 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 73.109999999999999 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.577 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 74.109999999999999 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.120000000000005 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.530000000000001 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 72.310000000000002 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.439999999999998 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.420000000000002 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.340000000000003 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.099999999999994 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 67' ' ' LEU . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.329999999999998 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.510000000000005 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.209999999999994 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.439999999999998 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.140000000000001 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.009999999999998 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.319999999999993 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.030000000000001 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.423 HG11 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 60.229999999999997 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.099999999999994 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.200000000000003 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.140000000000001 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.030000000000001 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.140000000000001 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.030000000000001 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.020000000000003 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.140000000000001 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.319999999999993 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.129999999999995 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.539999999999999 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.209999999999994 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.049999999999997 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.030000000000001 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.420000000000002 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 37' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 71.150000000000006 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.299999999999997 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.420000000000002 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.230000000000004 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.530000000000001 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.240000000000002 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.409999999999997 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 71.420000000000002 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.605 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.310000000000002 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.209999999999994 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.530000000000001 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 73.230000000000004 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.230000000000004 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.454 176.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 60.549999999999997 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.319999999999993 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 64.140000000000001 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.420000000000002 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.329999999999998 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.229999999999997 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.019999999999996 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.229999999999997 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.340000000000003 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.439999999999998 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.420000000000002 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.329999999999998 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.119999999999997 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.240000000000002 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.229999999999997 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 73.25 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.239999999999995 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 73.209999999999994 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.099999999999994 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.329999999999998 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.439999999999998 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.400000000000006 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.329999999999998 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.319999999999993 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.400000000000006 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.450000000000003 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.109999999999999 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.119999999999997 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.230000000000004 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.430000000000007 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 112.144 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 65.430000000000007 111.394 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.510000000000005 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.350000000000001 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 72.430000000000007 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.030000000000001 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.239999999999995 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.040000000000006 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 79' ' ' MET . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.040000000000006 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.340000000000003 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.219999999999999 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 74.049999999999997 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.510000000000005 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.239999999999995 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.450000000000003 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.230000000000004 112.252 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.140000000000001 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.310000000000002 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.219999999999999 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.310000000000002 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.430000000000007 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.299999999999997 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 72.409999999999997 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.450000000000003 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.409999999999997 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.340000000000003 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.109999999999999 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.349999999999994 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.130000000000003 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.559 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.019999999999996 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 HD21 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.519999999999996 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.239999999999995 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 54.109999999999999 111.645 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.969 0.414 . . . . 74.430000000000007 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 75.430000000000007 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 111.829 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.420000000000002 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.120000000000005 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 75.400000000000006 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 73.430000000000007 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.100000000000001 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.510000000000005 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.400000000000006 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.109999999999999 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.319999999999993 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.140000000000001 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.219999999999999 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.439999999999998 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.140000000000001 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.319999999999993 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.129999999999995 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.030000000000001 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.420000000000002 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.129999999999995 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.340000000000003 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.420000000000002 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.329999999999998 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.611 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.1 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.030000000000001 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.420000000000002 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.450000000000003 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.230000000000004 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.530000000000001 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 61.130000000000003 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.019999999999996 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.439999999999998 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.510000000000005 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.109999999999999 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 65.109999999999999 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.239999999999995 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.340000000000003 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.510000000000005 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.559 HD11 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.239999999999995 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.426 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.200000000000003 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.240000000000002 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.019999999999996 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 73.340000000000003 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 74.340000000000003 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.030000000000001 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.210000000000001 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.019999999999996 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.150000000000006 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.349999999999994 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.310000000000002 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.340000000000003 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.200000000000003 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.030000000000001 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 75.219999999999999 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.439999999999998 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 38.460000000000001 111.737 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.100000000000001 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.140000000000001 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.415 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 73.409999999999997 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.310000000000002 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.409999999999997 111.785 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.3 0.571 . . . . 51.310000000000002 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.319999999999993 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.200000000000003 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.299999999999997 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.319999999999993 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.299999999999997 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.319999999999993 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.099999999999994 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.439999999999998 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.109999999999999 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.420000000000002 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.130000000000003 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.329999999999998 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.510000000000005 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.430000000000007 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.329999999999998 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.85 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.200000000000003 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 74.530000000000001 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.340000000000003 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.209999999999994 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.430000000000007 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HZ2' ' HG2' ' A' ' 63' ' ' GLU . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.310000000000002 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.399999999999999 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.210000000000001 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.010000000000005 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.340000000000003 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.510000000000005 113.202 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.200000000000003 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 37.5 112.575 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.109999999999999 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.530000000000001 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.450000000000003 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.109999999999999 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.400000000000006 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.019999999999996 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.652 HD23 HD12 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.140000000000001 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.230000000000004 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.129999999999995 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.420000000000002 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.340000000000003 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.510000000000005 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.209999999999994 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.130000000000003 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.239999999999995 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.349999999999994 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 70.209999999999994 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.329999999999998 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.400000000000006 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.540000000000006 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.400000000000006 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.340000000000003 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.230000000000004 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.430000000000007 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.420000000000002 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.019999999999996 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.329999999999998 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 42.100000000000001 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.129999999999995 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.150000000000006 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.546 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.399999999999999 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.109999999999999 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.539999999999999 110.459 178.609 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.239999999999995 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.450000000000003 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.409999999999997 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.109999999999999 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.546 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 71.219999999999999 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.400000000000006 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 72.420000000000002 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 72.239999999999995 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.450000000000003 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.209999999999994 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.340000000000003 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 74.439999999999998 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 64.219999999999999 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 61.310000000000002 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.219999999999999 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.539999999999999 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 64.549999999999997 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.019999999999996 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.430000000000007 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.340000000000003 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.420000000000002 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.420000000000002 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.450000000000003 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.400000000000006 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.487 HD12 HD12 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.310000000000002 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.239999999999995 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.119999999999997 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.510000000000005 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.519999999999996 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.409999999999997 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.530000000000001 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.209999999999994 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.209999999999994 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.430000000000007 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.049999999999997 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 74.409999999999997 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.439999999999998 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 75.409999999999997 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.310000000000002 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.349999999999994 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.140000000000001 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.230000000000004 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.299999999999997 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.420000000000002 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.240000000000002 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.109999999999999 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG21 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.310000000000002 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 71.510000000000005 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.430000000000007 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 75.129999999999995 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.540000000000006 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.030000000000001 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD12 HD12 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.340000000000003 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.019999999999996 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.319999999999993 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.310000000000002 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.400000000000006 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.400000000000006 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.140000000000001 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.150000000000006 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.439999999999998 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.120000000000005 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.632 ' HZ1' ' HB2' ' A' ' 77' ' ' LYS . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.319999999999993 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.549999999999997 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.019999999999996 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.310000000000002 110.662 178.301 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.239999999999995 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 75.299999999999997 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.549999999999997 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.340000000000003 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.329999999999998 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.430000000000007 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.530000000000001 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 75.030000000000001 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.319999999999993 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.539999999999999 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.219999999999999 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 52.32 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.239999999999995 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.340000000000003 113.382 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.319999999999993 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.340000000000003 111.902 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.109999999999999 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.109999999999999 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.140000000000001 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 63.43 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.310000000000002 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HB ' HD11 ' A' ' 54' ' ' LEU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 75.420000000000002 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 70.530000000000001 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.420000000000002 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.340000000000003 111.711 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.230000000000004 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 54.420000000000002 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.329999999999998 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.420000000000002 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.239999999999995 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.040000000000006 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.040000000000006 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.319999999999993 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG21 ' HG3' ' A' ' 52' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.310000000000002 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.109999999999999 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.030000000000001 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.319999999999993 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.239999999999995 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.239999999999995 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.019999999999996 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.530000000000001 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 75.519999999999996 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.430000000000007 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.530000000000001 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.140000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.109999999999999 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 50.200000000000003 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 64.25 110.704 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.439999999999998 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.120000000000005 111.904 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.230000000000004 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.430000000000007 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.450000000000003 110.367 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.400000000000006 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.530000000000001 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.140000000000001 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 37.399999999999999 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 43.420000000000002 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.439999999999998 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.340000000000003 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.510000000000005 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 HD13 HD22 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.329999999999998 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.458 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.319999999999993 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD13 HD21 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.209999999999994 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.561 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.350000000000001 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.420000000000002 110.842 179.201 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.400000000000006 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 72.230000000000004 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.450000000000003 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.350000000000001 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.119999999999997 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.230000000000004 110.737 176.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 73.219999999999999 110.911 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.219999999999999 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.009999999999998 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.349999999999994 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.319999999999993 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.430000000000007 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.439999999999998 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.319999999999993 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 60.039999999999999 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 65.349999999999994 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.439999999999998 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.150000000000006 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 72.010000000000005 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.150000000000006 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.129999999999995 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.200000000000003 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 64.430000000000007 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.010000000000005 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.510000000000005 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.310000000000002 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.540000000000006 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.409999999999997 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.319999999999993 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.574 ' OG1' HG11 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.109999999999999 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.140000000000001 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.574 HG11 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.450000000000003 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 75.519999999999996 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 71.120000000000005 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.540000000000006 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.430000000000007 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.210000000000001 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.487 HD21 HD11 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.239999999999995 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.340000000000003 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.129999999999995 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.299999999999997 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.219999999999999 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.420000000000002 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.310000000000002 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 75.450000000000003 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.461 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.209999999999994 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.409999999999997 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.430000000000007 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.400000000000006 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.409999999999997 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.299999999999997 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.310000000000002 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 74.219999999999999 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.450000000000003 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.409999999999997 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.129999999999995 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.310000000000002 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.340000000000003 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.230000000000004 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.049999999999997 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD11 HD21 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 74.420000000000002 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.129999999999995 111.484 179.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.754 0.311 . . . . 75.209999999999994 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.54 90.14 0.29 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.238 -0.506 . . . . 63.310000000000002 112.946 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -63.57 127.23 30.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.603 -0.351 . . . . 73.349999999999994 111.15 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -73.96 95.15 2.44 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.94 0.4 . . . . 63.43 110.984 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -79.64 6.58 10.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.206 0.817 . . . . 73.329999999999998 113.206 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -63.12 -52.97 60.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.945 0.339 . . . . 72.019999999999996 111.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.94 68.4 2.01 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.07 0.462 . . . . 72.129999999999995 111.373 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -146.79 168.82 20.45 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.296 -0.411 . . . . 73.019999999999996 111.046 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t 56.97 16.9 3.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.327 0.492 . . . . 73.450000000000003 112.327 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.0 m170 -92.04 166.99 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.952 0.406 . . . . 73.349999999999994 111.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -155.47 172.75 17.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.9 0.381 . . . . 72.310000000000002 111.021 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p -91.38 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 62.310000000000002 111.564 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.150000000000006 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.399999999999999 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.540000000000006 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.209999999999994 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.310000000000002 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.409999999999997 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CZ ' HG22 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.319999999999993 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.210000000000001 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.150000000000006 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.239999999999995 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 74.120000000000005 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.200000000000003 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.439999999999998 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 111.602 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 64.519999999999996 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 74.129999999999995 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.450000000000003 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.540000000000006 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 63.340000000000003 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HB ' HD13 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.010000000000005 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.239999999999995 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 73.030000000000001 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.099999999999994 111.593 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.129999999999995 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.109999999999999 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.510000000000005 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.340000000000003 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.531 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.310000000000002 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.439999999999998 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG11 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.140000000000001 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 44.310000000000002 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.430000000000007 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.129999999999995 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.450000000000003 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.109999999999999 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.130000000000003 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.129999999999995 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.329999999999998 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 37.700000000000003 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.329999999999998 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 62.009999999999998 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.219999999999999 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.450000000000003 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 74.030000000000001 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.099999999999994 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.420000000000002 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.310000000000002 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.319999999999993 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.200000000000003 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.120000000000005 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.420000000000002 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 74.129999999999995 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.439999999999998 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.724 ' HZ1' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.450000000000003 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.319999999999993 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.319999999999993 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.535 HD13 HD21 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.420000000000002 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.544 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.540000000000006 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.98 -172.48 2.62 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.557 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -118.81 117.46 28.93 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.042 0.386 . . . . 65.430000000000007 112.042 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -93.76 -11.88 30.39 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.42 0.629 . . . . 72.230000000000004 110.324 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.758 -1.024 . . . . 71.239999999999995 113.115 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.683 0.277 . . . . 64.209999999999994 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.97 0.03 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.209 -0.52 . . . . 63.32 113.775 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -68.55 89.91 0.37 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.432 0.634 . . . . 64.349999999999994 112.048 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -96.69 140.11 31.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.053 -0.521 . . . . 71.129999999999995 111.341 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -121.92 154.3 37.33 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.09 0.471 . . . . 72.109999999999999 112.015 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -134.91 -170.23 2.52 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 110.25 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -77.72 -49.48 14.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.712 0.291 . . . . 74.140000000000001 110.419 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 65.64 -6.62 0.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.003 1.112 . . . . 74.230000000000004 114.003 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -89.97 -18.88 25.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.615 0.968 . . . . 71.430000000000007 113.615 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -58.47 -17.88 24.46 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.495 0.924 . . . . 63.539999999999999 113.495 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 t -62.74 143.1 57.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.963 0.411 . . . . 64.099999999999994 110.948 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p -86.2 123.16 31.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.329999999999998 112.179 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.310000000000002 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.530000000000001 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.299999999999997 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.019999999999996 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.299999999999997 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.329999999999998 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.229999999999997 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.340000000000003 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 72.239999999999995 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.409999999999997 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.120000000000005 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 74.530000000000001 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.230000000000004 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.230000000000004 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 54.399999999999999 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.120000000000005 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.129999999999995 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.040000000000006 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 74.519999999999996 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.439999999999998 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.129999999999995 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.510000000000005 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 74.049999999999997 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.430000000000007 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.9 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.130000000000003 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 74.439999999999998 112.303 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.140000000000001 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.130000000000003 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.329999999999998 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.040000000000006 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.520000000000003 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 72.120000000000005 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.129999999999995 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 75.129999999999995 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.140000000000001 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.140000000000001 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.229999999999997 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.549999999999997 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.439999999999998 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.120000000000005 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.510000000000005 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.299999999999997 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.439999999999998 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.430000000000007 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.109999999999999 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.530000000000001 111.835 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.129999999999995 111.036 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.420000000000002 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.150000000000006 111.911 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.340000000000003 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.420000000000002 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.109999999999999 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 70.109999999999999 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.430000000000007 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 73.049999999999997 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.549999999999997 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.240000000000002 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.030000000000001 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.219999999999999 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.329999999999998 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 63.329999999999998 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.510000000000005 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.230000000000004 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.310000000000002 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.409999999999997 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.53 144.73 36.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 64.200000000000003 111.4 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -96.18 146.19 24.89 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.947 0.404 . . . . 63.420000000000002 111.623 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -60.75 -25.09 66.22 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.549 0.574 . . . . 71.010000000000005 112.549 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 119.143 -0.809 . . . . 72.349999999999994 114.023 178.219 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.586 0.231 . . . . 72.5 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.52 37.8 58.1 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.167 -0.54 . . . . 53.229999999999997 113.849 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -138.9 110.12 6.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.142 0.471 . . . . 73.450000000000003 111.336 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -115.57 174.52 5.97 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.265 0.555 . . . . 72.310000000000002 112.126 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.15 114.79 19.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.108 -0.496 . . . . 75.340000000000003 110.404 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -89.49 16.99 6.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.512 0.56 . . . . 65.329999999999998 112.512 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -68.63 145.1 54.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.929 0.395 . . . . 74.040000000000006 110.745 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -149.1 124.8 10.46 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.568 0.581 . . . . 74.340000000000003 112.568 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.2 m -151.85 168.34 25.44 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.97 -0.559 . . . . 74.150000000000006 110.867 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -74.62 99.26 3.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 72.319999999999993 111.484 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -146.73 -172.83 4.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.088 -0.506 . . . . 53.340000000000003 110.697 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -92.36 151.48 20.25 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.100000000000001 111.881 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HD22 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.439999999999998 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.149999999999999 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.219999999999999 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HZ1' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.310000000000002 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.259 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.430000000000007 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.239999999999995 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.549999999999997 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.439999999999998 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.530000000000001 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.510000000000005 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.140000000000001 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.010000000000005 111.472 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.430000000000007 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.349999999999994 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.310000000000002 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.230000000000004 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.100000000000001 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.409999999999997 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.239999999999995 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.230000000000004 111.508 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 71.319999999999993 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.310000000000002 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.299999999999997 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.428 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.149999999999999 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 62.25 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.200000000000003 113.244 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.239999999999995 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.340000000000003 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.420000000000002 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.340000000000003 111.238 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.209999999999994 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.448 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.519999999999996 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.487 HD11 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.009999999999998 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.549999999999997 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.450000000000003 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.329999999999998 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.319999999999993 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.420000000000002 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.010000000000005 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 HD21 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.439999999999998 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.239999999999995 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.150000000000006 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 73.25 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.420000000000002 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.230000000000004 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.319999999999993 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.3 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.540000000000006 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.140000000000001 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.120000000000005 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.510000000000005 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.409999999999997 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.439999999999998 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.510000000000005 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.030000000000001 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.200000000000003 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.520000000000003 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.239999999999995 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.040000000000006 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.509 ' HB3' HG11 ' A' ' 47' ' ' VAL . . . -121.07 150.41 41.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 63.130000000000003 112.442 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -93.88 116.4 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.081 -0.509 . . . . 73.239999999999995 111.558 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -141.49 125.03 16.71 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.294 -0.412 . . . . 63.439999999999998 110.027 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.861 -0.966 . . . . 74.329999999999998 113.003 178.881 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.8 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.783 0.325 . . . . 73.329999999999998 111.281 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.99 114.59 3.34 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.348 -0.454 . . . . 42.409999999999997 112.548 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -64.85 92.02 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.348 0.594 . . . . 75.010000000000005 112.558 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -161.06 103.01 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.323 0.582 . . . . 75.439999999999998 111.108 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -83.57 149.41 26.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.287 0.565 . . . . 61.32 112.323 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.08 176.95 8.19 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.611 -0.722 . . . . 74.450000000000003 110.691 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -147.14 -176.71 5.32 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.139 -0.351 . . . . 74.010000000000005 111.722 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -67.32 165.78 15.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.23 0.538 . . . . 74.420000000000002 111.895 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -138.71 171.97 13.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.047 -0.524 . . . . 73.230000000000004 111.685 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -128.57 31.47 4.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.993 -0.549 . . . . 74.319999999999993 110.848 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.9 m -69.18 179.46 1.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.887 -0.597 . . . . 72.409999999999997 111.747 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p -86.55 150.31 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 75.150000000000006 111.79 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.230000000000004 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.745 ' HZ2' ' HB3' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD21 HG23 ' A' ' 28' ' ' VAL . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.299999999999997 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.219999999999999 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 64.319999999999993 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 73.239999999999995 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.400000000000006 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.549999999999997 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.340000000000003 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.340000000000003 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.239999999999995 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 54.340000000000003 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.420000000000002 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 51.119999999999997 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 72.519999999999996 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 HD21 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.340000000000003 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.530000000000001 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.430000000000007 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.299999999999997 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 75.230000000000004 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.329999999999998 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' HB ' HD13 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.209999999999994 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 HD23 ' NE2' ' A' ' 40' ' ' GLN . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.200000000000003 111.425 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.540000000000006 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.230000000000004 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' NE2' HD23 ' A' ' 37' ' ' LEU . 25.7 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 74.5 111.793 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.349999999999994 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.219999999999999 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.530000000000001 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.400000000000006 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.554 ' OG1' HG13 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.319999999999993 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.519999999999996 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.150000000000006 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 75.340000000000003 113.406 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.019999999999996 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.040000000000006 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.485 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 50.2 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.140000000000001 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.430000000000007 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.47 HD13 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.409999999999997 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.540000000000006 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 71.329999999999998 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.430000000000007 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.549999999999997 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.319999999999993 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 75.25 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.099999999999994 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.219999999999999 111.167 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 73.409999999999997 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.140000000000001 112.361 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.349999999999994 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.219999999999999 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 74.340000000000003 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.409999999999997 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.349999999999994 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.209999999999994 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.409999999999997 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.219999999999999 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.6 ' HB3' ' HZ2' ' A' ' 77' ' ' LYS . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.400000000000006 111.679 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.129999999999995 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.030000000000001 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.239999999999995 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.591 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.27 140.32 50.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.420000000000002 111.436 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -75.65 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.458 . . . . 72.239999999999995 111.119 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -66.24 0.92 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.062 0.458 . . . . 71.120000000000005 110.217 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.416 0 CA-C-O 118.699 -1.056 . . . . 73.310000000000002 113.088 -178.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.763 0.316 . . . . 74.150000000000006 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.39 -167.02 47.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.27 -0.491 . . . . 71.049999999999997 113.437 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -102.48 45.94 0.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.39 0.614 . . . . 75.329999999999998 111.114 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -67.61 -42.86 81.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.974 -0.557 . . . . 75.420000000000002 112.052 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.75 90.28 0.41 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.686 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -152.6 142.2 21.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.705 0.288 . . . . 74.519999999999996 111.321 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.52 -39.7 9.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.752 0.311 . . . . 75.010000000000005 111.451 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -110.74 113.89 26.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.011 0.434 . . . . 71.450000000000003 110.944 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -76.91 134.51 38.93 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.906 0.384 . . . . 60.109999999999999 111.576 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -130.12 157.28 42.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.391 -0.368 . . . . 74.219999999999999 111.456 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t 64.86 86.74 0.12 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.426 0.631 . . . . 74.209999999999994 111.189 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -118.21 154.11 32.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.007 -0.542 . . . . 73.200000000000003 112.147 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.540000000000006 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.150000000000006 112.065 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.010000000000005 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.230000000000004 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.219999999999999 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.606 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.540000000000006 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.040000000000006 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.409999999999997 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.439999999999998 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.450000000000003 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.549999999999997 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.049999999999997 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 63.240000000000002 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.540000000000006 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.129999999999995 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.149999999999999 111.817 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.489 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 74.209999999999994 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.109999999999999 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 72.209999999999994 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.409999999999997 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.349999999999994 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.129999999999995 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.510000000000005 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.513 HD22 ' NE2' ' A' ' 40' ' ' GLN . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 74.239999999999995 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HZ2' ' CD ' ' A' ' 63' ' ' GLU . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.140000000000001 110.576 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.120000000000005 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.513 ' NE2' HD22 ' A' ' 37' ' ' LEU . 24.4 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.430000000000007 111.751 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.340000000000003 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.129999999999995 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.299999999999997 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.200000000000003 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.450000000000003 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.229999999999997 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.329999999999998 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.349999999999994 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.310000000000002 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.140000000000001 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 38.560000000000002 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.109999999999999 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.120000000000005 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 74.019999999999996 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.230000000000004 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.510000000000005 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.040000000000006 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.239999999999995 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.420000000000002 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.409999999999997 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.530000000000001 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.109999999999999 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.040000000000006 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.140000000000001 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.240000000000002 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.430000000000007 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.709 HD13 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.340000000000003 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.319999999999993 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.439999999999998 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.209999999999994 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 54.539999999999999 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.520000000000003 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 72.120000000000005 111.526 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.310000000000002 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.009999999999998 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.430000000000007 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.209999999999994 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.349999999999994 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 63.520000000000003 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.519 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.219999999999999 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.95 159.88 15.11 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 112.25 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -89.73 14.02 12.84 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.188 -0.46 . . . . 63.340000000000003 111.353 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.45 154.24 50.83 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.637 0.375 . . . . 74.109999999999999 110.74 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 119.124 -0.82 . . . . 42.149999999999999 113.19 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.615 0.245 . . . . 70.439999999999998 111.378 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.87 -129.59 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.916 -0.659 . . . . 64.349999999999994 113.347 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -80.19 40.88 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.279 0.562 . . . . 62.409999999999997 111.204 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -85.78 88.95 7.63 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.872 -0.604 . . . . 71.349999999999994 110.734 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 70.67 -35.05 0.31 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.576 0.75 . . . . 74.439999999999998 112.835 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -57.13 99.07 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.039 0.447 . . . . 74.129999999999995 112.033 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -132.45 160.32 36.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.482 -0.326 . . . . 72.420000000000002 111.451 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -166.99 137.19 3.03 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.199 0.444 . . . . 63.0 112.199 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.5 m 65.49 17.95 11.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.668 0.988 . . . . 64.219999999999999 113.668 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -113.53 8.46 17.75 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.947 -0.471 . . . . 73.340000000000003 111.776 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 m -72.08 72.25 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.268 0.556 . . . . 64.209999999999994 110.149 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p -86.87 127.42 35.04 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 75.239999999999995 112.521 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 74.319999999999993 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.519999999999996 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 74.219999999999999 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.540000000000006 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.450000000000003 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.120000000000005 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.219999999999999 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.219999999999999 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.230000000000004 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.519999999999996 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.140000000000001 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 72.120000000000005 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 73.209999999999994 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.329999999999998 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.519999999999996 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 73.010000000000005 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.140000000000001 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.129999999999995 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.540000000000006 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.209999999999994 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.120000000000005 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.109999999999999 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.539999999999999 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.239999999999995 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 73.430000000000007 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 72.140000000000001 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 75.209999999999994 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.020000000000003 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.219999999999999 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.200000000000003 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.319999999999993 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.120000000000005 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.120000000000005 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.120000000000005 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.230000000000004 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 65.25 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 72.129999999999995 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.409999999999997 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.239999999999995 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.439999999999998 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.859 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.310000000000002 110.554 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 34' ' ' VAL . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 111.363 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.310000000000002 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.210000000000001 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.561 HD13 HD12 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.430000000000007 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.239999999999995 111.936 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 72.230000000000004 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.420000000000002 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.510000000000005 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.230000000000004 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.409999999999997 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.200000000000003 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.039999999999999 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.461 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.129999999999995 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.230000000000004 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.340000000000003 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.319999999999993 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.329999999999998 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.09 38.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.540000000000006 111.402 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -119.62 171.46 8.36 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.922 0.391 . . . . 64.019999999999996 111.53 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.87 111.97 24.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.007 0.432 . . . . 72.129999999999995 110.859 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.454 0 CA-C-O 118.855 -0.969 . . . . 62.149999999999999 113.372 178.692 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.89 0.376 . . . . 71.219999999999999 111.48 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.76 -131.22 10.5 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.215 -0.517 . . . . 41.420000000000002 112.844 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.27 113.3 18.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.375 0.607 . . . . 65.349999999999994 111.496 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.97 98.98 3.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.504 -0.771 . . . . 75.129999999999995 112.087 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -70.49 81.16 0.57 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.698 -0.683 . . . . 75.219999999999999 111.017 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -67.17 161.45 24.67 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.576 . . . . 74.129999999999995 111.927 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -78.02 156.27 30.21 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 111.447 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -101.62 -27.0 13.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.729 0.299 . . . . 70.120000000000005 111.472 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -57.48 117.76 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.569 -0.287 . . . . 75.140000000000001 111.714 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 61.33 24.92 14.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.752 0.421 . . . . 64.439999999999998 111.888 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 t -64.18 136.93 57.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.947 0.403 . . . . 54.350000000000001 111.209 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -123.63 138.18 54.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 74.040000000000006 112.02 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.010000000000005 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.099999999999994 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.129999999999995 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.099999999999994 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.239999999999995 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.120000000000005 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.409999999999997 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.340000000000003 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 61.450000000000003 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.109999999999999 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.329999999999998 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.420000000000002 112.694 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.319999999999993 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.450000000000003 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.209999999999994 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.140000000000001 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 53.229999999999997 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 54' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.049999999999997 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.430000000000007 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.530000000000001 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.657 HD12 HD22 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.530000000000001 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.450000000000003 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.040000000000006 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.219999999999999 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.009999999999998 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.409999999999997 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.030000000000001 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.299999999999997 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.532 ' OG1' HG11 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.230000000000004 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.430000000000007 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG11 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 63.240000000000002 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 72.329999999999998 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.439999999999998 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.239999999999995 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.439999999999998 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.450000000000003 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 70.120000000000005 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.526 HD11 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 74.219999999999999 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.329999999999998 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 72.209999999999994 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.349999999999994 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.509999999999998 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.439999999999998 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 75.299999999999997 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.219999999999999 110.506 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.219999999999999 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.409999999999997 112.375 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.129999999999995 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 HD12 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.400000000000006 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.109999999999999 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.240000000000002 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.040000000000006 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.120000000000005 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.340000000000003 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.240000000000002 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.099999999999994 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.329999999999998 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.420000000000002 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.409999999999997 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 111.299 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.409999999999997 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.040000000000006 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.010000000000005 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 47' ' ' VAL . . . -129.74 146.32 51.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.040000000000006 111.504 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p 54.33 19.68 2.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.433 0.693 . . . . 75.25 112.606 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.13 -178.66 5.68 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.066 0.46 . . . . 75.200000000000003 111.548 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.714 -1.048 . . . . 64.319999999999993 112.588 176.544 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.9 0.381 . . . . 63.340000000000003 111.397 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 74.99 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.3 -0.476 . . . . 55.240000000000002 112.841 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -64.41 -10.64 26.25 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.122 0.786 . . . . 73.430000000000007 113.122 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -86.61 106.55 17.65 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.199 -0.313 . . . . 74.439999999999998 110.66 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -99.48 111.51 23.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.883 0.373 . . . . 70.209999999999994 111.784 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -72.12 121.79 19.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.985 0.421 . . . . 75.010000000000005 112.015 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.69 136.22 21.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.883 0.473 . . . . 75.129999999999995 110.811 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -76.91 -45.8 26.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.846 0.355 . . . . 74.140000000000001 111.594 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -86.18 163.72 17.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.891 0.377 . . . . 75.5 111.745 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.9 m80 55.9 22.32 5.59 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 112.213 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -76.7 81.94 3.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.155 0.502 . . . . 74.150000000000006 111.261 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p -86.5 117.53 25.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.111 -0.495 . . . . 62.030000000000001 111.344 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.019999999999996 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.540000000000006 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.439999999999998 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 62.520000000000003 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 73.319999999999993 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 39.280000000000001 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.230000000000004 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.329999999999998 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.010000000000005 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.030000000000001 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.120000000000005 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.546 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.340000000000003 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.519999999999996 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 HD12 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 73.430000000000007 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.757 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.129999999999995 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 72.310000000000002 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.335 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.439999999999998 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.420000000000002 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.598 HD23 ' NE2' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 70.200000000000003 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.219999999999999 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 61.009999999999998 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.598 ' NE2' HD23 ' A' ' 37' ' ' LEU . 26.8 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.340000000000003 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.519999999999996 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.530000000000001 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.120000000000005 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.400000000000006 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.209999999999994 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.340000000000003 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.409999999999997 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.420000000000002 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.230000000000004 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.230000000000004 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB2' ' NZ ' ' A' ' 53' ' ' LYS . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.400000000000006 111.381 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.240000000000002 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.209999999999994 111.382 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.219999999999999 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.219999999999999 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.539999999999999 111.712 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 64.519999999999996 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 54.340000000000003 112.085 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 73.219999999999999 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.420000000000002 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 74.450000000000003 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.049999999999997 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.219999999999999 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' HD21 ' A' ' 15' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.049999999999997 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.120000000000005 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.099999999999994 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.519999999999996 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 63.409999999999997 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.439999999999998 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.140000000000001 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.510000000000005 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.319999999999993 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.450000000000003 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.349999999999994 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.310000000000002 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.11 146.7 51.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.140000000000001 112.021 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -99.91 134.05 43.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.994 -0.548 . . . . 72.510000000000005 111.268 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -74.96 -52.54 10.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.046 0.451 . . . . 72.420000000000002 111.295 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 CA-C-O 118.853 -0.97 . . . . 75.230000000000004 113.085 -178.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.637 0.256 . . . . 71.230000000000004 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.04 121.94 4.64 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.957 -0.639 . . . . 54.140000000000001 113.563 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -87.44 142.03 28.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.937 0.398 . . . . 75.239999999999995 111.057 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -129.62 116.44 18.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.969 0.414 . . . . 71.319999999999993 111.198 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -124.89 106.54 10.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.704 -0.48 . . . . 74.400000000000006 109.704 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -69.74 117.39 11.27 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.906 0.706 . . . . 75.450000000000003 112.906 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -92.16 108.37 19.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.8 -0.636 . . . . 73.319999999999993 111.284 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -74.42 135.18 42.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.503 -0.317 . . . . 63.43 111.034 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -174.07 175.05 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.145 0.498 . . . . 62.350000000000001 111.591 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -73.67 82.13 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.91 0.386 . . . . 71.0 110.671 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -105.37 169.16 8.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.864 0.364 . . . . 70.340000000000003 111.505 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -115.88 128.52 55.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.458 -0.337 . . . . 73.400000000000006 111.683 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.230000000000004 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.310000000000002 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.219999999999999 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 71.0 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 73.329999999999998 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.400000000000006 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.329999999999998 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.219999999999999 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.319999999999993 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 74.510000000000005 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.519999999999996 112.182 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.310000000000002 112.624 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.445 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.219999999999999 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.229999999999997 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.209999999999994 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.109999999999999 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.019999999999996 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.530000000000001 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.310000000000002 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.430000000000007 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.450000000000003 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.140000000000001 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.340000000000003 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 23.1 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.200000000000003 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 55.130000000000003 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.409999999999997 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.340000000000003 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.319999999999993 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.456 HG22 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 65.450000000000003 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG11 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.040000000000006 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.130000000000003 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.420000000000002 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.100000000000001 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.520000000000003 111.902 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.340000000000003 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 80' ' ' LEU . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 74.120000000000005 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.319999999999993 111.957 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.119999999999997 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.310000000000002 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.340000000000003 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 110.991 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.310000000000002 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.519999999999996 111.954 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.120000000000005 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 74.230000000000004 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.513 ' HG ' HD12 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.310000000000002 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.229999999999997 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.140000000000001 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.319999999999993 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.200000000000003 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 72.430000000000007 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.539999999999999 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.140000000000001 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.420000000000002 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.299999999999997 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.239999999999995 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.129999999999995 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.450000000000003 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.120000000000005 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.329999999999998 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.58 112.71 13.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.329999999999998 111.172 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.8 p -100.21 143.36 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.941 0.401 . . . . 42.420000000000002 112.061 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -75.37 -31.88 60.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.102 -0.499 . . . . 71.549999999999997 111.45 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.36 0 CA-C-O 118.975 -0.903 . . . . 65.239999999999995 113.457 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.596 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.629 0.252 . . . . 54.310000000000002 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.73 -80.86 0.36 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.928 -0.653 . . . . 54.439999999999998 113.679 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -106.73 3.25 26.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.474 0.546 . . . . 73.230000000000004 112.474 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 76.5 m-70 -85.03 77.23 10.15 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.289 0.566 . . . . 74.340000000000003 110.524 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -101.39 -38.24 8.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.9 -0.591 . . . . 74.420000000000002 111.48 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -93.05 -4.4 52.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.997 0.427 . . . . 74.230000000000004 110.665 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 4' ' ' HIS . 79.9 m-70 -135.82 140.4 44.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.44 -0.345 . . . . 75.239999999999995 110.662 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -99.01 130.83 45.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.978 0.362 . . . . 71.219999999999999 111.978 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -69.43 -172.34 0.45 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.641 -0.254 . . . . 75.209999999999994 110.803 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -65.26 128.97 38.01 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.119 -0.363 . . . . 73.319999999999993 111.364 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.5 t -58.18 103.96 0.18 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.067 0.461 . . . . 72.299999999999997 112.179 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p -137.35 121.21 17.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.24 -0.436 . . . . 43.240000000000002 111.348 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.510000000000005 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.686 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.200000000000003 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 74.25 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.540000000000006 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.299999999999997 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.420000000000002 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.539999999999999 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.439999999999998 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.450000000000003 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 74.209999999999994 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.519999999999996 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 HD23 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.420000000000002 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.319999999999993 111.593 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.209999999999994 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.540000000000006 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.350000000000001 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.219999999999999 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.400000000000006 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.200000000000003 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.219999999999999 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.450000000000003 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.109999999999999 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.049999999999997 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.510000000000005 110.559 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.340000000000003 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 63.6 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.319999999999993 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.239999999999995 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.350000000000001 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.349999999999994 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.439999999999998 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.519999999999996 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.120000000000005 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.099999999999994 113.405 -176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.209999999999994 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.466 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.109999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HD2' ' SD ' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.420000000000002 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 72.200000000000003 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.519999999999996 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 73.530000000000001 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.299999999999997 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.329999999999998 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.340000000000003 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.319999999999993 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.109999999999999 110.921 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.019999999999996 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.040000000000006 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 63.43 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.409999999999997 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.439999999999998 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.209999999999994 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.299999999999997 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 76' ' ' ALA . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.040000000000006 111.233 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.420000000000002 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.109999999999999 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.210000000000001 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 71.409999999999997 111.707 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.140000000000001 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 74.450000000000003 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.559 ' SD ' ' HD2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB3' HG12 ' A' ' 47' ' ' VAL . . . -145.96 117.08 7.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -76.94 130.22 37.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.411 -0.359 . . . . 74.420000000000002 111.35 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -73.54 91.73 1.85 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.999 0.428 . . . . 73.129999999999995 110.911 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.85 -0.972 . . . . 70.120000000000005 113.13 179.317 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' C ' ' SD ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 112.475 0.546 . . . . 73.530000000000001 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.25 177.98 19.63 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.834 -0.698 . . . . 72.319999999999993 113.688 -175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -141.74 106.91 4.97 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.544 0.337 . . . . 73.340000000000003 111.122 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -59.9 130.25 45.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.09 0.472 . . . . 71.540000000000006 111.561 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -71.79 108.72 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.156 -0.474 . . . . 74.239999999999995 111.85 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -84.21 103.86 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.064 0.459 . . . . 71.430000000000007 111.341 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -79.6 107.68 12.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.697 0.628 . . . . 71.299999999999997 112.697 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.95 145.52 46.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.391 -0.368 . . . . 72.040000000000006 110.601 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 t -144.36 -176.45 5.03 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.811 0.339 . . . . 74.519999999999996 111.312 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -106.61 -167.03 1.24 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.349 -0.387 . . . . 75.329999999999998 110.489 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 t -74.78 37.36 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.085 0.469 . . . . 74.019999999999996 111.746 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -116.28 126.5 53.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.128 -0.358 . . . . 71.030000000000001 111.676 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.349999999999994 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.329999999999998 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.310000000000002 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.329999999999998 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.340000000000003 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.439999999999998 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.200000000000003 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.539999999999999 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.049999999999997 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.019999999999996 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.420000000000002 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.450000000000003 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.329999999999998 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.230000000000004 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.319999999999993 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.340000000000003 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 63.399999999999999 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.539999999999999 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.340000000000003 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.510000000000005 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.420000000000002 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.549999999999997 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.439999999999998 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.430000000000007 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.120000000000005 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.439999999999998 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.409999999999997 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.340000000000003 112.393 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.439999999999998 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.019999999999996 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.430000000000007 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.310000000000002 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.540000000000006 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.099999999999994 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 74.109999999999999 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.310000000000002 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 63.109999999999999 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.530000000000001 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' HG3' HG21 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.119999999999997 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.129999999999995 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 74.099999999999994 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.150000000000006 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.239999999999995 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.329999999999998 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 62.340000000000003 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.010000000000005 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' N ' HD23 ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.319999999999993 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.239999999999995 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.439999999999998 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.239999999999995 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 71.310000000000002 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.219999999999999 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.340000000000003 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.200000000000003 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.129999999999995 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.530000000000001 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.239999999999995 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.109999999999999 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.530000000000001 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 73.010000000000005 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 HD12 HD21 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.319999999999993 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.409999999999997 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.99 151.1 50.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.140000000000001 110.824 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -71.37 -37.38 71.61 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.817 0.303 . . . . 73.230000000000004 111.817 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' OE1' HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -97.92 151.26 20.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.82 0.343 . . . . 75.430000000000007 111.103 176.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.325 0 CA-C-O 118.842 -0.976 . . . . 37.829999999999998 113.197 -177.666 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.786 0.327 . . . . 61.119999999999997 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.28 -122.8 1.46 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.912 -0.661 . . . . 45.229999999999997 113.199 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -140.25 120.09 13.48 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.361 -0.493 . . . . 72.230000000000004 111.651 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -121.53 107.17 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.782 0.325 . . . . 74.239999999999995 111.16 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -86.32 136.02 33.31 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.057 0.456 . . . . 71.319999999999993 111.52 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -83.13 23.61 0.85 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.259 0.552 . . . . 65.340000000000003 110.717 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -68.48 84.49 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.207 -0.451 . . . . 75.439999999999998 111.737 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -118.87 -16.31 9.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.139 0.495 . . . . 71.099999999999994 110.957 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -86.26 133.57 33.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.258 -0.428 . . . . 64.030000000000001 111.454 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -109.3 -49.15 3.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.416 -0.357 . . . . 75.010000000000005 111.213 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -142.46 27.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.19 0.441 . . . . 60.409999999999997 112.19 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p -97.96 142.48 29.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.791 -0.568 . . . . 61.43 111.981 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.439999999999998 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.319999999999993 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.219999999999999 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.120000000000005 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.209999999999994 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.329999999999998 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.549999999999997 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.420000000000002 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.409999999999997 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.129999999999995 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.712 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.219999999999999 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.219999999999999 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.030000000000001 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.100000000000001 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.310000000000002 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 64.109999999999999 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 72.129999999999995 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.209999999999994 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.350000000000001 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.439999999999998 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 38' ' ' LYS . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 75.439999999999998 111.36 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.329999999999998 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.120000000000005 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.219999999999999 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.329999999999998 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.340000000000003 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.129999999999995 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.429 HG23 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.520000000000003 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 62.240000000000002 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.509999999999998 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 73.340000000000003 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.349999999999994 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.040000000000006 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.209999999999994 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.099999999999994 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 71.450000000000003 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.319999999999993 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.430000000000007 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.219999999999999 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.299999999999997 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.430000000000007 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 72.530000000000001 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.019999999999996 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.030000000000001 110.92 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.439999999999998 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 60.420000000000002 112.389 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.340000000000003 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.219999999999999 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.030000000000001 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.230000000000004 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.519999999999996 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.450000000000003 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.530000000000001 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 53.399999999999999 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.219999999999999 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.219999999999999 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.049999999999997 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.219999999999999 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.109999999999999 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.340000000000003 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.29 167.48 17.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.420000000000002 111.541 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 m -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.481 -0.327 . . . . 72.340000000000003 111.548 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.68 -27.81 64.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.081 0.467 . . . . 60.229999999999997 111.235 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.924 -0.931 . . . . 64.319999999999993 113.013 178.838 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' A' ' 1' ' ' MET . 11.6 tmm? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.715 0.293 . . . . 74.340000000000003 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.44 168.68 35.39 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.216 -0.516 . . . . 36.390000000000001 112.677 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -70.48 78.07 0.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.161 0.505 . . . . 74.230000000000004 110.847 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -102.03 -14.47 17.13 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.239 -0.437 . . . . 73.340000000000003 111.836 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -75.62 126.58 31.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.714 0.292 . . . . 61.240000000000002 110.998 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -138.55 135.92 35.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.653 -0.249 . . . . 61.420000000000002 110.972 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -149.44 135.88 19.24 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.671 0.272 . . . . 70.5 111.67 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -147.06 151.99 37.8 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.611 0.243 . . . . 60.240000000000002 111.082 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.9 m -70.95 159.02 35.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.634 0.254 . . . . 70.510000000000005 110.909 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -149.43 157.17 43.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.998 0.428 . . . . 63.409999999999997 112.067 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -98.67 -32.91 11.16 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.115 0.483 . . . . 73.450000000000003 112.262 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p -92.19 113.61 25.93 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.530000000000001 112.733 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.120000000000005 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.129999999999995 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.209999999999994 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.140000000000001 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.219999999999999 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.340000000000003 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 74.049999999999997 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.310000000000002 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.329999999999998 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.129999999999995 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.409999999999997 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.109999999999999 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.019999999999996 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.32 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG21 HD22 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 71.030000000000001 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 73.439999999999998 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.409999999999997 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 74.530000000000001 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 51.520000000000003 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.230000000000004 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 75.140000000000001 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.349999999999994 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD22 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.219999999999999 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.200000000000003 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 73.310000000000002 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.109999999999999 112.558 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.109999999999999 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.350000000000001 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.129999999999995 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 72.209999999999994 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.120000000000005 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.109999999999999 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 71.25 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.329999999999998 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.420000000000002 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.310000000000002 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 74.329999999999998 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.099999999999994 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.019999999999996 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.439999999999998 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.329999999999998 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.519999999999996 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.439999999999998 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 70.310000000000002 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 74.400000000000006 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.430000000000007 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.400000000000006 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.549999999999997 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.450000000000003 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.439999999999998 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.319999999999993 110.505 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.430000000000007 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.420000000000002 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 73.129999999999995 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.430000000000007 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.409999999999997 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.210000000000001 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.329999999999998 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.209999999999994 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.120000000000005 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.450000000000003 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.566 HD11 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.430000000000007 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.239999999999995 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . -93.17 139.93 30.06 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.219999999999999 112.704 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -164.75 102.26 0.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.776 -0.647 . . . . 75.129999999999995 110.523 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -72.98 91.15 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.927 0.394 . . . . 73.319999999999993 111.774 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.264 0 CA-C-O 118.783 -1.009 . . . . 53.450000000000003 113.225 174.541 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HE1' ' HA ' ' A' ' 40' ' ' GLN . 21.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.361 0.124 . . . . 75.310000000000002 110.803 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.11 155.3 18.97 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.119 -1.038 . . . . 62.240000000000002 114.236 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -63.8 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.053 0.541 . . . . 73.049999999999997 111.763 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -52.86 117.55 3.03 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.978 -0.451 . . . . 75.030000000000001 110.765 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -79.39 121.72 25.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 111.739 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -89.64 133.71 34.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.46 0.647 . . . . 74.219999999999999 111.791 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -84.85 88.41 7.41 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.634 -0.712 . . . . 72.329999999999998 111.759 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -129.0 95.51 4.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.129 0.418 . . . . 65.310000000000002 112.129 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m 48.83 24.67 0.87 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.586 0.587 . . . . 50.329999999999998 112.586 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -106.06 127.22 53.03 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 111.545 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -122.49 -172.52 2.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.46 -0.336 . . . . 63.119999999999997 110.726 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -116.34 144.22 44.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.209999999999994 111.18 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.428 HD11 HD23 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.129999999999995 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.230000000000004 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 71.409999999999997 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 75.120000000000005 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.150000000000006 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' HZ ' HG23 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 61.509999999999998 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.229999999999997 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.229999999999997 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.319999999999993 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 72.310000000000002 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.049999999999997 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 65.109999999999999 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.209999999999994 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 73.109999999999999 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.577 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 74.109999999999999 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.120000000000005 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.530000000000001 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 72.310000000000002 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.439999999999998 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.420000000000002 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.340000000000003 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.099999999999994 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 67' ' ' LEU . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.329999999999998 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.533 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 26.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.510000000000005 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.209999999999994 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.439999999999998 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.140000000000001 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.009999999999998 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.319999999999993 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.030000000000001 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.423 HG11 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 60.229999999999997 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.099999999999994 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.200000000000003 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.140000000000001 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.030000000000001 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.140000000000001 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.030000000000001 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.020000000000003 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.140000000000001 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.319999999999993 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.129999999999995 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.539999999999999 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.209999999999994 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.049999999999997 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.030000000000001 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.420000000000002 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 37' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 71.150000000000006 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.299999999999997 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.420000000000002 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.230000000000004 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.530000000000001 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.240000000000002 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.409999999999997 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 71.420000000000002 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.605 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.310000000000002 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.209999999999994 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.530000000000001 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 73.230000000000004 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.230000000000004 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -115.21 106.2 13.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.454 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -141.01 168.02 20.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.894 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.76 -9.65 22.76 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.052 -0.522 . . . . 40.200000000000003 111.503 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.813 -0.993 . . . . 35.049999999999997 113.112 -178.834 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.615 0.245 . . . . 60.43 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.5 112.09 2.41 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.399 -0.429 . . . . 72.430000000000007 113.713 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -69.64 122.67 19.57 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.518 -0.401 . . . . 74.109999999999999 111.263 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -105.35 179.3 4.31 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.798 0.332 . . . . 73.439999999999998 111.33 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -131.2 134.96 46.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.212 0.53 . . . . 72.129999999999995 111.6 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -77.94 137.45 38.34 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 112.118 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -161.4 156.74 24.16 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.07 -0.514 . . . . 74.319999999999993 110.768 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -62.62 136.96 58.14 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.688 0.28 . . . . 74.409999999999997 110.947 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -116.67 101.48 8.62 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.826 0.346 . . . . 74.200000000000003 111.238 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -73.41 94.67 2.1 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.086 0.469 . . . . 75.439999999999998 111.684 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 p -139.52 -176.67 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.96 0.409 . . . . 73.5 111.329 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p -87.54 127.08 35.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 60.549999999999997 111.835 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.319999999999993 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 64.140000000000001 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.420000000000002 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.329999999999998 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.229999999999997 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.019999999999996 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.229999999999997 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.340000000000003 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.439999999999998 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.420000000000002 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.329999999999998 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.119999999999997 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.240000000000002 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.229999999999997 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 73.25 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.239999999999995 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 73.209999999999994 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.099999999999994 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.329999999999998 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.439999999999998 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.400000000000006 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.329999999999998 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.319999999999993 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.400000000000006 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.450000000000003 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.109999999999999 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.119999999999997 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.230000000000004 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.430000000000007 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 112.144 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 65.430000000000007 111.394 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.510000000000005 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.350000000000001 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 72.430000000000007 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.030000000000001 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.239999999999995 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.040000000000006 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 79' ' ' MET . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.040000000000006 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.340000000000003 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.219999999999999 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 74.049999999999997 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.510000000000005 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.239999999999995 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.450000000000003 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.230000000000004 112.252 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.140000000000001 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.310000000000002 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.219999999999999 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.310000000000002 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.430000000000007 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.299999999999997 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 72.409999999999997 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.450000000000003 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.409999999999997 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.340000000000003 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.109999999999999 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.349999999999994 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.130000000000003 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.559 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.019999999999996 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 HD21 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.519999999999996 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.239999999999995 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.71 174.2 12.42 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 54.109999999999999 111.645 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -114.3 162.94 15.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.267 -0.424 . . . . 71.340000000000003 111.424 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 67.22 16.09 10.12 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.334 0.494 . . . . 65.109999999999999 112.334 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.371 0 CA-C-O 118.895 -0.947 . . . . 72.219999999999999 113.004 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.784 0.326 . . . . 70.340000000000003 111.555 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.48 -162.1 31.31 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.322 -0.399 . . . . 38.460000000000001 112.46 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -137.07 109.92 7.62 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.346 0.593 . . . . 70.129999999999995 110.794 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -70.37 -33.48 71.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 111.608 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -85.82 165.09 17.13 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.863 0.363 . . . . 74.5 111.338 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.92 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.989 0.737 . . . . 73.019999999999996 112.989 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.61 ' NE2' ' HB2' ' A' ' 9' ' ' SER . 83.1 t60 -56.7 109.33 0.61 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.122 -0.944 . . . . 74.230000000000004 110.751 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -59.79 -37.47 79.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.478 . . . . 74.450000000000003 112.292 -173.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.61 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 50.7 m -64.02 133.91 54.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.612 -0.514 . . . . 74.129999999999995 109.612 173.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -52.69 140.09 24.46 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.357 0.873 . . . . 71.310000000000002 113.357 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -111.57 -168.07 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.825 -0.625 . . . . 71.349999999999994 111.571 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p -106.44 163.13 13.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.058 -0.519 . . . . 74.430000000000007 111.154 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 75.430000000000007 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 111.829 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.420000000000002 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.120000000000005 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 75.400000000000006 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 73.430000000000007 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.100000000000001 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.510000000000005 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.400000000000006 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.109999999999999 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.319999999999993 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.140000000000001 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.219999999999999 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.439999999999998 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.140000000000001 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.319999999999993 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.129999999999995 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.030000000000001 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.420000000000002 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.129999999999995 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.340000000000003 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.420000000000002 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.329999999999998 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.611 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.1 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.030000000000001 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.420000000000002 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.450000000000003 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.230000000000004 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.530000000000001 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 61.130000000000003 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.019999999999996 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.439999999999998 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.510000000000005 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.109999999999999 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 65.109999999999999 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.239999999999995 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.340000000000003 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.510000000000005 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.559 HD11 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.239999999999995 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.426 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.200000000000003 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.240000000000002 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.019999999999996 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 73.340000000000003 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 74.340000000000003 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.030000000000001 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.210000000000001 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.019999999999996 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.150000000000006 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.349999999999994 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.310000000000002 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.340000000000003 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.200000000000003 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.030000000000001 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 75.219999999999999 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.439999999999998 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 38.460000000000001 111.737 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.100000000000001 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.140000000000001 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.415 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 73.409999999999997 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.310000000000002 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 47' ' ' VAL . . . -97.45 96.32 8.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.409999999999997 111.785 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.4 m -115.47 119.95 37.9 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.388 -0.369 . . . . 74.120000000000005 111.109 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -80.0 -73.93 0.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.417 0.525 . . . . 73.239999999999995 112.417 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.782 -1.01 . . . . 55.329999999999998 114.185 -175.386 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.58 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.809 0.337 . . . . 37.5 111.098 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.56 -26.58 14.97 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 114.736 0.654 . . . . 37.5 114.736 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.05 45.53 0.84 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.672 0.736 . . . . 73.25 112.44 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.45 154.26 50.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.662 0.268 . . . . 74.420000000000002 111.226 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 53.76 81.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.129 0.572 . . . . 72.209999999999994 112.535 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -73.48 -29.23 62.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.262 0.553 . . . . 74.109999999999999 110.326 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -116.83 93.76 4.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 74.409999999999997 110.776 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -78.06 123.23 26.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 110.218 -0.29 . . . . 74.239999999999995 110.218 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -68.09 136.27 53.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.458 0.647 . . . . 73.0 112.74 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -160.03 20.54 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.319 -0.855 . . . . 75.099999999999994 109.576 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -88.45 -174.71 4.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.566 -0.743 . . . . 74.049999999999997 112.604 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -92.58 175.41 6.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.807 -0.633 . . . . 51.310000000000002 112.297 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.319999999999993 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.200000000000003 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.299999999999997 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.319999999999993 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.299999999999997 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.319999999999993 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.099999999999994 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.439999999999998 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.109999999999999 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.420000000000002 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.130000000000003 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.329999999999998 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.510000000000005 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.430000000000007 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.329999999999998 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.85 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.200000000000003 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 74.530000000000001 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.340000000000003 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.209999999999994 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.430000000000007 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HZ2' ' HG2' ' A' ' 63' ' ' GLU . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.310000000000002 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.399999999999999 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.210000000000001 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.010000000000005 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.340000000000003 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.510000000000005 113.202 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.200000000000003 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 37.5 112.575 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.109999999999999 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.530000000000001 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.450000000000003 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.109999999999999 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.400000000000006 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.019999999999996 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.652 HD23 HD12 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.140000000000001 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.230000000000004 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.129999999999995 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.420000000000002 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.340000000000003 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.510000000000005 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.209999999999994 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.130000000000003 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.239999999999995 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.349999999999994 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 70.209999999999994 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.329999999999998 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.400000000000006 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.540000000000006 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.400000000000006 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.340000000000003 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.230000000000004 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.430000000000007 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.420000000000002 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.019999999999996 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.329999999999998 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 42.100000000000001 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.129999999999995 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.150000000000006 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.546 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.399999999999999 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.109999999999999 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.87 140.0 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.539999999999999 110.459 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -87.71 -66.1 0.95 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.982 0.42 . . . . 73.239999999999995 112.053 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 115.87 15.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.224 -0.444 . . . . 64.349999999999994 111.006 -178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 119.195 -0.78 . . . . 37.5 113.105 177.744 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.775 0.321 . . . . 65.450000000000003 110.992 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.76 87.15 0.5 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.027 -0.606 . . . . 42.119999999999997 113.539 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -73.0 80.26 1.19 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.374 0.607 . . . . 74.209999999999994 110.195 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -52.83 145.41 12.54 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.399 -0.819 . . . . 74.439999999999998 113.014 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.99 150.05 28.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 60.149999999999999 111.845 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -100.46 -22.83 14.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.008 0.432 . . . . 74.010000000000005 110.884 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -166.63 168.73 14.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.477 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -80.33 134.45 36.06 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.23 -0.294 . . . . 63.439999999999998 110.462 173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -108.01 176.36 5.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.001 0.429 . . . . 71.310000000000002 111.379 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.95 122.8 39.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.437 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -72.92 103.19 3.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.808 -0.441 . . . . 65.420000000000002 109.808 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p -115.66 142.9 46.12 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.239999999999995 112.501 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.450000000000003 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.409999999999997 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.109999999999999 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.546 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 71.219999999999999 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.400000000000006 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 72.420000000000002 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 72.239999999999995 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.450000000000003 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.209999999999994 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.340000000000003 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 74.439999999999998 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 64.219999999999999 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 61.310000000000002 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.219999999999999 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.539999999999999 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 64.549999999999997 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.019999999999996 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.430000000000007 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.340000000000003 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.420000000000002 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.420000000000002 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.450000000000003 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.400000000000006 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.487 HD12 HD12 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.310000000000002 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.239999999999995 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.119999999999997 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.510000000000005 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.519999999999996 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.409999999999997 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.530000000000001 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.209999999999994 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.209999999999994 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.430000000000007 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.049999999999997 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 74.409999999999997 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.439999999999998 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 75.409999999999997 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.310000000000002 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.349999999999994 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.140000000000001 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.230000000000004 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.299999999999997 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.420000000000002 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.240000000000002 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.109999999999999 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG21 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.310000000000002 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 71.510000000000005 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.430000000000007 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 75.129999999999995 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.540000000000006 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.030000000000001 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD12 HD12 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.340000000000003 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.019999999999996 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.319999999999993 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.310000000000002 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.400000000000006 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.400000000000006 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.140000000000001 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.150000000000006 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.439999999999998 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.120000000000005 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.632 ' HZ1' ' HB2' ' A' ' 77' ' ' LYS . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.319999999999993 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.549999999999997 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.019999999999996 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.11 51.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.310000000000002 110.662 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -156.71 169.26 25.12 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.972 0.415 . . . . 72.310000000000002 111.506 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.4 -44.66 51.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.996 0.427 . . . . 72.230000000000004 111.118 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.259 0 CA-C-O 118.94 -0.922 . . . . 61.350000000000001 113.002 -179.347 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.736 0.303 . . . . 72.040000000000006 111.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.78 153.68 25.03 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.738 -0.545 . . . . 72.329999999999998 111.738 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -78.96 52.47 1.26 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 117.473 0.637 . . . . 72.430000000000007 112.718 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t60 70.36 -32.23 0.23 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.654 1.353 . . . . 74.239999999999995 114.654 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.99 122.14 12.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.816 0.672 . . . . 73.430000000000007 112.816 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -66.17 134.87 53.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.793 -0.64 . . . . 74.439999999999998 110.926 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -135.23 155.38 50.76 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.112 -0.367 . . . . 73.329999999999998 111.29 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -68.92 142.18 54.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.749 -0.205 . . . . 72.030000000000001 110.853 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -168.16 167.51 12.3 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.294 0.569 . . . . 52.210000000000001 112.236 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -111.78 8.22 20.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.742 -0.663 . . . . 73.329999999999998 110.822 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 m -56.62 155.7 7.16 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 75.400000000000006 112.699 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p -87.18 126.14 34.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.239999999999995 111.039 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 75.299999999999997 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.549999999999997 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.340000000000003 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.329999999999998 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.430000000000007 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.530000000000001 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 75.030000000000001 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.319999999999993 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.539999999999999 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.219999999999999 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 52.32 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.239999999999995 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.340000000000003 113.382 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.319999999999993 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.340000000000003 111.902 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.109999999999999 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.109999999999999 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.140000000000001 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 63.43 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.310000000000002 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HB ' HD11 ' A' ' 54' ' ' LEU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 75.420000000000002 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 70.530000000000001 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.420000000000002 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.340000000000003 111.711 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.230000000000004 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 54.420000000000002 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.329999999999998 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.420000000000002 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.239999999999995 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.040000000000006 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.040000000000006 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.319999999999993 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.310000000000002 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.109999999999999 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.030000000000001 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.319999999999993 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.239999999999995 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.239999999999995 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.019999999999996 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.530000000000001 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 75.519999999999996 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.430000000000007 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.530000000000001 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.140000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.109999999999999 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 50.200000000000003 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 64.25 110.704 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.439999999999998 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.120000000000005 111.904 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.230000000000004 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.430000000000007 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.450000000000003 110.367 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.400000000000006 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.530000000000001 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.140000000000001 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 37.399999999999999 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 43.420000000000002 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.439999999999998 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.340000000000003 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.510000000000005 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 HD13 HD22 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.329999999999998 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.458 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.319999999999993 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD13 HD21 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.209999999999994 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.561 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.350000000000001 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.49 132.38 17.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.420000000000002 110.842 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.5 p -80.02 30.33 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.245 0.461 . . . . 71.120000000000005 112.245 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.476 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 13.7 mm100 -99.53 -163.38 1.03 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.669 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.767 -1.018 . . . . 51.109999999999999 112.646 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' ' N ' ' A' ' 2' ' ' GLY . 21.1 ttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 110.677 -0.12 . . . . 71.109999999999999 110.677 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . 140.22 -144.17 14.57 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.599 -0.81 . . . . 73.140000000000001 113.628 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -98.84 -174.74 2.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.788 0.435 . . . . 64.200000000000003 109.898 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -55.83 147.61 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.011 -0.676 . . . . 74.120000000000005 109.862 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 67.21 38.82 3.24 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.919 0.866 . . . . 72.120000000000005 108.955 -165.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -52.27 156.19 1.77 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.94 -1.027 . . . . 64.319999999999993 112.58 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -149.54 159.1 44.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 74.420000000000002 111.119 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -92.31 137.56 32.26 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.46 -0.336 . . . . 74.040000000000006 110.775 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -64.31 94.6 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.212 0.529 . . . . 74.010000000000005 111.702 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -117.56 155.91 28.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.609 -0.723 . . . . 73.329999999999998 109.809 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.8 t -53.67 102.48 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.002 0.429 . . . . 64.319999999999993 111.751 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p -117.39 114.54 23.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.400000000000006 110.987 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 72.230000000000004 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.450000000000003 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.350000000000001 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.119999999999997 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.230000000000004 110.737 176.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' HZ ' ' HB2' ' A' ' 84' ' ' GLN . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 73.219999999999999 110.911 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.219999999999999 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.009999999999998 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.349999999999994 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.319999999999993 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.430000000000007 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.439999999999998 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.319999999999993 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 60.039999999999999 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 65.349999999999994 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.439999999999998 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.150000000000006 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 72.010000000000005 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.150000000000006 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.129999999999995 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.200000000000003 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 64.430000000000007 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.010000000000005 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.510000000000005 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.310000000000002 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.540000000000006 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.409999999999997 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.319999999999993 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.574 ' OG1' HG11 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.109999999999999 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.140000000000001 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.574 HG11 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.450000000000003 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 75.519999999999996 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 71.120000000000005 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.540000000000006 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.430000000000007 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.210000000000001 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.487 HD21 HD11 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.239999999999995 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.340000000000003 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.129999999999995 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.299999999999997 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.219999999999999 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.420000000000002 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.310000000000002 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 75.450000000000003 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.461 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.209999999999994 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.409999999999997 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.430000000000007 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.400000000000006 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.409999999999997 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.299999999999997 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.310000000000002 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 74.219999999999999 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.450000000000003 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.409999999999997 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.129999999999995 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.310000000000002 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.340000000000003 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.230000000000004 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.049999999999997 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD11 HD21 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 74.420000000000002 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.04 -177.54 5.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.129999999999995 111.484 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -92.11 16.86 10.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.888 0.375 . . . . 74.200000000000003 111.998 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 19' ' ' PHE . 81.5 mm-40 -128.54 164.25 23.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.797 0.332 . . . . 71.349999999999994 111.562 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.422 0 CA-C-O 118.909 -0.939 . . . . 65.430000000000007 113.414 179.746 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.951 0.405 . . . . 62.31 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.15 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.4 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.54 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.21 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.31 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.41 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.32 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.21 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.15 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.24 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 72.41 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.2 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.44 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.33 111.602 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 62.03 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 71.14 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.45 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.54 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.42 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 62.4 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.01 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.24 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.21 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 71.14 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 93.5 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.1 111.593 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.13 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.11 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.51 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.34 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.544 HG21 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.31 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.14 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.14 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 35.24 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.43 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.12 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.45 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.11 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.12 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD23 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.13 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.13 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.33 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.24 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 31.14 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.33 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 61.11 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.22 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.45 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 65.43 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.1 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.42 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 44.0 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.31 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.32 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.31 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.2 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.12 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.42 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 73.23 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.42 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.44 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' NZ ' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.45 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.32 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.32 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.54 HD13 HD23 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.42 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.54 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 43.02 111.557 -176.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.33 112.179 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.31 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.3 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.02 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.3 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.33 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 63.13 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.23 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.34 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 71.13 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.41 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.12 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 73.41 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.23 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.23 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 33.21 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.12 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.13 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.04 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 73.44 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.44 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.13 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.51 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 70.51 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.43 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 98.5 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.13 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.403 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 43.11 112.303 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.14 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.13 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.33 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.52 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 65.14 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.13 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 51.2 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.14 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.14 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.23 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.55 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.44 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.12 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.51 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.3 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.44 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.11 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.11 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.53 111.835 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 64' ' ' THR . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.13 111.036 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.42 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 62' ' ' VAL . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.15 111.911 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.34 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.42 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.11 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 61.2 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.43 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 71.15 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.55 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.24 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.03 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.22 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.33 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 62.43 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.51 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.23 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.31 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.41 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 55.25 111.4 -178.393 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.1 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.498 HG13 HD21 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.44 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.15 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.22 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.31 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 45' ' ' THR . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.259 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.43 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.24 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.55 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.44 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.53 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.35 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.14 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 15' ' ' LEU . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.01 111.472 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.43 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.35 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.31 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.23 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.1 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.41 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.11 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.24 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.23 111.508 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 52.25 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.31 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.3 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.15 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 60.22 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 19' ' ' PHE . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.2 113.244 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.34 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.42 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 50' ' ' ARG . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.34 111.238 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.21 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' HD11 ' A' ' 80' ' ' LEU . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.12 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.52 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.01 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.55 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.45 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.33 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.32 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.42 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.01 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.44 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.24 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.15 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 43.54 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 71.45 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.23 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.2 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 28.6 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.54 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.14 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.12 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.51 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.41 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.44 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.21 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.51 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.03 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.2 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.52 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.24 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.04 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 62.13 112.442 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 74.13 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.23 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.3 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.15 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 54.51 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 71.12 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.4 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.55 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.34 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.34 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.24 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 52.43 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.42 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 40.12 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 61.44 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.34 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.53 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.43 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.3 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 71.21 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.33 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.21 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.32 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.2 111.425 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.54 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 65.22 111.793 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.35 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.417 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.22 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.53 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.4 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.565 ' OG1' HG12 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.32 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.52 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG12 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.15 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 74.55 113.406 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.02 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.04 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.494 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 51.5 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.14 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.43 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.41 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.54 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 70.35 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.43 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.55 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.32 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 51.11 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.1 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.22 111.167 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 71.01 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.14 112.361 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.35 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.22 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 70.31 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.41 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.35 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.21 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.41 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.43 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.22 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.4 111.679 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.13 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.03 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.24 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.541 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.42 111.436 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.027 0.441 . . . . 73.2 112.147 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.54 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 74' ' ' SER . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.15 112.065 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.01 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.23 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.22 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.54 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CE1' HG21 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.04 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.41 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.44 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.45 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.55 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.05 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 51.31 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.54 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.13 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.15 111.817 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 62.2 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 72.34 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.11 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 55.12 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.41 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.35 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.13 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.51 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 73.44 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.14 110.576 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.12 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.43 111.751 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.34 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.13 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.25 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.2 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.45 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.23 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.33 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.35 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.31 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.14 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 23.13 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.11 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.12 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 63.53 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.23 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.51 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.04 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.24 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.42 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.41 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.53 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.11 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.04 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.14 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.24 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.13 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.34 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.32 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.21 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 43.45 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.52 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 71.42 111.526 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.31 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.01 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.43 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.35 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 62.24 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.22 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 62.44 112.25 -175.642 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 71.51 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 62.52 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.52 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 73.41 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.54 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.45 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.12 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.22 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.22 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.23 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.13 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.52 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.14 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 71.54 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 72.34 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.33 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.52 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 64.41 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.14 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.43 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.13 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.54 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.21 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.12 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.11 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.43 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.54 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.24 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 72.03 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.419 ' OG1' HG12 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 62.34 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 70.12 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG12 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.02 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.22 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.2 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.32 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.12 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.12 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.12 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.23 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 62.13 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 65.03 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.41 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.24 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.44 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.21 111.859 -176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 64' ' ' THR . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.31 110.554 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.44 ' H ' HG12 ' A' ' 62' ' ' VAL . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.43 111.363 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.31 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.21 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 62.52 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.43 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 66' ' ' THR . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.24 111.936 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 64.42 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.42 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.51 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.23 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.41 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.2 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.04 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.13 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.23 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.34 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.632 HD13 HD23 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.32 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.33 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.54 111.402 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 62.04 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.01 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.1 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.13 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.1 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.24 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.12 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.41 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.34 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 55.32 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.11 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.33 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.42 112.694 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.32 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.45 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.21 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.14 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 43.41 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.52 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 61' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.05 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.43 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.53 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.53 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.45 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.04 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.22 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.01 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.41 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.03 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.3 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.23 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.43 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 51.1 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 54.31 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.44 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.24 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.44 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.45 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 64.15 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 63.15 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.33 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 64.1 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.35 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.51 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 61' ' ' LEU . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.44 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 72.4 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 64' ' ' THR . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.22 110.506 174.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.22 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 62' ' ' VAL . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.41 112.375 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 64.23 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.13 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.4 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.11 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.24 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.04 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.34 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.24 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.1 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.33 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.42 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.41 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 15' ' ' LEU . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.13 111.299 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.41 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.04 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.01 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.04 111.504 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.033 0.444 . . . . 62.03 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.41 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.24 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.02 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.54 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 52.34 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 70.24 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 33.11 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.23 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.33 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.01 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.03 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.12 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.34 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.52 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 HD13 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 72.01 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.767 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 51.52 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.13 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.12 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 71.02 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.21 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 61' ' ' LEU . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.02 111.335 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.44 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.42 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.457 HD23 ' OE1' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 64.14 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.22 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 55.2 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.457 ' OE1' HD23 ' A' ' 37' ' ' LEU . 95.6 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.34 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.52 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.53 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.12 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.4 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.21 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.34 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.41 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.42 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.23 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.33 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.23 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.11 111.381 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.24 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.21 111.382 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.22 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.22 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.54 111.712 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 60.13 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 52.42 112.085 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 70.43 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.42 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 60.12 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.05 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.22 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.05 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.12 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.1 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.52 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 44.4 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.44 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.14 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.51 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.45 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.21 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 HD23 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.35 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.31 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.14 112.021 -178.149 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.791 0.329 . . . . 73.4 111.683 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.23 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.31 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD11 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.22 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 54.01 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 54.43 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.4 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.33 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.22 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.32 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 52.41 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.52 112.182 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.31 112.624 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.42 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.456 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.22 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.23 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.21 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.11 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.2 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.02 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.53 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.24 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.43 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.45 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.14 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.34 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 96.0 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.2 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 44.02 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.41 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.34 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.32 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.04 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.13 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.42 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.33 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.1 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 49' ' ' PRO . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.52 111.902 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 34' ' ' VAL . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 73.13 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.402 HD11 ' NZ ' ' A' ' 53' ' ' LYS . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.32 111.957 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.11 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.12 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.31 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.34 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 64' ' ' THR . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.991 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.31 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.421 ' H ' HG12 ' A' ' 62' ' ' VAL . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.52 111.954 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.12 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 73.32 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' HD11 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.31 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.23 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.14 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.32 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.2 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 70.43 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.54 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.14 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.42 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.3 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.24 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.13 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.45 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.12 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.33 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.33 111.172 179.622 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.796 0.332 . . . . 43.24 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.51 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.2 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 70.13 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.44 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.3 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.42 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.24 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.54 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.44 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.45 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 70.22 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.52 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.42 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.32 111.593 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.21 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.54 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.35 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.22 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.4 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.2 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.22 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.45 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.05 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.21 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.51 110.559 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.34 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 9.5 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.32 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.24 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.35 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.35 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.44 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.52 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.12 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.1 113.405 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.42 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.21 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.11 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.42 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.433 HD12 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 55.34 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.52 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 61.23 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.2 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.3 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.33 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.34 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.32 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' THR . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.11 110.921 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.02 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.413 ' H ' HG12 ' A' ' 62' ' ' VAL . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.04 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 54.24 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD11 HD12 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.41 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.44 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.21 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 64.25 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.3 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.04 111.233 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.42 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.11 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.21 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 52.02 111.707 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.14 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 71.25 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.774 0.321 . . . . 71.03 111.676 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.35 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.33 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.31 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.33 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.44 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.2 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.54 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.05 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.02 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.42 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.45 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.33 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.23 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.32 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.34 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 54.22 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.54 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.34 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.12 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.25 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.42 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.55 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.44 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.43 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.12 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.44 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.41 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.34 112.393 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.44 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.02 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.43 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.31 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.54 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.1 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 72.23 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.31 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 60.43 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.53 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG3' HG22 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.12 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.13 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 73.12 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.15 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.24 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.33 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 52.0 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.01 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.32 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.24 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.44 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.24 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 63.24 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.13 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.22 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.34 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.2 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.53 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.24 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.11 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.01 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.53 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 61.31 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.32 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.41 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.14 110.824 179.08 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.24 0.543 . . . . 61.43 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.44 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.32 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.22 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.12 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.21 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.33 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.55 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.42 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.41 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.13 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.45 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.22 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.32 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 62.55 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.22 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.03 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.1 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.31 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 54.44 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 44.41 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.21 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.35 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.44 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 52.14 111.36 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.33 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.12 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.22 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.33 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.34 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.13 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.52 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 60.11 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.51 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 72.43 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.35 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.04 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.21 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.1 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 61.04 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.32 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.43 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.22 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.3 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.43 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 64.15 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.02 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.03 110.92 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.44 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 53.31 112.389 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.34 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.22 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.03 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.23 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.52 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.45 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.53 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 51.44 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.22 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.22 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.635 HD11 HD23 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.05 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.22 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.11 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.34 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.42 111.541 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.53 112.733 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.12 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.13 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.21 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.14 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.22 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.34 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 73.52 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.31 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.33 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.13 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.41 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.11 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.02 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.23 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 50.32 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 53.22 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.41 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 65.32 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 44.43 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.23 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 61.11 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.35 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.22 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.2 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 54.33 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.11 112.558 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.11 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.35 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.13 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 55.01 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.12 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.11 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 64.14 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.33 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.42 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.12 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.31 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 54.52 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.1 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD23 HD13 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.02 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.44 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.33 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.52 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.44 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 51.32 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 63.15 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.43 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.4 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.55 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.45 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.24 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.32 110.505 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.43 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.32 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.42 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 52.05 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.43 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.41 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.21 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.33 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.21 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.12 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.551 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.45 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.43 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.24 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.22 112.704 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.21 111.18 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.471 HD12 HD21 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.13 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.23 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 63.23 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 32.01 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.15 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HZ ' HG21 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 53.51 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.23 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.23 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.32 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 63.25 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.05 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 60.54 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.21 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 44.14 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 60.34 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.12 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.53 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 62.32 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.44 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.42 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.34 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.1 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.404 HD11 HD21 ' A' ' 67' ' ' LEU . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.24 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.03 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.33 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 97.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.51 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.21 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.44 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.14 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.01 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.506 HG21 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.32 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.03 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 52.41 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.1 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.2 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.14 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.03 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 80' ' ' LEU . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.14 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.03 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.02 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.14 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.32 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.13 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.54 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.21 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.05 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.03 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.42 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.1 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 70.31 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.3 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.42 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.23 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.53 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.24 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.41 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 53.02 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.31 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.21 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.53 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD13 HD23 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 55.5 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.23 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.3 110.454 176.963 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 54.02 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.32 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 62.51 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.42 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.33 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.23 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.02 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.31 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.23 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.34 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.44 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.42 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.31 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.12 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.24 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 70.11 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.24 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 63.5 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.1 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.33 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.44 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.4 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.33 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.32 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.4 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.45 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.11 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.12 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.23 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.22 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.43 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG12 ' A' ' 47' ' ' VAL . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.15 112.144 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 42.21 111.394 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.51 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.35 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 71.21 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.03 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.24 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.04 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD23 HD13 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.04 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.34 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.22 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 63.21 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.51 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.24 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 64' ' ' THR . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.45 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' HG12 ' A' ' 62' ' ' VAL . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.23 112.252 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.14 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.31 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.22 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.21 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.31 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.43 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.3 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 61.24 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.45 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.41 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.34 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.11 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.35 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.13 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.565 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.02 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.561 HD13 HD23 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.52 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.24 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 50.13 111.645 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.969 0.414 . . . . 73.35 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 74.44 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 74' ' ' SER . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.32 111.829 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.42 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.12 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 73.5 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 71.23 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.1 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.51 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.4 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.11 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.32 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.14 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.22 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.44 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.14 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.32 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.13 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.03 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.42 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.13 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.34 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.42 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.33 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 95.6 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.03 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.42 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.59 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.45 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.23 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.53 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 55.21 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.02 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.527 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.44 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.51 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.11 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 64.23 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.24 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.34 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.51 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.582 HD12 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.24 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.33 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.2 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.24 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.02 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 65.14 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 56' ' ' PHE . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 62.53 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.03 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.21 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.02 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.15 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.13 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.35 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.31 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.34 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.2 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.03 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 71.45 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.44 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 32.04 111.737 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.1 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.14 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 60.13 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 71.34 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.44 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.22 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.31 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.41 111.785 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.3 0.571 . . . . 44.32 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.2 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.3 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.32 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.3 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.32 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.1 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.44 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.11 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.42 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.13 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.33 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.51 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.43 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.33 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.867 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.2 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 62.34 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.34 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.21 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 62.25 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.43 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.31 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.4 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.21 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.01 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.34 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.51 113.202 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.2 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 32.42 112.575 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.11 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 72.51 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.53 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.45 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.34 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.11 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.4 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.02 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HD13 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.14 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.23 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.23 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.13 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.42 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.34 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.51 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.21 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.13 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.24 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.35 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 65.32 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.33 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.4 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.54 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.4 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.34 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.23 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.43 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.42 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.02 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.33 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 35.25 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.13 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.575 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.4 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.651 HD13 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.34 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.11 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.54 110.459 178.609 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.24 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.45 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.41 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.11 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.557 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 63.33 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.4 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 64.43 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 71.1 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.45 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.21 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.34 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 72.21 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 62.31 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 41.22 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' HG22 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.22 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.54 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 63.13 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.02 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.43 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.34 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.42 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.42 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.45 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.4 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.31 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.24 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.12 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.51 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.52 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.41 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.53 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.21 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.21 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.43 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.05 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 52.12 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.44 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 74.51 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.31 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.35 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.14 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.23 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.3 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.42 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.24 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.11 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.31 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 64.05 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.42 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.43 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 61.52 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.54 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.03 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.34 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.02 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.32 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.31 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.4 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.4 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.14 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.15 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.44 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.12 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.55 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.02 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.31 110.662 178.301 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.24 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 64.33 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.55 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.34 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.33 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.43 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.53 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 71.31 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.32 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.54 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.22 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 31.23 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.24 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.34 113.382 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.32 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.24 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.409 HG22 HD13 ' A' ' 15' ' ' LEU . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.34 111.902 -177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.11 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.11 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 34.15 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.31 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 64.41 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 61.31 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.42 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 28' ' ' VAL . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.34 111.711 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.23 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 44.34 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.3 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.33 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.42 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.24 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.04 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.04 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.32 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 52' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.31 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.11 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.03 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.32 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.24 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' HG22 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.24 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.02 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.23 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.547 HG12 HG22 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.53 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 74.12 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.43 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.53 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.14 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.11 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 43.22 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 64' ' ' THR . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 62.04 110.704 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.44 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.12 111.904 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.23 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.43 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.45 110.367 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.41 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.43 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.4 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.53 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.14 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 23.33 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 34.32 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.44 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.34 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.51 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.33 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.32 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.421 HD13 HD23 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.21 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.591 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.35 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.42 110.842 179.201 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.4 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 45.14 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.24 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.35 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.12 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.23 110.737 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 72.23 110.911 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.22 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.01 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.35 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.32 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.43 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.44 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.32 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.24 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 50.22 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 64.34 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.44 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.15 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 64.14 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.15 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.13 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.31 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.2 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 45.34 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.24 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.01 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.51 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.31 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.54 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.41 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.32 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.586 ' OG1' HG12 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.11 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.14 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.45 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 74.55 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 32.34 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.54 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.43 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.21 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.24 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.34 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.13 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.3 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.22 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.42 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.31 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 64.3 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.21 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.41 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.43 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.4 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.41 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.3 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.31 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 71.25 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.45 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.41 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.13 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.31 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.34 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.23 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.05 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 61.13 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.23 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HB3' ' HE1' ' A' ' 19' ' ' PHE . . . . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.13 111.484 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.754 0.311 . . . . 75.21 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.54 90.14 0.29 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.238 -0.506 . . . . 63.31 112.946 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -63.57 127.23 30.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.603 -0.351 . . . . 73.35 111.15 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -73.96 95.15 2.44 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.94 0.4 . . . . 62.1 110.984 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -79.64 6.58 10.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.206 0.817 . . . . 73.33 113.206 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -63.12 -52.97 60.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.945 0.339 . . . . 72.02 111.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.94 68.4 2.01 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.07 0.462 . . . . 72.13 111.373 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -146.79 168.82 20.45 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.296 -0.411 . . . . 72.2 111.046 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t 56.97 16.9 3.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.327 0.492 . . . . 61.31 112.327 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.0 m170 -92.04 166.99 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.952 0.406 . . . . 73.35 111.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -155.47 172.75 17.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.9 0.381 . . . . 72.31 111.021 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p -91.38 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 62.31 111.564 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.15 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.4 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.54 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.21 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.31 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.41 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.32 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.21 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.15 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.24 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 72.41 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.2 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.44 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.33 111.602 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 62.03 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 71.14 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.45 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.54 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.42 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 62.4 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.01 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.24 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.21 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 71.14 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 93.5 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.1 111.593 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.13 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.11 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.51 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.34 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.544 HG21 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.31 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.14 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.14 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 35.24 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.43 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.12 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.45 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.11 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.12 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD23 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.13 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.13 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.33 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.24 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 31.14 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.33 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 61.11 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.22 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.45 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 65.43 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.1 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.42 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 44.0 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.31 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.32 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.31 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.2 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.12 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.42 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 73.23 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.42 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.44 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' NZ ' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.45 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.32 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.32 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.54 HD13 HD23 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.42 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.54 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.98 -172.48 2.62 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 43.02 111.557 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -118.81 117.46 28.93 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.042 0.386 . . . . 65.43 112.042 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -93.76 -11.88 30.39 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.42 0.629 . . . . 72.23 110.324 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.758 -1.024 . . . . 71.24 113.115 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.683 0.277 . . . . 64.21 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.97 0.03 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.209 -0.52 . . . . 63.32 113.775 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -68.55 89.91 0.37 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.432 0.634 . . . . 64.35 112.048 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -96.69 140.11 31.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.053 -0.521 . . . . 71.13 111.341 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -121.92 154.3 37.33 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.09 0.471 . . . . 72.11 112.015 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -134.91 -170.23 2.52 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.018 -0.537 . . . . 75.23 110.25 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -77.72 -49.48 14.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.712 0.291 . . . . 62.32 110.419 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 65.64 -6.62 0.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.003 1.112 . . . . 74.23 114.003 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -89.97 -18.88 25.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.615 0.968 . . . . 61.35 113.615 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -58.47 -17.88 24.46 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.495 0.924 . . . . 63.54 113.495 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 t -62.74 143.1 57.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.963 0.411 . . . . 64.1 110.948 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p -86.2 123.16 31.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.33 112.179 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.31 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.3 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.02 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.3 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.33 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 63.13 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.23 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.34 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 71.13 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.41 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.12 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 73.41 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.23 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.23 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 33.21 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.12 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.13 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.04 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 73.44 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.44 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.13 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.51 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 70.51 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.43 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 98.5 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.13 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.403 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 43.11 112.303 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.14 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.13 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.33 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.52 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 65.14 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.13 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 51.2 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.14 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.14 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.23 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.55 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.44 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.12 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.51 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.3 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.44 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.11 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.11 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.53 111.835 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 64' ' ' THR . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.13 111.036 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.42 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 62' ' ' VAL . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.15 111.911 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.34 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.42 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.11 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 61.2 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.43 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 71.15 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.55 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.24 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.03 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.22 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.33 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 62.43 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.51 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.23 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.31 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.41 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.53 144.73 36.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 55.25 111.4 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -96.18 146.19 24.89 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.947 0.404 . . . . 63.42 111.623 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -60.75 -25.09 66.22 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.549 0.574 . . . . 71.01 112.549 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 119.143 -0.809 . . . . 72.35 114.023 178.219 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.586 0.231 . . . . 72.5 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.52 37.8 58.1 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.167 -0.54 . . . . 53.23 113.849 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -138.9 110.12 6.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.142 0.471 . . . . 63.3 111.336 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -115.57 174.52 5.97 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.265 0.555 . . . . 72.31 112.126 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.15 114.79 19.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.108 -0.496 . . . . 75.34 110.404 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -89.49 16.99 6.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.512 0.56 . . . . 65.33 112.512 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -68.63 145.1 54.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.929 0.395 . . . . 74.04 110.745 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -149.1 124.8 10.46 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.568 0.581 . . . . 73.43 112.568 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.2 m -151.85 168.34 25.44 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.97 -0.559 . . . . 74.15 110.867 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -74.62 99.26 3.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 72.32 111.484 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -146.73 -172.83 4.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.088 -0.506 . . . . 53.34 110.697 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -92.36 151.48 20.25 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.1 111.881 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.498 HG13 HD21 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.44 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.15 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.22 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.31 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 45' ' ' THR . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.259 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.43 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.24 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.55 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.44 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.53 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.35 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.14 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 15' ' ' LEU . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.01 111.472 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.43 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.35 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.31 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.23 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.1 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.41 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.11 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.24 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.23 111.508 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 52.25 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.31 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.3 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.15 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 60.22 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 19' ' ' PHE . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.2 113.244 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.34 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.42 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 50' ' ' ARG . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.34 111.238 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.21 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' HD11 ' A' ' 80' ' ' LEU . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.12 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.52 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.01 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.55 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.45 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.33 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.32 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.42 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.01 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.44 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.24 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.15 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 43.54 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 71.45 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.23 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.2 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 28.6 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.54 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.14 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.12 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.51 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.41 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.44 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.21 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.51 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.03 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.2 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.52 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.24 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.04 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . -121.07 150.41 41.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 62.13 112.442 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -93.88 116.4 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.081 -0.509 . . . . 72.24 111.558 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -141.49 125.03 16.71 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.294 -0.412 . . . . 63.44 110.027 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.861 -0.966 . . . . 74.33 113.003 178.881 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.8 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.783 0.325 . . . . 73.33 111.281 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.99 114.59 3.34 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.348 -0.454 . . . . 42.41 112.548 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -64.85 92.02 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.348 0.594 . . . . 75.01 112.558 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -161.06 103.01 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.323 0.582 . . . . 65.52 111.108 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -83.57 149.41 26.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.287 0.565 . . . . 54.32 112.323 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.08 176.95 8.19 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.611 -0.722 . . . . 70.14 110.691 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -147.14 -176.71 5.32 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.139 -0.351 . . . . 70.44 111.722 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -67.32 165.78 15.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.23 0.538 . . . . 74.42 111.895 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -138.71 171.97 13.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.047 -0.524 . . . . 63.54 111.685 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -128.57 31.47 4.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.993 -0.549 . . . . 74.32 110.848 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.9 m -69.18 179.46 1.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.887 -0.597 . . . . 72.41 111.747 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p -86.55 150.31 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 74.13 111.79 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.23 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.3 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.15 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 54.51 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 71.12 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.4 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.55 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.34 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.34 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.24 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 52.43 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.42 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 40.12 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 61.44 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.34 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.53 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.43 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.3 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 71.21 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.33 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.21 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.32 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.2 111.425 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.54 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 65.22 111.793 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.35 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.22 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.53 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.4 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.565 ' OG1' HG12 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.32 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.52 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG12 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.15 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 74.55 113.406 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.02 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.04 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.494 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 51.5 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.14 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.43 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.41 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.54 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 70.35 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.43 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.55 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.32 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 51.11 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.1 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.22 111.167 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 71.01 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.14 112.361 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.35 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.22 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 70.31 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.41 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.35 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.21 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.41 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.43 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.22 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.4 111.679 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.13 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.03 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.24 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.541 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.27 140.32 50.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.42 111.436 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -75.65 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.458 . . . . 72.24 111.119 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -66.24 0.92 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.062 0.458 . . . . 71.12 110.217 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.416 0 CA-C-O 118.699 -1.056 . . . . 73.31 113.088 -178.054 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.763 0.316 . . . . 74.15 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.39 -167.02 47.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.27 -0.491 . . . . 71.05 113.437 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -102.48 45.94 0.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.39 0.614 . . . . 75.33 111.114 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -67.61 -42.86 81.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.974 -0.557 . . . . 75.42 112.052 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.75 90.28 0.41 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 73.41 111.686 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -152.6 142.2 21.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.705 0.288 . . . . 74.52 111.321 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.52 -39.7 9.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.752 0.311 . . . . 75.01 111.451 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -110.74 113.89 26.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.011 0.434 . . . . 71.45 110.944 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -76.91 134.51 38.93 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.906 0.384 . . . . 60.11 111.576 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -130.12 157.28 42.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.391 -0.368 . . . . 74.22 111.456 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t 64.86 86.74 0.12 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.426 0.631 . . . . 74.21 111.189 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -118.21 154.11 32.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.007 -0.542 . . . . 73.2 112.147 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.54 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 74' ' ' SER . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.15 112.065 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.01 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.23 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.22 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.54 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CE1' HG21 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.04 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.41 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.44 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.45 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.55 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.05 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 51.31 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.54 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.13 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.15 111.817 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 62.2 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 72.34 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.11 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 55.12 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.41 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.35 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.13 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.51 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 73.44 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.14 110.576 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.12 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.43 111.751 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.34 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.13 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.25 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.2 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.45 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.23 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.33 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.35 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.31 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.14 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 23.13 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.11 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.12 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 63.53 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.23 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.51 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.04 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.24 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.42 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.41 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.53 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.11 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.04 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.14 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.24 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.13 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.34 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.32 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.21 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 43.45 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.52 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 71.42 111.526 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.31 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.01 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.43 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.35 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 62.24 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.22 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.95 159.88 15.11 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 62.44 112.25 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -89.73 14.02 12.84 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.188 -0.46 . . . . 63.34 111.353 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.45 154.24 50.83 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.637 0.375 . . . . 74.11 110.74 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 119.124 -0.82 . . . . 42.15 113.19 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.615 0.245 . . . . 70.44 111.378 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.87 -129.59 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.916 -0.659 . . . . 64.35 113.347 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -80.19 40.88 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.279 0.562 . . . . 62.41 111.204 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -85.78 88.95 7.63 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.872 -0.604 . . . . 70.24 110.734 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 70.67 -35.05 0.31 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.576 0.75 . . . . 74.44 112.835 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -57.13 99.07 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.039 0.447 . . . . 74.13 112.033 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -132.45 160.32 36.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.482 -0.326 . . . . 72.42 111.451 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -166.99 137.19 3.03 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.199 0.444 . . . . 62.55 112.199 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.5 m 65.49 17.95 11.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.668 0.988 . . . . 64.22 113.668 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -113.53 8.46 17.75 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.947 -0.471 . . . . 71.44 111.776 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 m -72.08 72.25 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.268 0.556 . . . . 64.21 110.149 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p -86.87 127.42 35.04 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 71.51 112.521 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 62.52 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.52 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 73.41 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.54 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.45 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.12 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.22 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.22 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.23 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.13 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.52 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.14 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 71.54 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 72.34 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.33 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.52 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 64.41 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.14 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.43 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.13 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.54 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.21 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.12 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.11 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.43 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.54 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.24 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 72.03 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 ' OG1' HG12 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 62.34 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 70.12 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG12 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.02 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.22 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.2 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.32 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.12 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.12 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.12 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.23 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 62.13 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 65.03 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.41 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.24 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.44 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.21 111.859 -176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 64' ' ' THR . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.31 110.554 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.44 ' H ' HG12 ' A' ' 62' ' ' VAL . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.43 111.363 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.31 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.21 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 62.52 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.43 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 66' ' ' THR . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.24 111.936 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 64.42 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.42 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.51 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.23 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.41 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.2 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.04 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.13 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.23 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.34 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.632 HD13 HD23 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.32 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.33 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -146.52 152.09 38.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.54 111.402 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -119.62 171.46 8.36 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.922 0.391 . . . . 64.02 111.53 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.87 111.97 24.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.007 0.432 . . . . 72.13 110.859 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.454 0 CA-C-O 118.855 -0.969 . . . . 62.15 113.372 178.692 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.89 0.376 . . . . 63.35 111.48 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.76 -131.22 10.5 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.215 -0.517 . . . . 41.42 112.844 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.27 113.3 18.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.375 0.607 . . . . 65.35 111.496 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.97 98.98 3.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.504 -0.771 . . . . 75.13 112.087 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -70.49 81.16 0.57 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.698 -0.683 . . . . 75.22 111.017 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -67.17 161.45 24.67 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.576 . . . . 74.13 111.927 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -78.02 156.27 30.21 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.21 111.447 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -101.62 -27.0 13.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.729 0.299 . . . . 70.12 111.472 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -57.48 117.76 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.569 -0.287 . . . . 54.45 111.714 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 61.33 24.92 14.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.752 0.421 . . . . 63.01 111.888 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 t -64.18 136.93 57.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.947 0.403 . . . . 54.35 111.209 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -123.63 138.18 54.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 62.04 112.02 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.01 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.1 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.13 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.1 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.24 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.12 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.41 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.34 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 55.32 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.11 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.33 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.42 112.694 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.32 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.45 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.21 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.14 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 43.41 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.52 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 61' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.05 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.43 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.53 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.53 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.45 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.04 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.22 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.01 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.41 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.03 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.3 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.23 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.43 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 51.1 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 54.31 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.44 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.24 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.44 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.45 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 64.15 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 63.15 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.33 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 64.1 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.35 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.51 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 61' ' ' LEU . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.44 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 72.4 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 64' ' ' THR . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.22 110.506 174.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.22 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 62' ' ' VAL . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.41 112.375 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 64.23 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.13 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.4 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.11 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.24 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.04 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.34 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.24 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.1 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.33 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.42 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.41 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 15' ' ' LEU . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.13 111.299 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.41 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.04 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.01 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -129.74 146.32 51.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.04 111.504 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p 54.33 19.68 2.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.433 0.693 . . . . 75.25 112.606 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.13 -178.66 5.68 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.066 0.46 . . . . 75.2 111.548 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.714 -1.048 . . . . 64.32 112.588 176.544 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.9 0.381 . . . . 63.34 111.397 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 74.99 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.3 -0.476 . . . . 55.24 112.841 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -64.41 -10.64 26.25 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.122 0.786 . . . . 73.43 113.122 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -86.61 106.55 17.65 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.199 -0.313 . . . . 74.44 110.66 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -99.48 111.51 23.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.883 0.373 . . . . 70.21 111.784 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -72.12 121.79 19.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.985 0.421 . . . . 75.01 112.015 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.69 136.22 21.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.883 0.473 . . . . 74.11 110.811 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -76.91 -45.8 26.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.846 0.355 . . . . 74.14 111.594 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -86.18 163.72 17.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.891 0.377 . . . . 75.5 111.745 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.9 m80 55.9 22.32 5.59 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.052 -0.522 . . . . 72.15 112.213 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -76.7 81.94 3.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.155 0.502 . . . . 74.15 111.261 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p -86.5 117.53 25.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.344 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.41 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.24 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.02 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.54 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 52.34 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 70.24 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 33.11 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.23 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.33 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.01 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.03 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.12 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.34 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.52 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 HD13 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 72.01 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.767 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 51.52 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.13 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.12 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 71.02 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.21 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 61' ' ' LEU . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.02 111.335 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.44 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.42 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.457 HD23 ' OE1' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 64.14 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.22 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 55.2 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.457 ' OE1' HD23 ' A' ' 37' ' ' LEU . 95.6 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.34 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.52 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.53 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.12 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.4 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.21 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.34 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.41 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.42 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.23 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.33 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.23 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.11 111.381 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.24 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.21 111.382 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.22 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.22 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.54 111.712 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 60.13 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 52.42 112.085 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 70.43 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.42 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 60.12 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.05 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.22 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.05 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.12 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.1 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.52 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 44.4 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.44 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.14 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.51 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.45 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.21 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 HD23 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.35 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.31 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.11 146.7 51.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.14 112.021 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -99.91 134.05 43.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.994 -0.548 . . . . 72.51 111.268 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -74.96 -52.54 10.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.046 0.451 . . . . 43.22 111.295 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 CA-C-O 118.853 -0.97 . . . . 75.23 113.085 -178.201 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.637 0.256 . . . . 71.23 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.04 121.94 4.64 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.957 -0.639 . . . . 54.14 113.563 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -87.44 142.03 28.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.937 0.398 . . . . 75.24 111.057 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -129.62 116.44 18.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.969 0.414 . . . . 65.05 111.198 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -124.89 106.54 10.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.704 -0.48 . . . . 74.4 109.704 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -69.74 117.39 11.27 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.906 0.706 . . . . 74.54 112.906 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -92.16 108.37 19.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.8 -0.636 . . . . 73.32 111.284 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -74.42 135.18 42.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.503 -0.317 . . . . 63.43 111.034 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -174.07 175.05 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.145 0.498 . . . . 53.51 111.591 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -73.67 82.13 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.91 0.386 . . . . 54.51 110.671 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -105.37 169.16 8.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.864 0.364 . . . . 70.34 111.505 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -115.88 128.52 55.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.458 -0.337 . . . . 73.4 111.683 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.23 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.31 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD11 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.22 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 54.01 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 54.43 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.4 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.33 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.22 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.32 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 52.41 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.52 112.182 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.31 112.624 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.42 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.456 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.22 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.23 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.21 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.11 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.2 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.02 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.53 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.24 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.43 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.45 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.14 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.34 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 96.0 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.2 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 44.02 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.41 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.34 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.32 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.04 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.13 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.42 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.33 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.1 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 49' ' ' PRO . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.52 111.902 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 34' ' ' VAL . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 73.13 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.402 HD11 ' NZ ' ' A' ' 53' ' ' LYS . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.32 111.957 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.11 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.12 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.31 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.34 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 64' ' ' THR . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.991 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.31 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.421 ' H ' HG12 ' A' ' 62' ' ' VAL . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.52 111.954 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.12 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 73.32 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' HD11 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.31 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.23 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.14 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.32 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.2 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 70.43 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.54 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.14 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.42 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.3 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.24 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.13 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.45 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.12 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.33 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.58 112.71 13.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.33 111.172 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.8 p -100.21 143.36 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.941 0.401 . . . . 42.42 112.061 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -75.37 -31.88 60.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.102 -0.499 . . . . 64.42 111.45 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.36 0 CA-C-O 118.975 -0.903 . . . . 65.24 113.457 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.629 0.252 . . . . 54.31 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.73 -80.86 0.36 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.928 -0.653 . . . . 54.44 113.679 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -106.73 3.25 26.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.474 0.546 . . . . 73.14 112.474 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 76.5 m-70 -85.03 77.23 10.15 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.289 0.566 . . . . 74.34 110.524 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -101.39 -38.24 8.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.9 -0.591 . . . . 74.42 111.48 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -93.05 -4.4 52.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.997 0.427 . . . . 74.23 110.665 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 4' ' ' HIS . 79.9 m-70 -135.82 140.4 44.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.44 -0.345 . . . . 75.24 110.662 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -99.01 130.83 45.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.978 0.362 . . . . 71.22 111.978 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -69.43 -172.34 0.45 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.641 -0.254 . . . . 75.21 110.803 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -65.26 128.97 38.01 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.119 -0.363 . . . . 73.32 111.364 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.5 t -58.18 103.96 0.18 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.067 0.461 . . . . 72.3 112.179 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p -137.35 121.21 17.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.24 -0.436 . . . . 43.24 111.348 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.51 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.2 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 70.13 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.44 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.3 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.42 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.24 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.54 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.44 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.45 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 70.22 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.52 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.42 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.32 111.593 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.21 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.54 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.35 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.22 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.4 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.2 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.22 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.45 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.05 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.21 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.51 110.559 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.34 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 9.5 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.32 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.24 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.35 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.35 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.44 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.52 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.12 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.1 113.405 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.42 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.21 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.11 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.42 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.433 HD12 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 55.34 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.52 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 61.23 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.2 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.3 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.33 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.34 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.32 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' THR . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.11 110.921 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.02 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.413 ' H ' HG12 ' A' ' 62' ' ' VAL . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.04 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 54.24 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD11 HD12 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.41 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.44 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.21 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 64.25 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.3 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.04 111.233 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.42 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.11 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.21 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 52.02 111.707 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.14 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 71.25 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . -145.96 117.08 7.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -76.94 130.22 37.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.411 -0.359 . . . . 54.31 111.35 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -73.54 91.73 1.85 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.999 0.428 . . . . 72.4 110.911 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.85 -0.972 . . . . 70.12 113.13 179.317 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' C ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 112.475 0.546 . . . . 73.53 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.25 177.98 19.63 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.834 -0.698 . . . . 72.32 113.688 -175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -141.74 106.91 4.97 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.544 0.337 . . . . 73.34 111.122 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -59.9 130.25 45.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.09 0.472 . . . . 71.54 111.561 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -71.79 108.72 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.156 -0.474 . . . . 74.24 111.85 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -84.21 103.86 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.064 0.459 . . . . 71.43 111.341 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -79.6 107.68 12.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.697 0.628 . . . . 71.3 112.697 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.95 145.52 46.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.391 -0.368 . . . . 72.04 110.601 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 t -144.36 -176.45 5.03 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.811 0.339 . . . . 74.52 111.312 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -106.61 -167.03 1.24 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.349 -0.387 . . . . 75.33 110.489 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 t -74.78 37.36 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.085 0.469 . . . . 74.02 111.746 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -116.28 126.5 53.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.128 -0.358 . . . . 71.03 111.676 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.35 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.33 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.31 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.33 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.44 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.2 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.54 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.05 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.02 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.42 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.45 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.33 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.23 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.32 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.34 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 54.22 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.54 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.34 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.12 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.25 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.42 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.55 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.44 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.43 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.12 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.44 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.41 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.34 112.393 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.44 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.02 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.43 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.31 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.54 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.1 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 72.23 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.31 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 60.43 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.53 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG3' HG22 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.12 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.13 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 73.12 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.15 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.24 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.33 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 52.0 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.01 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.32 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.24 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.44 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.24 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 63.24 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.13 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.22 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.34 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.2 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.53 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.24 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.11 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.01 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.53 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 61.31 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.32 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.41 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.99 151.1 50.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.14 110.824 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -71.37 -37.38 71.61 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.817 0.303 . . . . 73.23 111.817 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -97.92 151.26 20.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.82 0.343 . . . . 75.43 111.103 176.125 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.325 0 CA-C-O 118.842 -0.976 . . . . 37.83 113.197 -177.666 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.786 0.327 . . . . 61.12 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.28 -122.8 1.46 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.912 -0.661 . . . . 45.23 113.199 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -140.25 120.09 13.48 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.361 -0.493 . . . . 72.23 111.651 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -121.53 107.17 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.782 0.325 . . . . 74.24 111.16 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -86.32 136.02 33.31 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.057 0.456 . . . . 71.32 111.52 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -83.13 23.61 0.85 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.259 0.552 . . . . 64.24 110.717 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -68.48 84.49 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.737 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -118.87 -16.31 9.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.139 0.495 . . . . 71.1 110.957 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -86.26 133.57 33.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.258 -0.428 . . . . 45.44 111.454 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -109.3 -49.15 3.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.416 -0.357 . . . . 75.01 111.213 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -142.46 27.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.19 0.441 . . . . 55.14 112.19 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p -97.96 142.48 29.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.791 -0.568 . . . . 61.43 111.981 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.44 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.32 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.22 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.12 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.21 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.33 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.55 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.42 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.41 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.13 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.45 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.22 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.32 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 62.55 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.22 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.03 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.1 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.31 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 54.44 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 44.41 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.21 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.35 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.44 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 52.14 111.36 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.33 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.12 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.22 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.33 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.34 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.13 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.52 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 60.11 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.51 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 72.43 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.35 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.04 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.21 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.1 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 61.04 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.32 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.43 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.22 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.3 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.43 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 64.15 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.02 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.03 110.92 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.44 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 53.31 112.389 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.34 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.22 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.03 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.23 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.52 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.45 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.53 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 51.44 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.22 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.22 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.635 HD11 HD23 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.05 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.22 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.11 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.34 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.29 167.48 17.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.42 111.541 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 m -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.481 -0.327 . . . . 72.34 111.548 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.68 -27.81 64.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.081 0.467 . . . . 60.23 111.235 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.924 -0.931 . . . . 64.32 113.013 178.838 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 1' ' ' MET . 11.6 tmm? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.715 0.293 . . . . 74.34 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.44 168.68 35.39 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.216 -0.516 . . . . 23.53 112.677 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -70.48 78.07 0.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.161 0.505 . . . . 73.31 110.847 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -102.03 -14.47 17.13 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.239 -0.437 . . . . 73.34 111.836 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -75.62 126.58 31.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.714 0.292 . . . . 50.2 110.998 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -138.55 135.92 35.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.653 -0.249 . . . . 61.42 110.972 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -149.44 135.88 19.24 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.671 0.272 . . . . 70.5 111.67 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -147.06 151.99 37.8 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.611 0.243 . . . . 54.1 111.082 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.9 m -70.95 159.02 35.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.634 0.254 . . . . 70.51 110.909 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -149.43 157.17 43.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.998 0.428 . . . . 61.3 112.067 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -98.67 -32.91 11.16 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.115 0.483 . . . . 73.45 112.262 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p -92.19 113.61 25.93 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.53 112.733 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.12 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.13 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.21 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.14 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.22 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.34 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 73.52 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.31 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.33 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.13 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.41 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.11 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.02 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.23 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 50.32 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 53.22 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.41 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 65.32 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 44.43 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.23 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 61.11 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.35 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.22 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.2 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 54.33 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.11 112.558 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.11 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.35 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.13 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 55.01 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.12 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.11 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 64.14 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.33 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.42 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.12 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.31 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 54.52 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.1 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD23 HD13 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.02 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.44 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.33 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.52 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.44 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 51.32 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 63.15 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.43 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.4 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.55 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.45 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.24 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.32 110.505 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.43 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.32 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.42 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 52.05 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.43 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.41 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.21 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.33 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.21 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.12 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.551 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.45 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.43 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.24 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . -93.17 139.93 30.06 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.22 112.704 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -164.75 102.26 0.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.776 -0.647 . . . . 75.13 110.523 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -72.98 91.15 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.927 0.394 . . . . 73.32 111.774 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.264 0 CA-C-O 118.783 -1.009 . . . . 53.45 113.225 174.541 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.361 0.124 . . . . 75.31 110.803 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.11 155.3 18.97 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.119 -1.038 . . . . 62.24 114.236 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -63.8 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.053 0.541 . . . . 73.05 111.763 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -52.86 117.55 3.03 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.978 -0.451 . . . . 65.43 110.765 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -79.39 121.72 25.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.86 0.362 . . . . 74.24 111.739 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -89.64 133.71 34.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.46 0.647 . . . . 74.22 111.791 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -84.85 88.41 7.41 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.634 -0.712 . . . . 72.33 111.759 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -129.0 95.51 4.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.129 0.418 . . . . 65.31 112.129 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m 48.83 24.67 0.87 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.586 0.587 . . . . 50.33 112.586 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.432 ' CE1' ' HG ' ' A' ' 29' ' ' SER . 75.1 t60 -106.06 127.22 53.03 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.877 0.37 . . . . 74.31 111.545 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -122.49 -172.52 2.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.46 -0.336 . . . . 62.2 110.726 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -116.34 144.22 44.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.21 111.18 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.471 HD12 HD21 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.13 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.23 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 63.23 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 32.01 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.15 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HZ ' HG21 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 53.51 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.23 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.23 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.32 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 63.25 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.05 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 60.54 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.21 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 44.14 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 60.34 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.12 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.53 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 62.32 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.44 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.49 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.42 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.34 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.1 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD23 ' NE2' ' A' ' 40' ' ' GLN . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.24 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.03 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.33 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.51 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.21 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.44 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.14 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.01 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.506 HG21 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.32 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.03 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 52.41 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.1 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.2 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.14 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.03 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 80' ' ' LEU . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.14 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.03 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.02 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.14 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.32 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.13 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.54 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.21 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.05 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.03 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.42 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.1 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 70.31 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.3 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.42 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.23 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.53 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.24 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.41 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 53.02 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.31 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.21 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.53 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD13 HD23 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 55.5 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.23 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -115.21 106.2 13.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.3 110.454 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -141.01 168.02 20.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.194 0.521 . . . . 73.42 111.894 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.76 -9.65 22.76 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.052 -0.522 . . . . 40.2 111.503 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.813 -0.993 . . . . 35.05 113.112 -178.834 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.615 0.245 . . . . 60.43 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.5 112.09 2.41 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.399 -0.429 . . . . 72.43 113.713 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -69.64 122.67 19.57 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.518 -0.401 . . . . 72.23 111.263 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -105.35 179.3 4.31 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.798 0.332 . . . . 72.15 111.33 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -131.2 134.96 46.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.212 0.53 . . . . 72.13 111.6 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -77.94 137.45 38.34 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.204 -0.453 . . . . 74.23 112.118 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -161.4 156.74 24.16 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.07 -0.514 . . . . 74.32 110.768 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -62.62 136.96 58.14 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.688 0.28 . . . . 72.34 110.947 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -116.67 101.48 8.62 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.826 0.346 . . . . 74.2 111.238 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -73.41 94.67 2.1 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.086 0.469 . . . . 73.23 111.684 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 p -139.52 -176.67 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.96 0.409 . . . . 73.5 111.329 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p -87.54 127.08 35.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 54.02 111.835 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.32 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 62.51 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.42 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.33 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.23 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.02 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.31 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.23 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.34 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.44 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.42 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.31 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.12 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.24 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 70.11 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.24 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 63.5 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.1 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.33 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.44 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.4 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.33 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.32 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.4 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.45 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.11 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.12 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.23 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.22 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.43 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG12 ' A' ' 47' ' ' VAL . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.15 112.144 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 42.21 111.394 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.51 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.35 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 71.21 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.03 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.24 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.04 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD23 HD13 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.04 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.34 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.22 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 63.21 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.51 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.24 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 64' ' ' THR . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.45 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' HG12 ' A' ' 62' ' ' VAL . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.23 112.252 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.14 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.31 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.22 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.21 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.31 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.43 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.3 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 61.24 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.45 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.41 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.34 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.11 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.35 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.13 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.565 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.02 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.561 HD13 HD23 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.52 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.24 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.71 174.2 12.42 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 50.13 111.645 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -114.3 162.94 15.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.267 -0.424 . . . . 71.34 111.424 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 67.22 16.09 10.12 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.334 0.494 . . . . 65.11 112.334 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.371 0 CA-C-O 118.895 -0.947 . . . . 72.22 113.004 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.784 0.326 . . . . 70.34 111.555 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.48 -162.1 31.31 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.322 -0.399 . . . . 31.33 112.46 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -137.07 109.92 7.62 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.346 0.593 . . . . 70.13 110.794 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -70.37 -33.48 71.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.152 -0.476 . . . . 73.01 111.608 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -85.82 165.09 17.13 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.863 0.363 . . . . 74.5 111.338 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.92 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.989 0.737 . . . . 73.02 112.989 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.623 ' NE2' ' HB2' ' A' ' 9' ' ' SER . 83.1 t60 -56.7 109.33 0.61 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.122 -0.944 . . . . 74.23 110.751 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -59.79 -37.47 79.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.478 . . . . 74.45 112.292 -173.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.623 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 50.7 m -64.02 133.91 54.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.612 -0.514 . . . . 74.13 109.612 173.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -52.69 140.09 24.46 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.357 0.873 . . . . 70.24 113.357 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -111.57 -168.07 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.825 -0.625 . . . . 70.22 111.571 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p -106.44 163.13 13.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.154 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 74.44 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 74' ' ' SER . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.32 111.829 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.42 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.12 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 73.5 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 71.23 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.1 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.51 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.4 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.11 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.32 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.14 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.22 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.44 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.14 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.32 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.13 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.03 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.42 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.13 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.34 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.42 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.33 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 95.6 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.03 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.42 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.59 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.45 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.23 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.53 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 55.21 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.02 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.527 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.44 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.51 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.11 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 64.23 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.24 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.34 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.51 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.582 HD12 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.24 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.33 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.2 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.24 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.02 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 65.14 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 56' ' ' PHE . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 62.53 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.03 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.21 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.02 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.15 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.13 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.35 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.31 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.34 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.2 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.03 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 71.45 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.44 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 32.04 111.737 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.1 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.14 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 60.13 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 71.34 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.44 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.22 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.31 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -97.45 96.32 8.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.41 111.785 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.4 m -115.47 119.95 37.9 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.388 -0.369 . . . . 74.12 111.109 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -80.0 -73.93 0.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.417 0.525 . . . . 73.24 112.417 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.782 -1.01 . . . . 55.33 114.185 -175.386 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.809 0.337 . . . . 24.33 111.098 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.56 -26.58 14.97 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 114.736 0.654 . . . . 35.02 114.736 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.05 45.53 0.84 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.672 0.736 . . . . 73.25 112.44 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.45 154.26 50.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.662 0.268 . . . . 74.42 111.226 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 53.76 81.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.129 0.572 . . . . 71.13 112.535 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -73.48 -29.23 62.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.262 0.553 . . . . 74.11 110.326 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -116.83 93.76 4.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 64.25 110.776 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -78.06 123.23 26.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 110.218 -0.29 . . . . 74.24 110.218 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -68.09 136.27 53.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.458 0.647 . . . . 63.35 112.74 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -160.03 20.54 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.319 -0.855 . . . . 75.1 109.576 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -88.45 -174.71 4.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.566 -0.743 . . . . 74.05 112.604 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -92.58 175.41 6.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.807 -0.633 . . . . 44.32 112.297 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.2 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.3 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.32 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.3 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.32 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.1 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.44 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.11 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.42 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.13 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.33 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.51 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.43 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.33 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.867 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.2 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 62.34 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.34 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.21 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 62.25 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.43 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.31 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.4 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.21 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.01 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.34 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.51 113.202 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.2 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HA2' ' A' ' 85' ' ' GLY . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 32.42 112.575 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.11 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 72.51 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.53 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.45 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.34 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.11 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.4 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.02 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HD13 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.14 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.23 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.23 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.13 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.42 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.34 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.51 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.21 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.13 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.24 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.35 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 65.32 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.33 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.4 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.54 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.4 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.34 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.23 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.43 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.42 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.02 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.33 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 35.25 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.13 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.575 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.4 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.651 HD13 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.34 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.11 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.87 140.0 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.54 110.459 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -87.71 -66.1 0.95 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.982 0.42 . . . . 65.34 112.053 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 115.87 15.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.224 -0.444 . . . . 64.35 111.006 -178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 119.195 -0.78 . . . . 37.5 113.105 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.775 0.321 . . . . 65.45 110.992 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.76 87.15 0.5 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.027 -0.606 . . . . 42.12 113.539 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -73.0 80.26 1.19 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.374 0.607 . . . . 63.42 110.195 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -52.83 145.41 12.54 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.399 -0.819 . . . . 74.44 113.014 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.99 150.05 28.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 60.14 111.845 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -100.46 -22.83 14.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.008 0.432 . . . . 74.01 110.884 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -166.63 168.73 14.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.477 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -80.33 134.45 36.06 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.23 -0.294 . . . . 41.03 110.462 173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -108.01 176.36 5.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.001 0.429 . . . . 71.31 111.379 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.95 122.8 39.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.828 0.347 . . . . 71.11 111.437 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 34.3 t -72.92 103.19 3.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.808 -0.441 . . . . 64.03 109.808 173.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p -115.66 142.9 46.12 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.24 112.501 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.45 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.41 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.11 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.557 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 63.33 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.4 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 64.43 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 71.1 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.45 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.21 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.34 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 72.21 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 62.31 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 41.22 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' HG22 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.22 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.54 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 63.13 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.02 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.43 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.34 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.42 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.42 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.45 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.4 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.31 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.24 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.12 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.51 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.52 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.41 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.53 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.21 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.21 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.43 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.05 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 52.12 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.44 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 74.51 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.31 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.35 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.14 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.23 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.3 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.42 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.24 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.11 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.31 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 64.05 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.42 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.43 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 61.52 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.54 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.03 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.34 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.02 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.32 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.31 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.4 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.4 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.14 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.15 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.44 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.12 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.55 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.02 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.11 51.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.31 110.662 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -156.71 169.26 25.12 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.972 0.415 . . . . 72.31 111.506 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.4 -44.66 51.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.996 0.427 . . . . 72.23 111.118 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.259 0 CA-C-O 118.94 -0.922 . . . . 61.35 113.002 -179.347 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.736 0.303 . . . . 72.04 111.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.78 153.68 25.03 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.738 -0.545 . . . . 72.33 111.738 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -78.96 52.47 1.26 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 117.473 0.637 . . . . 72.43 112.718 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t60 70.36 -32.23 0.23 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.654 1.353 . . . . 70.23 114.654 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.99 122.14 12.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.816 0.672 . . . . 73.43 112.816 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -66.17 134.87 53.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.793 -0.64 . . . . 74.44 110.926 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -135.23 155.38 50.76 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.112 -0.367 . . . . 73.33 111.29 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -68.92 142.18 54.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.749 -0.205 . . . . 72.03 110.853 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -168.16 167.51 12.3 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.294 0.569 . . . . 52.21 112.236 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -111.78 8.22 20.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.742 -0.663 . . . . 73.33 110.822 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 m -56.62 155.7 7.16 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 75.4 112.699 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p -87.18 126.14 34.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.24 111.039 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 64.33 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.55 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.34 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.33 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.43 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.53 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 71.31 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.32 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.54 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.22 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 31.23 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.24 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.34 113.382 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.32 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.24 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.409 HG22 HD13 ' A' ' 15' ' ' LEU . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.34 111.902 -177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.11 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.11 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 34.15 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.31 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 64.41 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 61.31 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.42 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 28' ' ' VAL . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.34 111.711 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.23 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 44.34 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.3 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.33 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.42 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.24 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.04 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.04 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.32 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.31 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.11 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.03 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.32 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.24 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' HG22 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.24 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.02 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.23 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.547 HG12 HG22 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.53 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 74.12 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.43 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.53 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.14 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.11 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 43.22 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 64' ' ' THR . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 62.04 110.704 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.44 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.12 111.904 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.23 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.43 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.45 110.367 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.41 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.43 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.4 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.53 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.14 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 23.33 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 34.32 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.44 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.34 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.51 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.33 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.32 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD13 HD23 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.21 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.591 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.35 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.49 132.38 17.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.42 110.842 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.5 p -80.02 30.33 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.245 0.461 . . . . 71.12 112.245 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 13.7 mm100 -99.53 -163.38 1.03 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.868 0.366 . . . . 71.34 111.669 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.767 -1.018 . . . . 51.11 112.646 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 2' ' ' GLY . 21.1 ttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 110.677 -0.12 . . . . 71.11 110.677 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . 140.22 -144.17 14.57 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.599 -0.81 . . . . 73.14 113.628 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -98.84 -174.74 2.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.788 0.435 . . . . 64.2 109.898 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -55.83 147.61 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.011 -0.676 . . . . 71.23 109.862 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 67.21 38.82 3.24 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.919 0.866 . . . . 72.12 108.955 -165.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -52.27 156.19 1.77 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.94 -1.027 . . . . 64.32 112.58 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -149.54 159.1 44.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.119 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -92.31 137.56 32.26 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.46 -0.336 . . . . 74.04 110.775 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -64.31 94.6 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.212 0.529 . . . . 74.01 111.702 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -117.56 155.91 28.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.609 -0.723 . . . . 71.01 109.809 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.8 t -53.67 102.48 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.002 0.429 . . . . 63.21 111.751 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p -117.39 114.54 23.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.4 110.987 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 45.14 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.24 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.35 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.12 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.23 110.737 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 84' ' ' GLN . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 72.23 110.911 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.22 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.01 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.35 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.32 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.43 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.44 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.32 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.24 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 50.22 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 64.34 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.44 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.15 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 64.14 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.15 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.13 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.31 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.2 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 45.34 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.24 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.01 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.51 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.31 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.54 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.41 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.32 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.586 ' OG1' HG12 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.11 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.14 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.45 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 74.55 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 32.34 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.54 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.43 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.21 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.24 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.34 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.13 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.3 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.22 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.42 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.31 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 64.3 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.21 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.41 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.43 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.4 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.41 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.3 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.31 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 71.25 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.45 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.41 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.13 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.31 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.34 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.23 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.05 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 61.13 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.23 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HB3' ' HE1' ' A' ' 19' ' ' PHE . . . -144.04 -177.54 5.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.13 111.484 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -92.11 16.86 10.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.888 0.375 . . . . 70.3 111.998 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 19' ' ' PHE . 81.5 mm-40 -128.54 164.25 23.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.797 0.332 . . . . 71.35 111.562 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.422 0 CA-C-O 118.909 -0.939 . . . . 65.43 113.414 179.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.951 0.405 . . . . 62.31 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.15 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.4 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.54 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.21 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.31 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.41 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.32 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.21 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.15 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.24 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 72.41 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.2 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.44 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.33 111.602 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 62.03 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 71.14 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.45 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.54 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.42 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 62.4 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.01 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.24 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.21 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 71.14 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.9 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.1 111.593 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.13 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.11 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.51 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.34 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.544 HG21 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.31 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.14 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.14 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 35.24 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.43 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.12 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.45 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.11 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.12 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD23 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.13 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.13 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.33 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.24 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 31.14 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.33 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 61.11 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.22 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.45 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 65.43 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.1 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.42 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 44.0 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.31 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.32 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.31 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.2 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.12 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.42 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 73.23 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.42 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.44 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' NZ ' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.45 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.32 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.32 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.54 HD13 HD23 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.42 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.54 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 43.02 111.557 -176.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.33 112.179 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.31 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.3 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.02 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.3 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.33 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 63.13 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.23 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.34 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 71.13 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.41 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.12 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 73.41 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.23 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.23 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 33.21 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.12 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.13 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.04 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 73.44 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.44 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.13 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.51 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 70.51 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.43 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.9 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.13 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.403 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 43.11 112.303 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.14 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.13 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.33 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.52 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 65.14 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.13 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 51.2 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.14 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.14 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.23 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.55 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.44 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.12 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.51 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.3 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.44 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.11 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.11 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.53 111.835 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 64' ' ' THR . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.13 111.036 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.42 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 62' ' ' VAL . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.15 111.911 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.34 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.42 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.11 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 61.2 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.43 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 71.15 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.55 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.24 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.03 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.22 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.33 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 62.43 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.51 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.23 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.31 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.41 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 55.25 111.4 -178.393 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.1 111.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.498 HG13 HD21 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.44 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.15 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.22 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.31 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 45' ' ' THR . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.259 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.43 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.24 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.55 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.44 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.53 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.35 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.14 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 15' ' ' LEU . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.01 111.472 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.43 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.35 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.31 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.23 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.1 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.41 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.11 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.24 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.23 111.508 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 52.25 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.31 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.3 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.15 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 60.22 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 19' ' ' PHE . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.2 113.244 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.34 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.42 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 50' ' ' ARG . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.34 111.238 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.21 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' HD11 ' A' ' 80' ' ' LEU . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.12 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.52 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.01 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.55 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.45 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.33 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.32 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.42 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.01 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.44 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.24 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.15 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 43.54 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 71.45 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.23 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.2 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.3 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.54 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.14 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.12 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.51 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.41 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.44 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.21 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.51 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.03 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.2 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.52 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.24 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.04 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 62.13 112.442 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 74.13 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.23 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.3 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.15 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 54.51 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 71.12 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.4 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.55 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.34 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.34 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.24 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 52.43 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.42 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 40.12 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 61.44 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.34 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.53 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.43 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.3 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 71.21 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.33 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.21 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.32 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.415 HD23 ' NE2' ' A' ' 40' ' ' GLN . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.2 111.425 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.54 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.415 ' NE2' HD23 ' A' ' 37' ' ' LEU . 25.7 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 65.22 111.793 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.35 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.417 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.22 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.53 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.4 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.565 ' OG1' HG12 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.32 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.52 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG12 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.15 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 74.55 113.406 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.02 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.04 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.494 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 50.2 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.14 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.43 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.41 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.54 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 70.35 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.43 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.55 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.32 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 51.11 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.1 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.22 111.167 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 71.01 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.14 112.361 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.35 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.22 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 70.31 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.41 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.35 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.21 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.41 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.43 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.22 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.4 111.679 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.13 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.03 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.24 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.541 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.42 111.436 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.027 0.441 . . . . 73.2 112.147 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.54 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 74' ' ' SER . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.15 112.065 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.01 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.23 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.22 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.54 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CE1' HG21 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.04 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.41 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.44 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.45 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.55 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.05 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 51.31 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.54 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.13 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG11 HE22 ' A' ' 40' ' ' GLN . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.15 111.817 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 62.2 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 72.34 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.11 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 55.12 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.41 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.35 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.13 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.51 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' NE2' ' A' ' 40' ' ' GLN . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 73.44 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.14 110.576 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.12 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.515 ' NE2' HD23 ' A' ' 37' ' ' LEU . 24.4 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.43 111.751 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.34 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.13 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.25 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.2 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.45 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.23 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.33 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.35 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.31 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.14 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 23.13 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.11 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.12 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 63.53 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.23 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.51 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.04 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.24 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.42 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.41 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.53 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.11 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.04 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.14 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.24 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.13 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.34 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.32 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.21 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 43.45 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.52 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 71.42 111.526 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.31 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.01 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.43 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.35 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 62.24 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.22 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 62.44 112.25 -175.642 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 71.51 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 62.52 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.52 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 73.41 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.54 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.45 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.12 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.22 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.22 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.23 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.13 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.52 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.14 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 71.54 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 72.34 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.33 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.52 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 64.41 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.14 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.43 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.13 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.54 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.21 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.12 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.11 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.43 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.54 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.24 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 72.03 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.419 ' OG1' HG12 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 62.34 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 70.12 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG12 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.02 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.22 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.2 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.32 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.12 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.12 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.12 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.23 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 62.13 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 65.03 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.41 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.24 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.44 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.21 111.859 -176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 64' ' ' THR . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.31 110.554 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.44 ' H ' HG12 ' A' ' 62' ' ' VAL . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.43 111.363 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.31 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.21 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 62.52 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.43 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 66' ' ' THR . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.24 111.936 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 64.42 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.42 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.51 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.23 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.41 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.2 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.04 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.13 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.23 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.34 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.632 HD13 HD23 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.32 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.33 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.54 111.402 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 62.04 112.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.01 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.1 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.13 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.1 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.24 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.12 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.41 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.34 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 55.32 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.11 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.33 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.42 112.694 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.32 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.45 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.21 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.14 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 43.41 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.52 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 61' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.05 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.43 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.53 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.53 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.45 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.04 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.22 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.01 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.41 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.03 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.3 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.23 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.43 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 51.1 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 54.31 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.44 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.24 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.44 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.45 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 64.15 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 63.15 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.33 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 64.1 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.35 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.51 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 61' ' ' LEU . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.44 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 72.4 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 64' ' ' THR . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.22 110.506 174.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.22 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 62' ' ' VAL . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.41 112.375 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 64.23 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.13 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.4 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.11 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.24 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.04 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.34 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.24 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.1 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.33 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.42 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.41 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 15' ' ' LEU . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.13 111.299 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.41 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.04 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.01 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.04 111.504 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.033 0.444 . . . . 62.03 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.41 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.24 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.02 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.54 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 52.34 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 70.24 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 33.11 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.23 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.33 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.01 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.03 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.12 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.34 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.52 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 HD13 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 72.01 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.767 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 51.52 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.13 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.12 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 71.02 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.21 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 61' ' ' LEU . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.02 111.335 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.44 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.42 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.609 HD23 ' NE2' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 64.14 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.22 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 55.2 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.609 ' NE2' HD23 ' A' ' 37' ' ' LEU . 26.8 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.34 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.52 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.53 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.12 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.4 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.21 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.34 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.41 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.42 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.23 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.33 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.23 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.11 111.381 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.24 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.21 111.382 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.22 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.22 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.54 111.712 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 60.13 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 52.42 112.085 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 70.43 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.42 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 60.12 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.05 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.22 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.05 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.12 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.1 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.52 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 44.4 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.44 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.14 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.51 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.45 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.21 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 HD23 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.35 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.31 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.14 112.021 -178.149 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.791 0.329 . . . . 73.4 111.683 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.23 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.31 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD11 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.22 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 54.01 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 54.43 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.4 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.33 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.22 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.32 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 52.41 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.52 112.182 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.31 112.624 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.42 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.456 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.22 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.23 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.21 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.11 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.2 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.02 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.53 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.24 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.43 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.45 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.14 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.34 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 23.1 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.2 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 44.02 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.41 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.34 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.32 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.04 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.13 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.42 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.33 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.1 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 49' ' ' PRO . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.52 111.902 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 34' ' ' VAL . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 73.13 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.402 HD11 ' NZ ' ' A' ' 53' ' ' LYS . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.32 111.957 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.11 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.12 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.31 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.34 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 64' ' ' THR . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.991 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.31 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.421 ' H ' HG12 ' A' ' 62' ' ' VAL . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.52 111.954 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.12 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 73.32 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' HD11 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.31 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.23 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.14 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.32 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.2 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 70.43 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.54 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.14 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.42 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.3 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.24 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.13 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.45 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.12 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.33 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.33 111.172 179.622 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.796 0.332 . . . . 43.24 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.51 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.2 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 70.13 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.44 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.3 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.42 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.24 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.54 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.44 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.45 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 70.22 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.52 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.42 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG11 HE22 ' A' ' 40' ' ' GLN . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.32 111.593 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.21 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.54 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.35 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.22 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.4 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.2 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.22 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.45 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.05 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.21 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.436 HE22 HG11 ' A' ' 28' ' ' VAL . 22.7 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.51 110.559 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.34 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 63.6 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.32 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.24 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.35 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.35 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.44 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.52 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.12 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.1 113.405 -176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.42 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.21 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.11 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.42 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.433 HD12 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 55.34 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.52 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 61.23 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.2 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.3 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.33 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.34 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.32 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' THR . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.11 110.921 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.02 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.413 ' H ' HG12 ' A' ' 62' ' ' VAL . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.04 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 54.24 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD11 HD12 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.41 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.44 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.21 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 64.25 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.3 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.04 111.233 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.42 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.11 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.21 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 52.02 111.707 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.14 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 71.25 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.774 0.321 . . . . 71.03 111.676 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.35 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.33 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.31 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.33 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.44 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.2 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.54 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.05 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.02 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.42 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.45 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.33 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.23 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.32 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.34 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 54.22 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.54 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.34 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.12 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.25 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.42 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.55 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.44 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.43 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.12 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.44 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.41 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.34 112.393 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.44 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.02 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.43 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.31 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.54 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.1 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 72.23 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.31 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 60.43 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.53 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG3' HG22 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.12 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.13 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 73.12 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.15 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.24 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.33 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 52.0 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.01 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.32 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.24 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.44 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.24 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 63.24 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.13 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.22 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.34 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.2 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.53 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.24 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.11 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.01 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.53 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 61.31 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.32 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.41 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.14 110.824 179.08 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.24 0.543 . . . . 61.43 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.44 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.32 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.22 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.12 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.21 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.33 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.55 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.42 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.41 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.13 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.45 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.22 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.32 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 62.55 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.22 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.03 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.1 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.31 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 54.44 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 44.41 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.21 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.35 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.44 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 52.14 111.36 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.33 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.12 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.22 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.33 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.34 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.13 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.52 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 60.11 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.51 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 72.43 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.35 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.04 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.21 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.1 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 61.04 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.32 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.43 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.22 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.3 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.43 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 64.15 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.02 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.03 110.92 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.44 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 53.31 112.389 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.34 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.22 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.03 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.23 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.52 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.45 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.53 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 51.44 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.22 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.22 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.635 HD11 HD23 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.05 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.22 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.11 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.34 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.42 111.541 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.53 112.733 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.12 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.13 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.21 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.14 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.22 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.34 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 73.52 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.31 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.33 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.13 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.41 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.11 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.02 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.23 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 50.32 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 53.22 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.41 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 65.32 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 44.43 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.23 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 61.11 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.35 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.22 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.2 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 54.33 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.424 HE22 HG11 ' A' ' 28' ' ' VAL . 24.6 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.11 112.558 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.11 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.35 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.13 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 55.01 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.12 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.11 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 64.14 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.33 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.42 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.12 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.31 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 54.52 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.1 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD23 HD13 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.02 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.44 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.33 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.52 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.44 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 51.32 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 63.15 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.43 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.4 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.55 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.45 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.24 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.32 110.505 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.43 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.32 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.42 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 52.05 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.43 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.41 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.21 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.33 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.21 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.12 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.551 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.45 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.43 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.24 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.22 112.704 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.21 111.18 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.471 HD12 HD21 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.13 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.23 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 63.23 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 32.01 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.15 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HZ ' HG21 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 53.51 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.23 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.23 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.32 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 63.25 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.05 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 60.54 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.21 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 44.14 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 60.34 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.12 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.53 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 62.32 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.44 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.42 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.34 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.1 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD23 ' NE2' ' A' ' 40' ' ' GLN . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.24 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.03 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.33 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.51 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.21 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.44 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.14 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.01 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.506 HG21 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.32 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.03 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 52.41 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.1 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.2 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.14 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.03 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 80' ' ' LEU . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.14 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.03 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.02 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.14 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.32 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.13 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.54 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.21 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.05 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.03 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.42 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.1 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 70.31 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.3 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.42 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.23 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.53 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.24 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.41 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 53.02 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.31 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.21 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.53 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD13 HD23 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 55.5 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.23 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.3 110.454 176.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 54.02 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.32 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 62.51 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.42 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.33 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.23 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.02 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.31 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.23 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.34 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.44 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.42 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.31 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.12 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.24 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 70.11 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.24 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 63.5 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.1 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.33 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.44 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.4 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.33 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.32 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.4 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.45 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.11 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.12 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.23 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.22 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.43 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG12 ' A' ' 47' ' ' VAL . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.15 112.144 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 42.21 111.394 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.51 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.35 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 71.21 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.03 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.24 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.04 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD23 HD13 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.04 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.34 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.22 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 63.21 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.51 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.24 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 64' ' ' THR . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.45 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' HG12 ' A' ' 62' ' ' VAL . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.23 112.252 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.14 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.31 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.22 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.21 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.31 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.43 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.3 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 61.24 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.45 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.41 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.34 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.11 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.35 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.13 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.565 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.02 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.561 HD13 HD23 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.52 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.24 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 50.13 111.645 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.969 0.414 . . . . 73.35 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 74.44 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 74' ' ' SER . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.32 111.829 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.42 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.12 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 73.5 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 71.23 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.1 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.51 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.4 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.11 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.32 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.14 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.22 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.44 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.14 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.32 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.13 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.03 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.42 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.13 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.34 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.42 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.33 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.1 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.03 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.42 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.59 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.45 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.23 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.53 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 55.21 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.02 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.527 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.44 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.51 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.11 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 64.23 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.24 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.34 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.51 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.582 HD12 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.24 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.33 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.2 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.24 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.02 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 65.14 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 56' ' ' PHE . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 62.53 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.03 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.21 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.02 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.15 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.13 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.35 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.31 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.34 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.2 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.03 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 71.45 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.44 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 32.04 111.737 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.1 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.14 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 60.13 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 71.34 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.44 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.22 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.31 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.41 111.785 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.3 0.571 . . . . 44.32 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.2 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.3 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.32 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.3 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.32 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.1 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.44 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.11 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.42 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.13 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.33 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.51 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.43 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.33 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.867 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.2 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 62.34 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.34 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.21 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 62.25 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.43 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.31 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.4 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.21 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.01 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.34 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.51 113.202 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.2 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 32.42 112.575 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.11 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 72.51 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.53 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.45 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.34 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.11 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.4 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.02 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HD13 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.14 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.23 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.23 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.13 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.42 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.34 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.51 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.21 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.13 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.24 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.35 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 65.32 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.33 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.4 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.54 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.4 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.34 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.23 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.43 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.42 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.02 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.33 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 35.25 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.13 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.575 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.4 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.651 HD13 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.34 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.11 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.54 110.459 178.609 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.24 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.45 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.41 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.11 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.557 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 63.33 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.4 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 64.43 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 71.1 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.45 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.21 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.34 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 72.21 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 62.31 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 41.22 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' HG22 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.22 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.54 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 63.13 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.02 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.43 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.34 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.42 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.42 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.45 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.4 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.31 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.24 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.12 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.51 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.52 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.41 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.53 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.21 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.21 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.43 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.05 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 52.12 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.44 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 74.51 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.31 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.35 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.14 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.23 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.3 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.42 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.24 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.11 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.31 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 64.05 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.42 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.43 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 61.52 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.54 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.03 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.34 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.02 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.32 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.31 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.4 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.4 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.14 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.15 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.44 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.12 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.55 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.02 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.31 110.662 178.301 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.24 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 64.33 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.55 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.34 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.33 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.43 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.53 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 71.31 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.32 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.54 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.22 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 31.23 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.24 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.34 113.382 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.32 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.24 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.409 HG22 HD13 ' A' ' 15' ' ' LEU . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.34 111.902 -177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.11 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.11 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 34.15 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.31 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 64.41 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 61.31 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.42 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 28' ' ' VAL . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.34 111.711 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.23 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 44.34 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.3 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.33 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.42 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.24 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.04 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.04 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.32 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 52' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.31 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.11 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.03 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.32 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.24 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' HG22 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.24 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.02 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.23 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.547 HG12 HG22 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.53 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 74.12 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.43 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.53 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.14 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.11 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 43.22 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 64' ' ' THR . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 62.04 110.704 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.44 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.12 111.904 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.23 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.43 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.45 110.367 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.41 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.43 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.4 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.53 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.14 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 23.33 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 34.32 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.44 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.34 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.51 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.33 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.32 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.421 HD13 HD23 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.21 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.591 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.35 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.42 110.842 179.201 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.4 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 45.14 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.24 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.35 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.12 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.23 110.737 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 72.23 110.911 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.22 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.01 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.35 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.32 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.43 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.44 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.32 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.24 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 50.22 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 64.34 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.44 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.15 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 64.14 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.15 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.13 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.31 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.2 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 45.34 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.24 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.01 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.51 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.31 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.54 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.41 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.32 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.586 ' OG1' HG12 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.11 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.14 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.45 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 74.55 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 32.34 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.54 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.43 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.21 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.24 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.34 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.13 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.3 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.22 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.42 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.31 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 64.3 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.21 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.41 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.43 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.4 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.41 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.3 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.31 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 71.25 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.45 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.41 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.13 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.31 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.34 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.23 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.05 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 61.13 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.23 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HB3' ' HE1' ' A' ' 19' ' ' PHE . . . . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.13 111.484 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.754 0.311 . . . . 75.21 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.54 90.14 0.29 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.238 -0.506 . . . . 63.31 112.946 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -63.57 127.23 30.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.603 -0.351 . . . . 73.35 111.15 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -73.96 95.15 2.44 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.94 0.4 . . . . 62.1 110.984 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -79.64 6.58 10.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.206 0.817 . . . . 73.33 113.206 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -63.12 -52.97 60.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.945 0.339 . . . . 72.02 111.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.94 68.4 2.01 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.07 0.462 . . . . 72.13 111.373 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -146.79 168.82 20.45 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.296 -0.411 . . . . 72.2 111.046 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t 56.97 16.9 3.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.327 0.492 . . . . 61.31 112.327 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.0 m170 -92.04 166.99 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.952 0.406 . . . . 73.35 111.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -155.47 172.75 17.73 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.9 0.381 . . . . 72.31 111.021 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 p -91.38 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 62.31 111.564 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' SER . 29.2 pt -85.46 150.44 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.842 0.354 . . . . 73.15 111.398 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -81.7 118.05 22.52 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.259 0.466 . . . . 52.4 112.259 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 13' ' ' ILE . 7.4 mp -108.05 117.5 34.31 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.515 -0.311 . . . . 73.54 111.202 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -93.48 92.54 7.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.144 0.497 . . . . 73.21 110.37 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.14 120.32 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.025 -0.534 . . . . 52.31 111.344 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -94.57 106.61 18.6 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.507 0.558 . . . . 63.41 112.507 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 45' ' ' THR . 28.6 m-85 -79.85 73.46 6.6 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.995 0.426 . . . . 72.32 110.352 169.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.4 -82.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.196 -0.526 . . . . 50.21 112.937 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.73 11.93 18.22 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 122.69 -0.3 . . . . 70.15 113.071 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -120.82 110.05 15.88 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.223 -0.575 . . . . 72.24 111.346 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 m -84.99 113.44 21.43 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.71 0.29 . . . . 72.41 110.814 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.41 110.6 63.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.552 -0.295 . . . . 75.2 111.664 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.66 117.51 4.79 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.57 2.18 . . . . 72.44 112.648 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 88.1 mt -116.73 169.5 9.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.156 0.503 . . . . 74.33 111.602 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 67.5 m -147.51 105.39 3.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.427 -0.351 . . . . 62.03 111.243 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.43 170.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.961 0.41 . . . . 62.32 111.82 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -94.75 146.42 31.38 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 116.417 -0.356 . . . . 71.14 111.473 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 31.2 Cg_endo -62.12 -8.6 12.48 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.674 2.249 . . . . 72.45 113.386 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.61 -28.59 66.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.979 0.418 . . . . 73.54 111.241 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.45 157.73 35.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.273 0.558 . . . . 74.42 112.184 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 65.0 p -102.69 162.09 13.21 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.999 -0.546 . . . . 62.4 110.647 174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 54' ' ' LEU . 26.3 m -62.71 -24.55 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.188 0.518 . . . . 73.01 110.727 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -69.82 -43.34 72.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.209 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.6 -40.67 72.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.986 -0.552 . . . . 73.42 110.182 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 67' ' ' LEU . 87.3 mt -58.17 -48.19 81.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.912 -0.586 . . . . 65.24 111.574 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 62.7 mttm -51.91 -44.81 63.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.139 0.495 . . . . 74.21 110.572 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.5 t -68.86 -35.86 77.42 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.916 -0.584 . . . . 71.14 112.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.9 mt-30 -70.41 -44.97 66.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.045 0.45 . . . . 72.1 111.593 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.38 -29.84 61.71 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.916 0.71 . . . . 72.13 112.916 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 64.9 tt0 -51.36 -51.76 65.8 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 113.23 0.826 . . . . 60.11 113.23 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 16.7 Cg_exo -68.88 -16.67 41.52 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.112 1.875 . . . . 64.51 113.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.25 -52.83 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.227 0.536 . . . . 52.34 111.498 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.544 HG21 ' CZ ' ' A' ' 19' ' ' PHE . 68.1 p -94.99 -20.35 19.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.167 -0.469 . . . . 63.31 112.142 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 68.68 27.6 5.89 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.676 0.621 . . . . 71.14 112.676 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.1 p -108.55 139.43 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 120.999 0.428 . . . . 44.14 111.357 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.75 131.49 37.49 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 112.848 0.684 . . . . 35.24 112.848 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -60.91 -30.57 90.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.913 2.409 . . . . 73.43 112.691 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -65.99 -37.5 86.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.132 0.491 . . . . 74.12 110.764 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.64 -27.72 58.52 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.787 -0.642 . . . . 73.45 112.902 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 50.8 mt-30 -66.21 83.31 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.122 0.486 . . . . 74.11 111.609 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 63.5 mttm -88.13 101.39 13.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.203 -0.453 . . . . 70.12 111.811 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD23 HD13 ' A' ' 80' ' ' LEU . 98.3 mt -78.64 118.59 20.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.3 -0.409 . . . . 50.13 110.914 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 62.1 mt -126.59 109.86 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.128 0.49 . . . . 74.13 111.62 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -127.59 144.38 51.08 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.342 -0.39 . . . . 72.33 110.373 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 66.38 16.05 10.3 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.061 0.458 . . . . 74.24 111.045 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.06 21.26 76.9 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.635 -0.586 . . . . 31.14 111.635 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -125.27 124.56 41.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.551 0.74 . . . . 64.33 110.639 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.0 133.79 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.865 0.364 . . . . 61.11 110.723 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.97 145.35 25.57 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.42 0.629 . . . . 71.22 112.196 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.96 149.01 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.637 -0.711 . . . . 72.45 111.314 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.32 -33.88 6.19 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.059 0.763 . . . . 65.43 113.059 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.9 p -79.97 -16.53 55.01 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.001 0.741 . . . . 72.1 113.001 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -83.5 125.03 31.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.115 0.483 . . . . 70.42 112.213 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 63.7 p -82.65 169.3 16.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.917 -0.583 . . . . 44.0 111.08 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.6 mm? -50.64 -39.51 50.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.936 0.398 . . . . 73.31 111.513 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -65.27 -49.29 70.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.325 -0.398 . . . . 71.32 111.057 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -67.95 -15.75 63.75 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.249 -0.432 . . . . 73.31 111.88 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -100.61 11.11 40.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.409 -0.36 . . . . 74.2 111.816 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 64.49 14.8 9.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.905 0.482 . . . . 75.12 112.294 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -82.59 140.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 61.25 112.174 -176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.98 176.33 22.6 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.004 -0.544 . . . . 61.42 112.152 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 t -64.38 109.97 2.1 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.186 -0.597 . . . . 73.23 111.318 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 14.09 21.12 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.222 -0.445 . . . . 75.42 112.516 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.24 131.65 38.31 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.137 0.494 . . . . 70.44 111.907 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' NZ ' ' HB2' ' A' ' 77' ' ' LYS . 8.9 mtmp? -89.97 99.0 12.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.891 -0.595 . . . . 74.45 110.839 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.01 114.6 26.82 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.938 0.399 . . . . 74.32 111.824 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 22.7 ttt -78.66 122.61 26.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.205 -0.295 . . . . 65.32 110.205 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.54 HD13 HD23 ' A' ' 54' ' ' LEU . 36.6 tp -113.55 104.73 12.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.062 0.458 . . . . 72.42 111.312 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 25.5 ttt -75.57 85.76 2.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 74.54 110.212 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.98 -172.48 2.62 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.236 -0.438 . . . . 43.02 111.557 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -118.81 117.46 28.93 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.042 0.386 . . . . 65.43 112.042 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -93.76 -11.88 30.39 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.42 0.629 . . . . 72.23 110.324 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.758 -1.024 . . . . 71.24 113.115 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.683 0.277 . . . . 64.21 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.97 0.03 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.209 -0.52 . . . . 63.32 113.775 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -68.55 89.91 0.37 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.432 0.634 . . . . 64.35 112.048 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -96.69 140.11 31.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.053 -0.521 . . . . 71.13 111.341 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -121.92 154.3 37.33 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.09 0.471 . . . . 72.11 112.015 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -134.91 -170.23 2.52 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.018 -0.537 . . . . 75.23 110.25 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -77.72 -49.48 14.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.712 0.291 . . . . 62.32 110.419 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 65.64 -6.62 0.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.003 1.112 . . . . 74.23 114.003 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -89.97 -18.88 25.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.615 0.968 . . . . 61.35 113.615 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -58.47 -17.88 24.46 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.495 0.924 . . . . 63.54 113.495 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.1 t -62.74 143.1 57.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.963 0.411 . . . . 64.1 110.948 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 p -86.2 123.16 31.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.175 0.512 . . . . 73.33 112.179 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' SER . 24.8 pt -88.53 147.16 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.872 -0.604 . . . . 65.31 111.306 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -91.85 123.17 35.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.996 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.5 mt -116.19 139.34 50.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.916 0.389 . . . . 60.3 112.008 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.4 m -108.83 102.18 11.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.406 -0.361 . . . . 74.02 110.269 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.48 124.72 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.282 0.563 . . . . 74.3 111.992 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.1 88.37 5.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.902 -0.59 . . . . 72.33 110.92 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.96 81.83 7.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.742 0.306 . . . . 63.13 110.278 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.27 52.77 45.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.215 -0.517 . . . . 54.23 113.214 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.28 -18.89 46.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.117 -0.564 . . . . 71.34 113.581 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -93.27 106.47 18.43 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.488 -0.419 . . . . 71.13 111.418 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.7 p -81.48 93.59 6.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.231 0.539 . . . . 74.41 111.461 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.09 124.08 70.92 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.29 -0.414 . . . . 70.12 111.362 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.25 108.97 1.59 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.723 2.282 . . . . 73.41 112.967 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.25 164.87 11.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.14 0.495 . . . . 73.23 111.86 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.3 p -148.13 101.49 3.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.301 -0.409 . . . . 72.23 111.065 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 37' ' ' LEU . 34.9 m -133.69 167.98 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.701 0.286 . . . . 33.21 111.566 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.0 p -82.99 139.72 42.82 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 120.658 0.266 . . . . 71.12 110.706 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 43.1 Cg_endo -67.05 -6.96 17.31 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.346 2.031 . . . . 73.13 113.398 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -74.96 -27.22 60.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.869 0.366 . . . . 75.04 111.495 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.85 156.27 38.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.278 0.561 . . . . 73.44 111.52 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 39.6 p -96.02 159.25 15.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.752 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 33.4 m -62.42 -24.1 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.086 0.47 . . . . 75.44 111.058 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 27.0 ttpp -67.94 -41.26 82.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.112 0.482 . . . . 64.13 110.185 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 8.5 t70 -68.92 -21.72 64.2 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.935 -0.575 . . . . 64.51 110.652 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 28' ' ' VAL . 61.0 mt -78.29 -45.24 23.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.282 -0.417 . . . . 70.51 111.694 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 8.8 mtmp? -64.47 -23.58 67.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.009 0.433 . . . . 74.43 111.465 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.2 p -77.82 -19.01 55.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.685 0.279 . . . . 54.32 111.311 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.9 mt-30 -87.76 -47.87 8.29 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.828 0.347 . . . . 62.13 111.295 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.403 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.6 mt -62.47 -27.81 69.38 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.303 0.483 . . . . 43.11 112.303 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.55 -59.83 12.28 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.72 0.637 . . . . 53.14 112.72 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.63 -9.42 20.62 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.042 1.828 . . . . 55.13 113.201 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.13 -40.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.719 0.295 . . . . 74.33 111.544 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -119.96 -0.24 10.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 66.04 10.49 7.04 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.453 0.538 . . . . 63.52 112.453 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.46 134.02 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.931 0.396 . . . . 65.14 111.163 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.38 145.01 98.35 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.262 -0.426 . . . . 73.13 111.965 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -59.96 -16.73 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.727 2.285 . . . . 51.2 113.321 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.204 0.526 . . . . 71.14 110.924 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.14 -33.88 86.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.224 -0.512 . . . . 61.14 112.082 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 70.6 mt-30 -72.75 95.71 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.099 0.476 . . . . 52.23 111.162 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 52.3 mttp -102.52 93.63 5.24 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.03 0.443 . . . . 74.55 111.577 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 80' ' ' LEU . 97.1 mt -74.67 104.5 5.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.977 -0.556 . . . . 52.44 111.285 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.0 mt -114.8 120.89 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.05 0.452 . . . . 65.12 111.433 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -129.31 128.43 43.15 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.374 -0.376 . . . . 64.51 110.981 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 63.7 25.31 14.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.86 0.464 . . . . 60.3 111.839 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.61 7.57 78.58 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.342 -0.456 . . . . 61.44 113.849 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -128.3 136.22 50.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.895 0.347 . . . . 73.11 111.457 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.66 131.95 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.835 0.35 . . . . 71.11 110.449 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -73.26 137.4 44.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.204 0.526 . . . . 70.53 111.835 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 64' ' ' THR . 43.8 t -69.86 131.91 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.05 -0.523 . . . . 74.13 111.036 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 49.3 mt-10 -58.77 -29.36 66.74 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.588 0.588 . . . . 72.42 112.588 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 62' ' ' VAL . 44.9 p -84.03 -1.91 55.68 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 111.911 0.337 . . . . 72.15 111.911 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 t -97.52 133.21 42.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.972 0.415 . . . . 73.34 111.642 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 25.7 p -80.2 167.33 20.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.402 -0.363 . . . . 73.42 110.787 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -62.63 -39.11 92.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.039 -0.413 . . . . 74.11 110.406 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttp -62.28 -43.66 98.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.379 -0.373 . . . . 61.2 111.274 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.21 -35.83 82.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.102 0.477 . . . . 74.43 110.978 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 m -82.19 3.03 28.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.104 -0.498 . . . . 71.15 112.186 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 64.74 18.44 11.43 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.997 0.519 . . . . 44.55 112.375 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 76' ' ' ALA . 96.5 t -71.26 112.32 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.858 0.361 . . . . 63.25 110.7 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.67 -166.02 39.77 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.252 -0.499 . . . . 62.24 114.073 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 68.0 p -80.32 25.63 0.39 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.547 0.573 . . . . 74.03 112.547 -174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.86 37.9 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.519 -0.372 . . . . 73.22 112.343 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -82.48 124.43 30.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.91 0.386 . . . . 62.33 111.292 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -91.3 95.92 10.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.107 0.48 . . . . 62.43 111.113 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.6 mt -83.02 147.35 28.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.045 -0.525 . . . . 73.51 111.617 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 ttt -105.32 110.81 23.3 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.746 0.308 . . . . 71.23 110.535 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 54' ' ' LEU . 28.2 tp -95.13 100.14 12.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.994 0.426 . . . . 64.31 111.047 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 50.4 ttm -77.33 86.52 3.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.135 0.493 . . . . 65.41 110.636 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.53 144.73 36.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.969 -0.559 . . . . 55.25 111.4 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -96.18 146.19 24.89 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.947 0.404 . . . . 63.42 111.623 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -60.75 -25.09 66.22 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.549 0.574 . . . . 71.01 112.549 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 119.143 -0.809 . . . . 72.35 114.023 178.219 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.586 0.231 . . . . 72.5 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.52 37.8 58.1 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.167 -0.54 . . . . 53.23 113.849 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -138.9 110.12 6.89 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.142 0.471 . . . . 63.3 111.336 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -115.57 174.52 5.97 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.265 0.555 . . . . 72.31 112.126 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -125.15 114.79 19.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.108 -0.496 . . . . 75.34 110.404 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -89.49 16.99 6.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.512 0.56 . . . . 65.33 112.512 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -68.63 145.1 54.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.929 0.395 . . . . 74.04 110.745 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -149.1 124.8 10.46 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.568 0.581 . . . . 73.43 112.568 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.2 m -151.85 168.34 25.44 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.97 -0.559 . . . . 74.15 110.867 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -74.62 99.26 3.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 72.32 111.484 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -146.73 -172.83 4.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.088 -0.506 . . . . 53.34 110.697 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -92.36 151.48 20.25 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.042 0.448 . . . . 52.1 111.881 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.498 HG13 HD21 ' A' ' 15' ' ' LEU . 28.2 pt -131.54 154.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.126 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.61 117.2 30.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.236 0.458 . . . . 73.44 112.236 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 13' ' ' ILE . 2.6 mm? -111.06 150.72 28.96 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.161 0.505 . . . . 72.25 111.309 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.0 m -122.89 93.96 4.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.365 -0.38 . . . . 63.15 110.757 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.01 116.46 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.805 0.336 . . . . 73.22 110.682 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 5.9 mtpm? -101.64 107.31 18.53 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.82 0.674 . . . . 72.31 112.82 -173.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 45' ' ' THR . 18.9 m-85 -79.33 78.45 5.83 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.259 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.24 73.88 0.34 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.29 -0.481 . . . . 64.43 113.398 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.5 -50.52 1.83 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.947 -0.644 . . . . 70.25 112.788 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 3.1 mmmp? -56.42 166.28 0.91 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.178 0.513 . . . . 71.24 112.114 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 p -134.55 119.65 18.69 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.213 -0.449 . . . . 75.55 111.021 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mm -110.41 104.31 55.6 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.294 0.238 . . . . 73.44 111.041 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 115.79 4.45 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.877 2.385 . . . . 72.53 112.905 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 41' ' ' LEU . 91.2 mt -122.2 140.84 52.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.796 0.331 . . . . 75.35 111.564 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -118.34 97.75 5.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.946 0.403 . . . . 64.14 110.817 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 15' ' ' LEU . 27.8 m -123.06 179.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.831 0.348 . . . . 73.01 111.472 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -99.84 147.13 33.01 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.762 -0.199 . . . . 70.43 111.261 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.72 -20.14 57.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.737 2.291 . . . . 73.35 113.082 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.39 -23.89 66.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.253 -0.431 . . . . 63.43 112.001 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.7 m -73.33 146.85 44.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.193 0.521 . . . . 74.31 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 47.3 p -97.37 168.31 10.48 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.053 -0.521 . . . . 72.23 111.388 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 54' ' ' LEU . 33.1 m -66.6 -21.62 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.919 0.39 . . . . 51.1 111.104 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 54.9 tttp -71.93 -38.91 69.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.35 0.595 . . . . 65.41 110.067 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.56 -41.16 85.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 72.11 110.203 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.24 -41.73 98.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.12 -0.491 . . . . 65.24 111.617 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -56.1 -39.88 72.84 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.074 0.464 . . . . 73.23 111.508 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -79.26 -13.23 59.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.946 0.35 . . . . 52.25 111.946 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -93.89 -41.01 9.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.05 0.389 . . . . 74.31 112.05 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 26' ' ' LEU . 96.5 mt -75.92 -34.99 59.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.792 0.664 . . . . 72.3 112.792 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.4 tt0 -55.9 -53.66 60.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 112.72 0.637 . . . . 55.32 112.72 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 24.5 Cg_endo -60.66 -10.79 15.01 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.19 1.927 . . . . 61.15 113.131 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -95.63 -44.42 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.975 0.417 . . . . 60.22 111.445 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 19' ' ' PHE . 72.5 p -112.98 1.15 15.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.244 0.831 . . . . 64.2 113.244 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 61.06 14.36 5.33 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 82' ' ' ALA . 62.4 t -83.68 129.42 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 122.014 -0.429 . . . . 60.34 111.711 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.38 147.26 98.18 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.302 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.76 -35.11 29.58 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.851 2.367 . . . . 71.42 113.011 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 50' ' ' ARG . 47.0 ttp180 -57.43 -43.07 83.54 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.285 0.564 . . . . 71.34 111.238 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.06 -35.25 50.14 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.961 -0.563 . . . . 65.21 112.477 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' HD11 ' A' ' 80' ' ' LEU . 49.6 mt-30 -67.06 79.96 0.13 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.912 0.387 . . . . 74.12 111.75 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -95.05 96.59 9.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.903 0.382 . . . . 74.52 111.484 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 34' ' ' VAL . 96.9 mt -82.68 111.69 18.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.952 0.406 . . . . 63.01 111.473 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.45 125.53 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.009 0.433 . . . . 75.55 111.208 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -127.58 130.73 49.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.645 -0.252 . . . . 71.45 111.167 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 60.78 21.18 11.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.228 0.455 . . . . 60.33 112.228 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.27 71.64 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.406 -0.426 . . . . 70.32 112.879 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -118.39 130.8 56.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.673 0.389 . . . . 63.42 111.492 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.3 120.83 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.155 0.503 . . . . 73.01 110.528 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -82.94 140.75 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.349 0.595 . . . . 72.44 112.484 -173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.15 143.88 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.713 -0.676 . . . . 64.24 110.597 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.7 mt-10 -54.69 -34.73 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.7 0.63 . . . . 74.15 112.7 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 p -83.65 5.78 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.528 0.566 . . . . 43.54 112.528 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -92.63 128.11 38.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.955 0.407 . . . . 71.45 111.446 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 71.5 p -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.175 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.15 -51.94 48.75 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.076 0.399 . . . . 71.23 112.076 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.55 -31.43 67.96 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.823 0.675 . . . . 72.2 112.823 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.3 mt-30 -56.9 -24.72 54.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.073 0.397 . . . . 73.54 112.073 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 t -107.93 28.69 7.98 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.741 0.305 . . . . 73.14 111.519 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 64.11 19.84 11.94 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.596 0.591 . . . . 65.12 112.596 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.65 126.52 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.818 0.342 . . . . 73.51 111.258 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.72 -151.68 7.34 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.247 -0.501 . . . . 65.41 112.864 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.5 p -75.14 77.2 2.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.275 0.559 . . . . 73.44 111.427 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.53 79.74 0.17 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.164 -0.471 . . . . 71.21 112.694 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.41 135.69 33.9 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.944 0.402 . . . . 71.51 111.812 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.35 109.12 21.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 71.03 111.252 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 127.39 41.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.091 -0.504 . . . . 64.2 111.501 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 50.8 ttm -88.98 101.53 14.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.041 0.448 . . . . 63.52 110.847 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 52' ' ' GLN . 36.2 tp -98.5 99.95 11.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.95 0.405 . . . . 75.24 111.259 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 56.3 ttp -84.67 83.7 7.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.147 0.499 . . . . 71.04 110.087 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . -121.07 150.41 41.23 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.976 -0.556 . . . . 62.13 112.442 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -93.88 116.4 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.081 -0.509 . . . . 72.24 111.558 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -141.49 125.03 16.71 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.294 -0.412 . . . . 63.44 110.027 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.861 -0.966 . . . . 74.33 113.003 178.881 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.8 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.783 0.325 . . . . 73.33 111.281 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.99 114.59 3.34 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.348 -0.454 . . . . 42.41 112.548 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -64.85 92.02 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.348 0.594 . . . . 75.01 112.558 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -161.06 103.01 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.323 0.582 . . . . 65.52 111.108 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -83.57 149.41 26.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.287 0.565 . . . . 54.32 112.323 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.08 176.95 8.19 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.611 -0.722 . . . . 70.14 110.691 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -147.14 -176.71 5.32 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.139 -0.351 . . . . 70.44 111.722 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -67.32 165.78 15.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.23 0.538 . . . . 74.42 111.895 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -138.71 171.97 13.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.047 -0.524 . . . . 63.54 111.685 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -128.57 31.47 4.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.993 -0.549 . . . . 74.32 110.848 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.9 m -69.18 179.46 1.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.887 -0.597 . . . . 72.41 111.747 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p -86.55 150.31 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.106 0.479 . . . . 74.13 111.79 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -102.3 138.75 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.159 0.504 . . . . 72.23 112.273 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 8.2 mtpm? -88.28 78.65 7.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.569 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -88.32 163.47 16.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.079 0.466 . . . . 74.3 111.179 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 79.6 m -128.98 109.86 11.59 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.945 -0.472 . . . . 73.15 111.447 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -98.01 127.95 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.902 0.382 . . . . 54.51 110.946 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -95.99 122.75 39.14 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.522 0.564 . . . . 71.12 112.522 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.05 94.8 6.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.129 -0.487 . . . . 73.4 110.783 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.9 -101.26 0.4 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.284 -0.484 . . . . 72.55 112.938 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.93 -4.78 54.17 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.3 -0.476 . . . . 62.34 113.047 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -97.21 144.99 26.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.886 0.374 . . . . 73.34 111.509 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -116.46 108.76 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.859 0.361 . . . . 74.24 110.342 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.93 110.9 65.1 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 112.016 0.376 . . . . 52.43 112.016 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.46 126.45 7.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 53.42 112.179 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.1 mt -124.02 172.07 9.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.784 0.326 . . . . 40.12 111.132 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 m -129.86 105.1 7.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.853 0.359 . . . . 61.44 110.525 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 15' ' ' LEU . 17.6 m -121.72 172.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.119 0.485 . . . . 53.34 111.637 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.3 m -89.22 127.79 53.94 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.223 -0.444 . . . . 65.53 111.29 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -64.9 -23.11 62.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.733 2.289 . . . . 74.43 113.209 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.46 2.49 24.94 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.047 0.388 . . . . 64.3 112.047 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 73.8 m -90.28 154.66 19.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.735 0.302 . . . . 71.21 111.327 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 46.5 p -86.57 154.03 21.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.724 0.297 . . . . 71.33 111.223 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 54' ' ' LEU . 30.6 m -65.84 -21.82 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.096 0.475 . . . . 72.21 111.142 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 57.5 tttp -76.07 -35.15 59.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.656 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.76 -33.34 75.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.012 0.434 . . . . 74.32 110.788 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.415 HD23 ' NE2' ' A' ' 40' ' ' GLN . 73.2 mt -55.2 -36.0 65.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.33 -0.395 . . . . 63.2 111.425 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' GLN . 96.1 mttt -58.59 -43.06 89.36 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 65.54 110.638 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.8 m -64.55 -29.0 70.03 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.587 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.415 ' NE2' HD23 ' A' ' 37' ' ' LEU . 25.7 mt-30 -82.76 -46.36 13.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.389 -0.369 . . . . 65.22 111.793 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.61 -32.13 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.958 0.725 . . . . 71.35 112.958 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 64.4 tt0 -54.25 -53.37 59.87 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 113.298 0.851 . . . . 73.22 113.298 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 56.3 Cg_endo -67.34 -12.2 34.95 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.908 1.739 . . . . 65.53 113.083 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.47 -36.63 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.978 0.418 . . . . 70.4 111.676 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.565 ' OG1' HG12 ' A' ' 47' ' ' VAL . 53.0 p -103.4 -16.51 15.59 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.274 0.472 . . . . 70.32 112.274 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 69.7 11.77 7.94 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.346 0.869 . . . . 64.52 113.346 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG12 ' OG1' ' A' ' 45' ' ' THR . 8.3 p -92.71 146.89 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.947 -0.471 . . . . 71.15 111.587 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.19 141.2 83.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 27.5 Cg_endo -60.81 -25.47 81.25 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.998 2.465 . . . . 74.55 113.406 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -60.07 -49.03 79.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.118 0.485 . . . . 72.02 111.169 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.3 65.15 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.959 -0.564 . . . . 73.04 113.007 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.494 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 50.2 mt-30 -56.57 92.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.508 0.558 . . . . 75.14 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' NZ ' ' SD ' ' A' ' 81' ' ' MET . 37.1 mtmm -108.07 110.98 22.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.359 -0.382 . . . . 72.43 111.196 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.9 mt -76.58 90.56 3.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.195 0.521 . . . . 62.41 110.292 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.5 mt -92.07 109.42 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.903 -0.59 . . . . 74.54 111.78 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -110.5 123.49 50.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.065 -0.516 . . . . 70.35 110.678 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 63.87 19.6 11.81 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.864 0.364 . . . . 73.43 111.701 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.07 5.54 70.39 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.174 -0.536 . . . . 71.55 113.098 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -129.6 125.17 35.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.695 0.398 . . . . 74.32 111.032 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.43 139.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.819 0.342 . . . . 51.11 111.009 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -77.71 147.17 35.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 72.1 111.654 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 61.5 t -66.14 127.67 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.307 -0.406 . . . . 62.22 111.167 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.1 mt-10 -57.52 -29.27 64.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.866 0.691 . . . . 71.01 112.866 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 76.3 p -84.26 4.97 28.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.361 0.504 . . . . 62.14 112.361 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 t -107.75 149.3 28.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.164 0.506 . . . . 75.35 111.498 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 58.1 p -88.3 162.49 16.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.202 -0.454 . . . . 70.22 111.327 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.95 -44.12 82.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.251 0.548 . . . . 70.31 110.675 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 41.5 tttm -60.65 -45.81 92.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.673 -0.694 . . . . 63.41 112.192 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.95 -37.04 86.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.278 0.561 . . . . 72.25 111.58 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 1.48 25.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.29 18.71 9.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.89 0.476 . . . . 71.35 112.226 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -88.45 88.72 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.765 -0.458 . . . . 75.21 109.765 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.59 -151.87 9.37 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.084 -0.579 . . . . 64.41 113.635 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 t -63.39 110.87 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.109 0.48 . . . . 73.43 111.568 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.59 -10.71 25.86 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 116.01 -0.541 . . . . 74.25 113.202 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.1 136.6 46.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.039 0.447 . . . . 73.22 111.885 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -108.44 103.6 12.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.956 0.408 . . . . 73.4 111.679 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.45 129.72 35.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.287 0.565 . . . . 75.13 112.449 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.0 105.89 18.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.058 -0.519 . . . . 65.03 110.188 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -100.05 117.08 33.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.213 0.53 . . . . 75.24 112.276 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.541 ' SD ' ' NZ ' ' A' ' 53' ' ' LYS . 25.0 ttt -82.16 110.81 17.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.661 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.27 140.32 50.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.867 0.365 . . . . 73.42 111.436 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -75.65 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.458 . . . . 72.24 111.119 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -66.24 0.92 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.062 0.458 . . . . 71.12 110.217 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.416 0 CA-C-O 118.699 -1.056 . . . . 73.31 113.088 -178.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.763 0.316 . . . . 74.15 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.39 -167.02 47.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.27 -0.491 . . . . 71.05 113.437 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -102.48 45.94 0.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.39 0.614 . . . . 75.33 111.114 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -67.61 -42.86 81.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.974 -0.557 . . . . 75.42 112.052 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.75 90.28 0.41 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 73.41 111.686 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -152.6 142.2 21.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.705 0.288 . . . . 74.52 111.321 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.52 -39.7 9.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.752 0.311 . . . . 75.01 111.451 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -110.74 113.89 26.84 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.011 0.434 . . . . 71.45 110.944 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -76.91 134.51 38.93 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.906 0.384 . . . . 60.11 111.576 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -130.12 157.28 42.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.391 -0.368 . . . . 74.22 111.456 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t 64.86 86.74 0.12 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.426 0.631 . . . . 74.21 111.189 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -118.21 154.11 32.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.007 -0.542 . . . . 73.2 112.147 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.6 pt -112.67 161.13 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.833 0.349 . . . . 71.54 111.057 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 74' ' ' SER . 94.9 mttt -86.25 109.19 18.77 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.065 0.394 . . . . 71.15 112.065 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 2.9 mm? -98.82 144.06 28.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.857 0.36 . . . . 75.01 110.864 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 77' ' ' LYS . 44.8 m -128.66 91.22 3.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.858 0.361 . . . . 75.23 110.732 174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.78 110.12 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 71.22 111.15 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.6 mtpm? -97.6 105.58 17.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.229 0.538 . . . . 73.54 112.241 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CE1' HG21 ' A' ' 45' ' ' THR . 33.4 m-85 -79.63 90.21 5.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.993 -0.549 . . . . 73.04 111.713 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 45.89 37.72 7.53 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.501 0.56 . . . . 72.41 114.501 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.38 -27.17 4.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.987 -0.625 . . . . 53.44 113.138 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.43 169.42 18.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.829 0.347 . . . . 74.45 111.13 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -135.57 96.99 3.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.554 -0.294 . . . . 62.55 110.966 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mm -92.5 110.54 45.65 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 120.658 0.266 . . . . 73.05 111.475 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.64 127.14 8.64 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.031 2.488 . . . . 51.31 113.016 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 97.8 mt -132.23 160.51 35.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.975 0.417 . . . . 71.54 111.048 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.5 m -144.32 99.62 3.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.333 . . . . 74.13 111.225 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG11 HE22 ' A' ' 40' ' ' GLN . 28.9 m -132.28 177.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.916 0.389 . . . . 53.15 111.817 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 31.2 t -74.62 136.17 74.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 116.323 -0.399 . . . . 62.2 111.555 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 45.1 Cg_endo -67.19 -12.85 37.5 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.534 2.156 . . . . 72.34 112.895 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -97.45 4.3 50.57 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.109 0.411 . . . . 64.11 112.109 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 99.6 m -81.04 140.36 35.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.144 -0.317 . . . . 55.12 110.144 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -70.3 136.21 49.59 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.194 -0.316 . . . . 74.41 110.901 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 61' ' ' LEU . 31.0 m -56.37 -22.32 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.041 0.448 . . . . 71.35 112.169 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 22.8 ttpp -57.79 -36.07 71.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.963 0.411 . . . . 73.13 111.378 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.63 -30.89 71.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.314 -0.403 . . . . 73.51 110.895 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' NE2' ' A' ' 40' ' ' GLN . 69.3 mt -58.17 -39.43 78.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.481 -0.327 . . . . 73.44 111.151 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.76 -41.91 98.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.134 0.493 . . . . 74.14 110.576 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -62.06 -23.65 66.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.928 -0.578 . . . . 73.12 111.616 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.515 ' NE2' HD23 ' A' ' 37' ' ' LEU . 24.4 mt-30 -89.06 -44.86 10.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.392 -0.367 . . . . 65.43 111.751 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 26' ' ' LEU . 95.0 mt -66.72 -39.08 87.86 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.585 0.587 . . . . 72.34 112.585 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.29 -53.65 50.47 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 113.135 0.791 . . . . 71.13 113.135 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.47 -3.76 10.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.997 1.798 . . . . 64.25 113.47 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.21 -59.75 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.168 0.508 . . . . 73.2 111.288 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 19' ' ' PHE . 75.9 p -89.73 -5.1 57.32 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.462 0.541 . . . . 63.45 112.462 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 69.48 12.06 8.15 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.826 0.676 . . . . 62.23 112.826 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -88.31 134.48 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.968 0.413 . . . . 73.33 111.864 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.4 mt -71.14 147.76 93.7 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.49 -0.323 . . . . 74.35 111.71 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.81 -35.05 77.81 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.187 2.591 . . . . 64.31 113.899 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -57.66 -55.13 38.83 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.829 0.347 . . . . 70.14 111.565 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.14 3.47 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.181 -0.533 . . . . 23.13 113.921 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -137.97 102.66 4.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.937 0.399 . . . . 74.11 111.193 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 91.2 mttt -107.27 94.18 4.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.31 -0.405 . . . . 72.12 111.42 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 80' ' ' LEU . 93.7 mt -70.75 109.52 5.0 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.694 -0.23 . . . . 63.53 110.985 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.6 115.2 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.161 0.505 . . . . 74.23 111.343 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -111.97 114.29 27.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.469 -0.332 . . . . 72.51 111.588 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 53.71 32.65 15.09 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.372 0.508 . . . . 74.04 112.372 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.45 -47.17 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.337 -0.458 . . . . 64.24 113.598 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -82.91 151.91 25.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.094 0.447 . . . . 74.42 111.536 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.33 139.1 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.224 0.535 . . . . 75.41 111.53 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.5 mm? -75.13 99.48 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.849 -0.614 . . . . 74.53 110.937 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.11 136.16 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.725 0.298 . . . . 75.11 110.685 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.6 mt-10 -59.69 -23.12 62.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.789 1.033 . . . . 72.04 113.789 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -84.95 -12.31 53.61 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.155 0.503 . . . . 72.14 111.689 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -89.72 150.69 22.2 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.285 0.564 . . . . 62.24 111.804 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 69' ' ' GLN . 30.9 p -93.26 177.84 5.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.016 -0.538 . . . . 71.13 110.454 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG11 ' A' ' 72' ' ' VAL . 3.1 mm? -65.99 -51.08 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.921 0.391 . . . . 65.34 111.326 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.78 -18.6 60.48 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.246 0.461 . . . . 74.32 112.246 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 79.2 mt-30 -82.67 -3.01 55.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -141.4 45.55 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.531 0.567 . . . . 71.21 112.531 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 63.69 9.39 4.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.241 0.83 . . . . 45.32 113.241 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 67' ' ' LEU . 97.6 t -86.18 127.49 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.992 0.425 . . . . 43.45 111.85 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -164.42 10.58 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.354 -0.45 . . . . 44.52 113.136 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 47.8 t -62.4 106.07 0.71 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.134 0.492 . . . . 71.42 111.526 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.37 25.63 7.71 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.459 -0.4 . . . . 61.31 112.757 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 72' ' ' VAL . . . -78.43 114.36 17.27 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.151 0.501 . . . . 54.01 111.956 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 16' ' ' THR . 56.4 mtpt -87.36 97.25 10.7 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.492 . . . . 72.43 110.992 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.49 125.84 33.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.358 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.3 ttt -92.71 101.42 13.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.079 0.466 . . . . 70.35 109.957 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 54' ' ' LEU . 33.5 tp -90.49 107.67 19.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.159 0.504 . . . . 62.24 112.259 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -81.86 92.89 6.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.22 0.533 . . . . 63.22 109.745 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.95 159.88 15.11 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 62.44 112.25 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -89.73 14.02 12.84 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.188 -0.46 . . . . 63.34 111.353 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.45 154.24 50.83 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.637 0.375 . . . . 74.11 110.74 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 119.124 -0.82 . . . . 42.15 113.19 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.615 0.245 . . . . 70.44 111.378 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.87 -129.59 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.916 -0.659 . . . . 64.35 113.347 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -80.19 40.88 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.279 0.562 . . . . 62.41 111.204 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -85.78 88.95 7.63 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.872 -0.604 . . . . 70.24 110.734 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 70.67 -35.05 0.31 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.576 0.75 . . . . 74.44 112.835 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -57.13 99.07 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.039 0.447 . . . . 74.13 112.033 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -132.45 160.32 36.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.482 -0.326 . . . . 72.42 111.451 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -166.99 137.19 3.03 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.199 0.444 . . . . 62.55 112.199 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.5 m 65.49 17.95 11.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.668 0.988 . . . . 64.22 113.668 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -113.53 8.46 17.75 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.947 -0.471 . . . . 71.44 111.776 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 m -72.08 72.25 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.268 0.556 . . . . 64.21 110.149 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 p -86.87 127.42 35.04 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.521 0.563 . . . . 71.51 112.521 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.95 136.08 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.781 -0.645 . . . . 62.52 111.637 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.71 129.53 34.98 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.056 0.455 . . . . 64.52 111.724 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -145.2 133.36 21.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.029 0.442 . . . . 73.41 111.146 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 68.6 m -97.12 113.93 25.55 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.592 -0.277 . . . . 72.54 111.001 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.38 128.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.079 0.466 . . . . 71.45 111.181 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -94.53 96.85 9.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.29 -0.414 . . . . 71.12 111.775 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 7.3 m-85 -78.91 74.91 5.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.86 0.362 . . . . 64.22 110.917 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.1 18.17 6.04 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 116.235 -0.439 . . . . 71.22 114.049 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.89 -34.29 1.96 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.38 -0.438 . . . . 72.23 112.24 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.8 mmtt -75.57 95.38 3.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.841 0.353 . . . . 75.13 110.987 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -78.07 102.29 7.38 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.827 0.346 . . . . 64.52 110.943 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.6 mm -101.34 109.09 57.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.58 -0.282 . . . . 75.14 111.413 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.27 103.07 1.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.323 2.016 . . . . 71.54 112.792 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.43 176.53 5.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.354 0.597 . . . . 72.34 112.072 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.4 m -149.11 100.79 3.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.962 -0.563 . . . . 72.33 110.496 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.0 m -111.89 171.17 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.465 0.65 . . . . 73.52 112.464 -173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -83.89 129.22 59.95 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.825 -0.625 . . . . 64.41 111.506 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -12.92 36.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.611 2.207 . . . . 72.14 113.114 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.13 -25.74 59.93 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.78 0.324 . . . . 72.43 111.488 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -74.87 151.28 38.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.328 0.585 . . . . 60.43 112.196 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 49.3 p -90.21 164.8 14.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.863 -0.608 . . . . 75.13 110.708 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.2 m -66.61 -20.04 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.16 0.505 . . . . 73.54 110.628 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 63' ' ' GLU . 16.3 tppt? -66.59 -48.4 69.68 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.992 -0.549 . . . . 70.21 110.114 169.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' SER . 7.7 t70 -65.44 -31.03 71.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.929 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 67' ' ' LEU . 42.8 mt -55.2 -44.94 75.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.667 -0.242 . . . . 74.12 111.26 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.37 -36.71 76.28 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.059 0.457 . . . . 72.25 110.998 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 28.0 t -63.83 -27.04 68.9 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.712 -0.676 . . . . 73.11 111.485 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -87.54 -44.62 11.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.349 -0.387 . . . . 74.43 111.424 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.24 -39.18 89.35 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.224 0.824 . . . . 60.54 113.224 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -57.05 -54.3 56.07 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.785 0.661 . . . . 74.24 112.785 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.76 -6.57 17.14 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.808 1.672 . . . . 63.32 113.111 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.95 -53.11 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.468 . . . . 72.03 111.682 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 ' OG1' HG12 ' A' ' 47' ' ' VAL . 76.8 p -105.32 -4.57 21.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.835 0.68 . . . . 62.34 112.835 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 65.54 21.11 11.75 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.726 0.639 . . . . 70.12 112.726 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG12 ' OG1' ' A' ' 45' ' ' THR . 9.1 p -89.03 139.63 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.072 0.463 . . . . 63.02 111.784 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.81 129.93 92.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.122 0.415 . . . . 74.22 112.122 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.11 -39.91 51.01 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.267 2.644 . . . . 65.2 113.889 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.58 -41.03 96.82 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.93 0.395 . . . . 74.32 111.321 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.23 -18.24 79.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.237 -0.506 . . . . 64.12 113.37 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' NE2' HG13 ' A' ' 47' ' ' VAL . 78.4 mt-30 -71.7 85.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.144 0.497 . . . . 65.12 111.687 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.74 90.94 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.014 0.435 . . . . 74.12 111.581 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 80' ' ' LEU . 94.8 mt -75.65 114.85 14.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.518 . . . . 71.23 110.788 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 60' ' ' VAL . 59.9 mt -121.06 121.24 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.879 0.371 . . . . 62.13 111.675 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -134.08 137.78 44.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.843 0.354 . . . . 65.03 110.601 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp 61.67 10.13 3.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.637 0.375 . . . . 62.41 111.72 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.98 -20.09 41.91 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.529 -0.367 . . . . 55.25 113.235 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -102.05 140.23 36.61 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.383 -0.48 . . . . 71.24 112.016 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 55' ' ' ILE . 61.0 t -70.52 125.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.563 -0.29 . . . . 73.44 110.241 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -66.38 127.71 33.33 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.184 0.516 . . . . 74.21 111.859 -176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 64' ' ' THR . 35.6 t -67.48 132.1 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.047 -0.524 . . . . 70.31 110.554 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 37.3 mt-10 -66.7 -3.35 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.106 0.78 . . . . 74.5 113.106 -173.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.44 ' H ' HG12 ' A' ' 62' ' ' VAL . 81.7 p -91.17 -7.83 50.35 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.044 0.45 . . . . 74.43 111.363 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 t -99.16 165.26 11.8 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.384 0.611 . . . . 61.31 112.251 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.3 p -114.58 177.42 4.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.85 -0.614 . . . . 53.21 111.109 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 37' ' ' LEU . 3.7 mm? -59.24 -47.25 86.03 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.032 0.444 . . . . 62.52 110.845 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.62 -39.1 91.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.501 -0.318 . . . . 73.43 111.33 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 66' ' ' THR . 79.0 mt-30 -69.37 -29.14 66.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.931 0.396 . . . . 71.24 111.936 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 p -89.75 6.99 39.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.671 0.272 . . . . 64.42 111.559 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 69.26 16.23 8.46 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.667 0.617 . . . . 73.42 112.667 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -84.29 101.8 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.989 -0.374 . . . . 72.51 109.989 172.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.03 -162.92 19.15 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.208 -0.52 . . . . 74.23 112.957 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.7 p -65.87 89.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.194 0.521 . . . . 74.41 111.532 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.6 71.55 0.49 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.136 -0.484 . . . . 45.2 112.676 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -144.33 162.5 36.27 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.756 0.312 . . . . 63.04 111.324 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 92.7 mttt -128.22 126.46 41.0 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.755 0.312 . . . . 72.13 111.258 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.64 132.2 51.17 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.919 0.39 . . . . 75.23 111.724 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.5 ttt -85.28 111.69 20.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.599 -0.273 . . . . 72.34 110.423 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.632 HD13 HD23 ' A' ' 54' ' ' LEU . 26.9 tp -108.2 108.53 19.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.304 0.574 . . . . 73.32 111.761 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.3 ttt -87.24 86.8 7.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.165 -0.471 . . . . 74.33 110.472 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -146.52 152.09 38.41 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.243 -0.435 . . . . 72.54 111.402 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -119.62 171.46 8.36 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.922 0.391 . . . . 64.02 111.53 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.87 111.97 24.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.007 0.432 . . . . 72.13 110.859 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.454 0 CA-C-O 118.855 -0.969 . . . . 62.15 113.372 178.692 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.89 0.376 . . . . 63.35 111.48 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.76 -131.22 10.5 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.215 -0.517 . . . . 41.42 112.844 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.27 113.3 18.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.375 0.607 . . . . 65.35 111.496 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.97 98.98 3.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.504 -0.771 . . . . 75.13 112.087 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -70.49 81.16 0.57 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.698 -0.683 . . . . 75.22 111.017 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -67.17 161.45 24.67 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.576 . . . . 74.13 111.927 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -78.02 156.27 30.21 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.21 111.447 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -101.62 -27.0 13.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.729 0.299 . . . . 70.12 111.472 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -57.48 117.76 4.48 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.569 -0.287 . . . . 54.45 111.714 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 61.33 24.92 14.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.752 0.421 . . . . 63.01 111.888 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 t -64.18 136.93 57.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.947 0.403 . . . . 54.35 111.209 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -123.63 138.18 54.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.392 0.615 . . . . 62.04 112.02 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.4 pt -86.35 132.57 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.009 -0.542 . . . . 75.01 110.943 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -97.96 102.65 14.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.438 0.637 . . . . 71.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 76' ' ' ALA . 48.6 mt -94.68 176.74 6.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.637 -0.71 . . . . 75.1 111.212 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 78.0 m -141.26 103.41 4.42 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.882 0.372 . . . . 73.13 111.172 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.82 144.02 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.082 0.401 . . . . 73.1 112.082 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -88.72 110.09 20.69 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.04 0.385 . . . . 72.24 112.04 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.26 68.33 8.04 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.496 -0.557 . . . . 75.12 109.496 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.37 -99.79 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.076 -0.583 . . . . 61.41 112.203 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.68 4.17 68.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 60.34 113.208 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.33 147.19 29.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.772 0.32 . . . . 55.32 111.421 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.4 p -119.78 100.73 7.42 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.964 0.412 . . . . 73.11 110.284 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.43 119.91 59.1 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.276 -0.42 . . . . 74.33 111.868 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 74.4 Cg_endo -76.75 130.68 11.72 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.185 1.924 . . . . 73.42 112.694 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.26 126.89 43.48 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.626 0.25 . . . . 74.25 111.566 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.2 p -103.37 106.11 16.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.618 0.247 . . . . 53.0 111.067 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.56 176.56 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 120.925 0.393 . . . . 74.32 111.81 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m -98.23 132.02 25.23 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 122.27 -0.269 . . . . 64.45 110.941 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.39 -27.53 85.03 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.847 2.365 . . . . 71.21 113.832 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.37 -8.5 56.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.409 0.522 . . . . 72.14 112.409 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.6 m -79.0 149.64 32.17 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.856 0.36 . . . . 43.41 111.392 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.7 p -83.4 159.38 21.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.52 110.98 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 61' ' ' LEU . 27.0 m -68.82 -22.06 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.989 0.424 . . . . 61.05 111.415 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.5 ttpt -75.01 -35.35 61.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.933 0.397 . . . . 74.43 110.383 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.81 -40.67 96.06 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.07 0.462 . . . . 51.53 109.917 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 67' ' ' LEU . 67.7 mt -55.91 -46.89 78.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 74.53 111.348 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -52.32 -43.55 64.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.017 0.437 . . . . 71.45 111.155 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -70.55 -34.4 72.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.863 -0.608 . . . . 71.04 111.907 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -75.92 -41.12 52.75 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.138 0.422 . . . . 61.22 112.138 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.02 -31.13 58.74 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.35 0.5 . . . . 63.01 112.35 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 62.8 tt0 -50.75 -51.56 64.95 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 113.561 0.949 . . . . 64.41 113.561 -175.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 22.9 Cg_exo -65.15 -12.44 34.77 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.034 1.823 . . . . 63.03 113.099 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.5 -50.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.974 0.416 . . . . 71.3 111.618 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 47' ' ' VAL . 69.4 p -89.47 -17.58 28.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.415 0.524 . . . . 74.23 112.415 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 69.47 16.93 8.14 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.964 0.727 . . . . 75.43 112.964 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.8 p -99.49 145.29 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.014 0.435 . . . . 51.1 111.321 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.46 148.31 76.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.313 0.486 . . . . 54.31 112.313 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.56 -24.45 53.6 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.075 2.517 . . . . 70.44 113.68 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -72.17 -37.29 69.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.705 0.288 . . . . 73.24 111.373 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.04 -21.5 60.97 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.125 -0.56 . . . . 45.44 113.222 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.15 90.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.166 0.508 . . . . 62.45 112.188 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 98.6 mttt -90.01 103.04 15.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.29 -0.414 . . . . 64.15 111.068 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 34' ' ' VAL . 95.3 mt -87.27 109.45 19.51 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.95 0.405 . . . . 63.15 110.985 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 60' ' ' VAL . 51.6 mt -117.17 136.09 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.572 -0.286 . . . . 54.33 111.122 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.21 128.8 10.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.706 0.289 . . . . 64.1 111.285 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 57.3 28.9 15.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.142 0.423 . . . . 72.35 112.142 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.9 -8.65 79.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.142 -0.551 . . . . 45.51 113.957 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' ' 61' ' ' LEU . 7.7 ttpm? -103.62 124.37 48.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.492 0.646 . . . . 75.44 111.473 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 55' ' ' ILE . 58.1 t -74.23 108.58 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.461 -0.57 . . . . 72.4 109.461 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 34' ' ' VAL . 4.1 mm? -54.46 113.09 1.15 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.666 0.617 . . . . 63.0 112.666 -174.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 64' ' ' THR . 45.0 t -63.83 140.1 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.758 -0.656 . . . . 64.22 110.506 174.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 37.9 mt-10 -56.94 -29.93 63.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.378 0.51 . . . . 75.22 112.378 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 62' ' ' VAL . 50.4 p -83.57 11.12 7.59 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.375 0.509 . . . . 72.41 112.375 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -108.51 145.46 34.71 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.053 0.454 . . . . 64.23 111.768 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.5 p -101.82 172.68 6.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.324 -0.398 . . . . 70.13 110.814 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 37' ' ' LEU . 2.8 mm? -66.44 -40.7 89.63 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.72 0.771 . . . . 65.4 109.542 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.83 -44.3 86.36 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.797 -1.092 . . . . 62.11 111.548 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.72 -14.71 62.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.279 0.474 . . . . 63.24 112.279 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -108.32 10.81 27.56 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.224 -0.297 . . . . 71.04 111.384 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 61.68 26.59 16.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 43.5 t -81.91 99.23 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.975 0.417 . . . . 75.34 111.121 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.55 172.66 21.33 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.423 -0.418 . . . . 61.24 112.946 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 t -56.16 126.13 24.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.988 0.423 . . . . 73.1 111.757 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.88 -1.57 44.86 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.282 -0.485 . . . . 73.33 112.985 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -77.58 137.91 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.893 0.377 . . . . 71.42 111.686 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -101.54 112.47 25.04 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.182 0.515 . . . . 71.41 111.9 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 15' ' ' LEU . 57.0 mt -94.21 169.39 10.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.171 -0.468 . . . . 75.13 111.299 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.3 ttt -128.04 123.58 34.99 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.295 -0.253 . . . . 74.41 110.776 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -105.58 99.73 9.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.156 0.503 . . . . 70.04 110.87 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 23.9 ttt -83.13 77.7 9.71 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.138 0.494 . . . . 75.01 110.276 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -129.74 146.32 51.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.961 -0.563 . . . . 71.04 111.504 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p 54.33 19.68 2.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.433 0.693 . . . . 75.25 112.606 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.13 -178.66 5.68 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.066 0.46 . . . . 75.2 111.548 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.714 -1.048 . . . . 64.32 112.588 176.544 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.9 0.381 . . . . 63.34 111.397 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 74.99 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.3 -0.476 . . . . 55.24 112.841 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -64.41 -10.64 26.25 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.122 0.786 . . . . 73.43 113.122 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -86.61 106.55 17.65 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.199 -0.313 . . . . 74.44 110.66 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -99.48 111.51 23.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.883 0.373 . . . . 70.21 111.784 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -72.12 121.79 19.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.985 0.421 . . . . 75.01 112.015 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.69 136.22 21.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.883 0.473 . . . . 74.11 110.811 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -76.91 -45.8 26.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.846 0.355 . . . . 74.14 111.594 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -86.18 163.72 17.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.891 0.377 . . . . 75.5 111.745 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.9 m80 55.9 22.32 5.59 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.052 -0.522 . . . . 72.15 112.213 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -76.7 81.94 3.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.155 0.502 . . . . 74.15 111.261 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.3 p -86.5 117.53 25.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.344 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 30' ' ' PRO . 40.5 pt -82.71 147.48 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.158 -0.474 . . . . 75.41 112.149 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.01 115.82 28.31 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.945 0.35 . . . . 74.24 111.945 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 28' ' ' VAL . 8.7 mp -100.96 122.56 43.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.328 -0.397 . . . . 73.02 110.542 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.6 m -93.24 89.73 6.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.107 0.48 . . . . 71.54 110.423 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 78' ' ' LEU . 45.5 t -85.15 116.43 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.371 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -92.74 105.65 17.76 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.642 0.608 . . . . 52.34 112.642 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 21.7 m-85 -79.45 81.58 5.69 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.568 -0.531 . . . . 70.24 109.568 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.23 -82.68 0.07 OUTLIER Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.294 -0.479 . . . . 33.11 112.417 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 3.85 12.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.622 -0.323 . . . . 71.23 112.79 176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 34.9 mmtp -94.01 111.29 22.99 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.565 -0.373 . . . . 55.33 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 48.1 m -85.14 102.15 13.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.749 0.309 . . . . 70.01 110.975 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.1 mm -96.39 104.69 18.47 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.604 -0.271 . . . . 65.03 111.259 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 23' ' ' SER . 88.4 Cg_endo -85.84 109.73 1.07 Allowed 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.681 2.254 . . . . 74.12 113.184 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 41' ' ' LEU . 92.6 mt -116.01 128.12 55.47 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.295 0.48 . . . . 74.34 112.295 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.7 m -92.23 105.74 17.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.776 0.322 . . . . 74.52 110.756 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 HD13 ' A' ' 15' ' ' LEU . 28.4 m -128.76 179.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.116 0.484 . . . . 72.01 112.067 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.767 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 15.1 m -90.09 131.63 38.42 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.25 -0.432 . . . . 51.52 111.004 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' HD13 ' A' ' 13' ' ' ILE . 37.2 Cg_endo -64.94 -24.87 60.08 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.428 2.085 . . . . 74.13 112.906 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -8.15 56.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.227 -0.442 . . . . 74.12 111.929 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 79.0 m -79.32 152.75 30.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.043 0.449 . . . . 71.02 111.402 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.3 p -83.25 154.55 24.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.948 0.404 . . . . 74.21 111.25 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 61' ' ' LEU . 24.7 m -67.33 -17.63 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.917 0.389 . . . . 71.02 111.335 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.5 tttp -69.09 -34.57 75.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.179 0.514 . . . . 74.44 110.336 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.7 -41.86 95.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.052 -0.522 . . . . 71.42 110.056 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.609 HD23 ' NE2' ' A' ' 40' ' ' GLN . 76.8 mt -51.94 -46.67 64.79 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.036 -0.529 . . . . 64.14 111.339 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 66.1 mttm -51.68 -41.31 61.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.01 0.433 . . . . 73.22 111.328 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 t -84.31 -14.01 50.88 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.198 0.444 . . . . 55.2 112.198 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.609 ' NE2' HD23 ' A' ' 37' ' ' LEU . 26.8 mt-30 -82.15 -40.34 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.854 0.359 . . . . 73.34 111.206 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 26' ' ' LEU . 76.3 mt -78.11 -31.91 50.26 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.197 0.443 . . . . 75.52 112.197 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -48.79 -52.85 42.38 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.483 0.919 . . . . 55.53 113.483 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.78 -16.05 41.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.945 1.764 . . . . 71.12 113.012 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.22 -53.78 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.125 0.488 . . . . 75.4 111.745 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 19' ' ' PHE . 65.0 p -99.92 -6.68 26.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.641 0.608 . . . . 72.21 112.641 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 69.91 5.34 5.21 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.673 0.62 . . . . 71.34 112.673 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.82 130.04 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.105 0.478 . . . . 45.41 111.983 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.83 137.75 96.88 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.088 -0.506 . . . . 74.42 111.663 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.4 Cg_endo -53.66 -28.11 45.04 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.818 2.345 . . . . 74.23 112.4 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -58.8 -53.67 55.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.778 -0.646 . . . . 74.33 111.303 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.81 -34.51 71.98 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.187 -0.46 . . . . 61.43 112.946 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.436 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 47.9 mt-30 -61.68 85.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.071 0.463 . . . . 72.23 112.012 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -97.37 95.78 7.92 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.186 0.517 . . . . 74.11 111.381 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 80' ' ' LEU . 88.2 mt -71.44 112.61 7.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.728 -0.669 . . . . 62.24 111.003 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 64.6 mt -118.22 106.51 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.355 0.597 . . . . 73.21 111.382 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -110.22 123.25 49.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.504 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 61.3 18.63 9.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.974 0.416 . . . . 74.22 111.911 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.0 -9.04 70.41 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.303 -0.475 . . . . 71.22 112.989 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 79.7 tttt -91.03 136.09 33.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.938 0.495 . . . . 60.54 111.712 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.33 123.28 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.266 0.555 . . . . 60.13 110.5 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.6 mm? -75.22 112.1 11.14 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.009 0.433 . . . . 52.42 112.085 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.62 136.0 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.238 -0.437 . . . . 70.43 110.912 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.3 mt-10 -46.72 -45.32 19.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.881 1.067 . . . . 71.42 113.881 -173.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 p -72.54 -10.87 60.32 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.628 0.603 . . . . 60.12 112.628 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -81.09 134.69 35.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.998 0.428 . . . . 73.05 111.3 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 26.3 p -92.11 158.26 16.29 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.848 0.356 . . . . 65.22 110.677 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.1 mm? -56.86 -40.07 75.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.254 0.55 . . . . 73.05 110.715 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -63.94 -41.04 97.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.799 -0.637 . . . . 73.12 111.82 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 66' ' ' THR . 77.8 mt-30 -66.99 -34.59 78.09 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.187 0.439 . . . . 75.1 112.187 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 t -95.9 13.59 26.32 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.189 0.44 . . . . 63.43 112.189 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.05 27.47 14.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.974 0.731 . . . . 75.52 112.974 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.06 99.41 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.009 0.433 . . . . 44.4 110.341 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.45 -175.22 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.117 -0.563 . . . . 45.32 114.256 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.4 p -63.99 112.85 3.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.982 0.364 . . . . 73.44 111.982 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.284 -0.484 . . . . 74.14 113.019 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.14 147.19 48.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.102 0.477 . . . . 71.51 111.815 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -116.6 115.19 25.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.979 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 17' ' ' VAL . 52.2 mt -99.64 127.16 45.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.358 -0.383 . . . . 64.45 111.42 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.56 101.39 12.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.864 0.364 . . . . 74.21 110.024 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 HD23 ' A' ' 54' ' ' LEU . 39.7 tp -92.32 108.61 20.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.282 0.563 . . . . 74.35 111.689 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.4 ttt -77.77 105.29 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.883 -0.599 . . . . 70.31 110.64 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.11 146.7 51.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.097 0.475 . . . . 71.14 112.021 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -99.91 134.05 43.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.994 -0.548 . . . . 72.51 111.268 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -74.96 -52.54 10.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.046 0.451 . . . . 43.22 111.295 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 CA-C-O 118.853 -0.97 . . . . 75.23 113.085 -178.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.637 0.256 . . . . 71.23 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.04 121.94 4.64 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.957 -0.639 . . . . 54.14 113.563 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -87.44 142.03 28.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.937 0.398 . . . . 75.24 111.057 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -129.62 116.44 18.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.969 0.414 . . . . 65.05 111.198 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -124.89 106.54 10.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.704 -0.48 . . . . 74.4 109.704 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -69.74 117.39 11.27 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.906 0.706 . . . . 74.54 112.906 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -92.16 108.37 19.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.8 -0.636 . . . . 73.32 111.284 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -74.42 135.18 42.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.503 -0.317 . . . . 63.43 111.034 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -174.07 175.05 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.145 0.498 . . . . 53.51 111.591 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -73.67 82.13 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.91 0.386 . . . . 54.51 110.671 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -105.37 169.16 8.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.864 0.364 . . . . 70.34 111.505 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -115.88 128.52 55.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.458 -0.337 . . . . 73.4 111.683 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 pt -86.71 128.72 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.192 0.52 . . . . 71.23 111.032 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' OG ' ' A' ' 27' ' ' SER . 48.8 mtmt -86.7 96.05 10.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.078 0.466 . . . . 73.31 111.348 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD11 ' HG ' ' A' ' 67' ' ' LEU . 76.1 mt -92.99 145.57 24.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 74.22 111.195 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -111.77 100.95 9.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.847 0.356 . . . . 54.01 111.112 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.67 120.53 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.805 0.336 . . . . 54.43 111.416 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 67.2 mttm -90.37 93.47 9.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.985 0.422 . . . . 75.4 111.9 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.1 m-85 -80.96 78.53 7.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.33 110.583 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 -78.5 0.08 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.271 -0.49 . . . . 44.43 112.897 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.15 5.18 10.35 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 122.707 -0.29 . . . . 62.22 112.692 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.23 120.69 39.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.875 0.369 . . . . 74.32 111.518 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -97.58 93.25 6.32 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.801 0.334 . . . . 52.41 110.305 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 31.4 mm -94.93 108.89 41.0 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.207 -0.451 . . . . 64.52 112.182 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ILE . 1.2 Cg_endo -85.04 112.98 1.48 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.966 2.444 . . . . 65.31 112.624 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.12 135.1 54.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.795 0.331 . . . . 71.42 111.515 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.456 ' OG ' ' HG2' ' A' ' 14' ' ' LYS . 68.1 m -98.34 94.13 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.809 0.338 . . . . 71.22 110.924 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.9 167.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.921 0.391 . . . . 55.23 111.849 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.568 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 74.3 m -80.78 138.23 50.43 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-O 120.732 0.301 . . . . 72.21 111.148 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 24.5 Cg_endo -59.87 -26.87 83.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.809 2.339 . . . . 74.11 112.992 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.34 4.95 21.85 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.843 0.354 . . . . 71.2 111.952 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 81.4 m -83.21 149.42 26.83 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.249 -0.282 . . . . 74.02 110.566 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 30.9 p -93.73 164.94 12.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.029 0.442 . . . . 73.53 111.424 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 54' ' ' LEU . 35.2 m -68.55 -23.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.245 0.545 . . . . 72.24 110.879 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 58.2 tttm -70.36 -39.67 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 70.43 110.181 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 30.3 t70 -59.13 -45.38 91.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.877 -0.601 . . . . 61.45 110.207 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.63 -53.45 56.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' PRO . 47.8 mtmt -55.31 -37.42 67.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.97 0.414 . . . . 71.14 111.327 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -66.62 -31.87 72.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.063 -0.517 . . . . 72.34 111.448 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 23.1 mt-30 -76.8 -42.84 39.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.295 -0.412 . . . . 74.2 111.007 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.17 -40.48 90.52 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.908 . . . . 44.02 113.45 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 59.0 tt0 -50.89 -56.23 21.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 113.494 0.924 . . . . 74.41 113.494 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.65 -7.42 16.33 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.971 1.78 . . . . 64.34 113.111 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.59 -51.79 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.25 0.548 . . . . 72.32 111.341 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 19' ' ' PHE . 64.3 p -98.08 -6.07 32.46 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.825 0.676 . . . . 64.12 112.825 -174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 64.12 21.08 12.45 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.954 0.724 . . . . 61.43 112.954 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 45' ' ' THR . 12.1 p -99.45 148.3 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 120.957 0.408 . . . . 71.04 111.811 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.0 133.0 87.24 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.251 0.463 . . . . 62.13 112.251 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 57.7 Cg_endo -70.02 -20.86 33.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.69 2.26 . . . . 74.42 113.036 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -76.12 -37.98 57.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.826 0.346 . . . . 73.33 111.472 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.48 -19.99 70.11 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.38 -0.438 . . . . 50.1 114.075 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 49' ' ' PRO . 48.7 mt-30 -66.98 94.87 0.35 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.336 0.589 . . . . 63.52 111.902 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 8.8 mtpm? -89.04 93.54 9.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.442 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 34' ' ' VAL . 70.6 mt -72.46 115.41 11.69 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.952 0.406 . . . . 73.13 111.141 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.402 HD11 ' NZ ' ' A' ' 53' ' ' LYS . 68.1 mt -122.4 133.52 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.134 0.492 . . . . 71.32 111.957 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.22 136.17 33.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.176 -0.466 . . . . 75.11 109.905 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 64.7 9.41 5.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 111.984 0.364 . . . . 63.12 111.984 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.9 8.81 75.39 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.301 -0.476 . . . . 70.31 112.352 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -108.22 133.79 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.935 0.494 . . . . 74.34 110.724 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.28 117.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.126 0.489 . . . . 65.0 110.233 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.2 mm? -70.01 154.23 42.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.239 0.543 . . . . 61.43 112.112 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 64' ' ' THR . 53.5 t -90.62 132.45 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.991 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 39.2 mt-10 -57.89 -30.59 65.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 70.31 113.24 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.421 ' H ' HG12 ' A' ' 62' ' ' VAL . 57.9 p -78.36 -15.94 58.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.876 0.37 . . . . 75.52 111.954 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -90.44 137.72 32.12 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.116 0.484 . . . . 75.12 111.808 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 29.7 p -85.56 165.8 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.382 -0.372 . . . . 73.32 110.913 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' HD11 ' A' ' 15' ' ' LEU . 3.8 mm? -63.17 -38.35 90.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.867 0.365 . . . . 65.31 111.116 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 83.8 tttt -68.21 -37.04 80.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.644 0.259 . . . . 62.23 111.158 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.91 -24.05 64.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.928 0.394 . . . . 63.14 111.152 173.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 m -102.73 8.84 39.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.306 -0.407 . . . . 73.32 111.155 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 58.44 22.7 9.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.126 0.787 . . . . 60.2 113.126 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.8 115.29 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.812 0.339 . . . . 70.43 110.99 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.2 -177.71 37.5 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.178 -0.534 . . . . 43.54 113.81 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -73.88 124.24 25.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.945 0.402 . . . . 60.14 111.499 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.48 13.92 23.17 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.352 -0.452 . . . . 51.42 113.155 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.39 28.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.019 0.438 . . . . 53.3 111.249 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 95.9 mttt -89.84 103.99 16.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.06 0.457 . . . . 71.24 111.243 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.5 135.85 34.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.955 -0.566 . . . . 72.13 111.893 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.8 ttt -90.71 109.46 20.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.812 0.339 . . . . 61.45 110.484 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 54' ' ' LEU . 22.0 tp -101.07 109.19 21.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.455 0.645 . . . . 72.12 112.157 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 53.1 ttm -85.11 91.36 8.09 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.837 -0.619 . . . . 74.33 110.354 174.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.58 112.71 13.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 65.33 111.172 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.8 p -100.21 143.36 30.5 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.941 0.401 . . . . 42.42 112.061 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -75.37 -31.88 60.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.102 -0.499 . . . . 64.42 111.45 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.36 0 CA-C-O 118.975 -0.903 . . . . 65.24 113.457 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.629 0.252 . . . . 54.31 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.73 -80.86 0.36 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.928 -0.653 . . . . 54.44 113.679 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -106.73 3.25 26.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.474 0.546 . . . . 73.14 112.474 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 76.5 m-70 -85.03 77.23 10.15 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.289 0.566 . . . . 74.34 110.524 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -101.39 -38.24 8.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.9 -0.591 . . . . 74.42 111.48 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -93.05 -4.4 52.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.997 0.427 . . . . 74.23 110.665 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 4' ' ' HIS . 79.9 m-70 -135.82 140.4 44.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.44 -0.345 . . . . 75.24 110.662 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -99.01 130.83 45.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.978 0.362 . . . . 71.22 111.978 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -69.43 -172.34 0.45 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.641 -0.254 . . . . 75.21 110.803 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -65.26 128.97 38.01 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.119 -0.363 . . . . 73.32 111.364 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.5 t -58.18 103.96 0.18 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.067 0.461 . . . . 72.3 112.179 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 p -137.35 121.21 17.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.24 -0.436 . . . . 43.24 111.348 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG13 HD11 ' A' ' 15' ' ' LEU . 32.3 pt -86.96 147.69 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.45 -0.341 . . . . 72.51 110.926 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 7.9 mtpm? -91.07 130.05 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.754 0.312 . . . . 73.2 111.221 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 15' ' ' LEU . 4.0 mp -118.92 154.78 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.781 0.324 . . . . 70.13 111.19 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 89.3 m -127.98 98.68 5.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.053 0.454 . . . . 75.44 110.318 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 61.1 t -82.21 117.85 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.184 0.516 . . . . 74.3 111.956 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.8 92.04 4.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.136 -0.483 . . . . 74.42 110.498 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -101.68 98.85 9.09 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.306 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.51 44.29 77.85 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.197 -0.456 . . . . 72.24 113.692 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.23 70.32 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.285 -0.483 . . . . 53.54 113.595 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -87.19 166.17 15.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.318 0.58 . . . . 71.44 111.786 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 72.2 p -119.4 104.94 10.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.838 -0.619 . . . . 71.45 110.594 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 38.2 mm -98.55 101.4 11.59 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 116.614 -0.266 . . . . 70.22 111.111 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 23' ' ' SER . 3.7 Cg_exo -80.74 104.24 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.717 2.278 . . . . 72.52 112.748 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 41' ' ' LEU . 89.1 mt -107.99 174.96 5.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.04 0.448 . . . . 62.42 111.275 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.5 p -154.11 107.69 2.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.615 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG11 HE22 ' A' ' 40' ' ' GLN . 16.1 m -125.83 165.72 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.01 0.433 . . . . 74.32 111.593 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.8 m -86.07 148.99 49.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.465 -0.334 . . . . 72.21 110.869 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.75 -10.63 12.3 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.566 2.178 . . . . 64.54 113.35 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.36 -29.92 65.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.695 0.398 . . . . 63.35 111.631 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -68.61 143.39 54.85 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.115 0.484 . . . . 73.22 112.169 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 44.0 p -95.65 163.31 13.25 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.014 -0.539 . . . . 73.4 111.026 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.7 m -63.61 -20.5 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.99 0.424 . . . . 74.2 111.025 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 64.6 tttp -78.47 -44.67 24.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 61.22 110.553 174.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.31 -35.16 73.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.289 0.566 . . . . 75.45 110.29 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 67' ' ' LEU . 3.7 tt -60.98 -39.5 89.86 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.42 175.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 96.5 mttt -56.74 -44.7 81.93 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.682 0.277 . . . . 64.05 111.353 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.7 p -70.53 -8.1 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.948 0.404 . . . . 74.21 111.773 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.436 HE22 HG11 ' A' ' 28' ' ' VAL . 22.7 mt-30 -88.58 -42.22 12.19 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.147 0.499 . . . . 74.51 110.559 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 HD11 ' A' ' 26' ' ' LEU . 73.4 mt -79.02 -35.34 42.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.329 0.492 . . . . 74.34 112.329 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' ' HD3' ' A' ' 49' ' ' PRO . 63.6 tt0 -50.02 -51.2 63.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.232 0.827 . . . . 71.32 113.232 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 31.2 Cg_endo -62.19 -14.73 39.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.93 1.753 . . . . 71.24 113.287 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -100.54 -45.47 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.952 0.406 . . . . 63.35 111.347 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -83.9 -23.71 31.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.082 0.401 . . . . 72.35 112.082 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 66.48 22.66 10.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.114 0.566 . . . . 74.44 111.826 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 ' HB1' ' A' ' 82' ' ' ALA . 24.4 t -100.77 143.8 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.823 0.344 . . . . 70.52 111.327 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.61 140.31 92.02 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 111.849 0.314 . . . . 70.12 111.849 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 30.5 Cg_endo -61.46 -33.1 88.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.86 2.373 . . . . 65.1 113.405 -176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -68.77 -23.05 64.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.907 0.384 . . . . 75.42 110.975 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.13 -35.29 8.21 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.224 -0.512 . . . . 71.21 113.019 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HB3' HD11 ' A' ' 80' ' ' LEU . 47.3 mt-30 -64.59 101.4 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 75.11 111.782 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 96.3 mttt -94.34 119.5 33.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.477 -0.329 . . . . 72.42 111.546 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.433 HD12 ' HB ' ' A' ' 34' ' ' VAL . 93.5 mt -97.2 113.36 24.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 55.34 110.576 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -119.61 129.44 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-O 120.904 0.383 . . . . 73.52 111.44 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -141.31 140.35 33.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.379 -0.373 . . . . 61.23 110.937 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 60.33 24.35 13.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.925 0.393 . . . . 75.2 111.471 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -0.58 74.06 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.136 -0.554 . . . . 75.3 112.796 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -105.12 125.88 51.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.949 0.5 . . . . 74.33 111.643 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.25 118.72 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.02 0.438 . . . . 73.34 110.057 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 70' ' ' SER . 2.8 mm? -78.47 158.09 28.74 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.82 0.674 . . . . 72.32 112.82 -171.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' THR . 49.0 t -92.06 135.74 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.385 -0.825 . . . . 61.11 110.921 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 38.0 mt-10 -56.0 -29.56 60.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.095 0.776 . . . . 73.02 113.095 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.413 ' H ' HG12 ' A' ' 62' ' ' VAL . 41.1 p -80.36 -16.85 53.57 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.025 0.75 . . . . 73.5 113.025 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.9 p -85.79 138.53 32.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 122.025 -0.422 . . . . 73.04 111.52 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 33.9 p -75.2 164.24 26.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.636 -0.256 . . . . 54.24 111.194 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD11 HD12 ' A' ' 37' ' ' LEU . 4.2 mm? -52.52 -46.36 66.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.724 0.297 . . . . 74.41 111.531 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -66.19 -40.19 90.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 72.44 111.008 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.46 -22.73 66.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.137 0.494 . . . . 73.21 111.133 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 60.7 m -86.76 9.93 17.43 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.1 -0.5 . . . . 64.25 111.181 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 69.02 15.9 8.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.2 0.6 . . . . 70.3 111.821 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -83.56 119.34 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.068 0.461 . . . . 73.04 111.233 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.72 177.43 22.71 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.24 -0.437 . . . . 73.42 113.102 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -72.08 94.33 1.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.498 0.666 . . . . 63.11 111.15 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.44 16.09 3.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.711 -0.677 . . . . 54.21 112.378 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.26 140.6 29.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.947 0.403 . . . . 52.02 111.707 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 64.1 mttp -97.12 122.82 40.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.012 0.434 . . . . 62.32 111.629 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.8 mt -102.46 122.46 44.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.336 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 ttm -76.34 113.07 13.5 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.7 0.286 . . . . 62.14 110.977 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 52' ' ' GLN . 55.1 tp -100.75 102.65 13.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.892 0.377 . . . . 71.25 111.393 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.2 ttt -77.91 89.17 4.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.014 0.435 . . . . 70.25 110.33 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 47' ' ' VAL . . . -145.96 117.08 7.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.244 -0.435 . . . . 72.25 111.196 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -76.94 130.22 37.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.411 -0.359 . . . . 54.31 111.35 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -73.54 91.73 1.85 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.999 0.428 . . . . 72.4 110.911 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.85 -0.972 . . . . 70.12 113.13 179.317 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' C ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 112.475 0.546 . . . . 73.53 112.475 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.25 177.98 19.63 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.834 -0.698 . . . . 72.32 113.688 -175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -141.74 106.91 4.97 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.544 0.337 . . . . 73.34 111.122 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -59.9 130.25 45.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.09 0.472 . . . . 71.54 111.561 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -71.79 108.72 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.156 -0.474 . . . . 74.24 111.85 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -84.21 103.86 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.064 0.459 . . . . 71.43 111.341 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -79.6 107.68 12.57 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.697 0.628 . . . . 71.3 112.697 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -135.95 145.52 46.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.391 -0.368 . . . . 72.04 110.601 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 t -144.36 -176.45 5.03 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.811 0.339 . . . . 74.52 111.312 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -106.61 -167.03 1.24 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.349 -0.387 . . . . 75.33 110.489 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 t -74.78 37.36 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.085 0.469 . . . . 74.02 111.746 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.8 p -116.28 126.5 53.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.128 -0.358 . . . . 71.03 111.676 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -95.13 149.72 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.06 0.457 . . . . 74.35 111.647 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -71.17 118.61 14.18 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.417 -0.356 . . . . 64.33 110.462 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HG ' ' A' ' 78' ' ' LEU . 39.7 tp -130.73 122.01 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.149 0.499 . . . . 73.31 111.791 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 87.2 m -102.03 104.37 15.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.023 -0.535 . . . . 73.33 111.486 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.29 125.87 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.853 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 9.9 mtpm? -95.74 105.58 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.754 0.649 . . . . 64.44 112.754 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 14.8 m-85 -78.97 82.75 5.13 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.023 -0.732 . . . . 75.2 109.023 167.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.94 -103.14 0.66 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.507 -0.854 . . . . 54.54 111.586 -170.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.93 -1.16 57.28 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.249 -0.5 . . . . 62.05 113.062 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 74.4 mmtt -83.79 105.72 14.91 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.521 -0.4 . . . . 74.02 111.454 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 79.5 p -81.23 101.06 9.47 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.68 0.276 . . . . 61.42 110.891 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -100.51 96.69 5.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 120.644 0.259 . . . . 71.45 111.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 23' ' ' SER . 4.8 Cg_endo -85.81 92.31 0.64 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.994 2.463 . . . . 75.33 113.174 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.51 -174.99 4.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.97 0.414 . . . . 72.23 111.463 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -141.71 101.72 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.27 -0.423 . . . . 70.32 110.241 174.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.34 162.08 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.455 -0.339 . . . . 71.34 111.348 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -76.99 136.45 66.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 120.721 0.296 . . . . 54.22 111.438 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 41.0 Cg_endo -65.73 -12.11 33.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.464 2.109 . . . . 60.54 113.097 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.49 -11.27 58.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.216 0.45 . . . . 52.34 112.216 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -71.05 148.01 47.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.937 0.399 . . . . 73.12 111.285 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.6 p -83.08 155.53 23.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.927 0.394 . . . . 72.25 110.94 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 25.8 m -65.35 -19.82 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 120.74 0.305 . . . . 71.42 111.589 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.578 ' HE3' ' HB3' ' A' ' 63' ' ' GLU . 40.6 ttmt -67.3 -45.94 75.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.914 0.388 . . . . 62.55 110.7 174.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.59 -37.32 80.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.003 0.43 . . . . 72.44 110.769 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -57.87 -47.68 82.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.445 -0.343 . . . . 73.43 111.174 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 95.8 mttt -55.44 -42.85 74.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.389 0.614 . . . . 70.12 110.727 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 t -61.58 -39.03 89.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.748 -0.66 . . . . 72.44 111.317 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.88 -42.36 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.358 0.503 . . . . 72.41 112.358 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 93.7 mt -74.2 -20.69 60.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.393 0.516 . . . . 73.34 112.393 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 15.9 tt0 -53.9 -55.54 34.96 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.227 0.454 . . . . 74.44 112.227 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 70.4 Cg_endo -71.42 -13.78 30.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.094 1.862 . . . . 70.02 113.348 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.27 -61.96 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.032 0.444 . . . . 73.43 111.219 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -97.68 -0.64 45.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.505 -0.316 . . . . 64.31 111.672 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.17 40.84 11.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.488 0.661 . . . . 75.54 111.066 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 52' ' ' GLN . 6.0 p -113.37 125.02 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.596 -0.729 . . . . 75.1 111.347 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.98 150.82 86.09 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 112.156 0.428 . . . . 72.23 112.156 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.93 -34.67 67.62 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.018 2.479 . . . . 63.31 112.878 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -59.66 -40.34 87.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.985 0.421 . . . . 60.43 111.391 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.27 -14.42 74.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.19 -0.529 . . . . 54.53 113.374 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG3' HG22 ' A' ' 47' ' ' VAL . 46.3 mt-30 -85.81 101.13 12.55 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.404 0.52 . . . . 63.12 112.404 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 28.1 mtpp -96.16 95.04 7.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.169 -0.469 . . . . 71.13 111.019 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 80' ' ' LEU . 86.7 mt -79.41 117.5 20.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.858 0.361 . . . . 73.12 111.213 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.05 129.77 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 120.966 0.412 . . . . 74.15 111.798 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.0 142.17 48.68 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.56 -0.291 . . . . 75.24 110.483 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 62.63 16.41 8.83 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.205 0.526 . . . . 74.25 110.764 -174.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.54 23.16 73.86 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.123 -0.56 . . . . 53.33 112.386 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -130.95 127.72 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.721 0.408 . . . . 52.0 110.787 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.2 137.92 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.884 0.373 . . . . 73.01 111.457 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -93.6 151.26 19.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.419 0.628 . . . . 72.32 111.887 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -88.72 145.23 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.789 -0.641 . . . . 75.25 110.636 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.578 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 48.3 mt-10 -54.89 -31.75 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.524 . . . . 70.24 112.416 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 p -77.22 -20.96 54.57 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.353 0.501 . . . . 73.44 112.353 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.8 p -83.9 141.89 30.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.196 0.522 . . . . 75.24 112.001 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -96.78 172.7 7.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.07 -0.513 . . . . 63.24 111.638 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.4 mm? -63.32 -41.05 98.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.011 0.434 . . . . 75.13 110.908 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 38.3 ttpt -63.45 -37.49 87.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.97 0.414 . . . . 75.22 111.152 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -64.47 -30.28 71.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.944 0.402 . . . . 72.34 111.224 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -91.37 16.43 10.18 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.458 0.54 . . . . 73.2 112.458 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.72 20.61 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -82.39 131.19 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.989 0.423 . . . . 62.53 111.535 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -175.49 13.87 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.358 -0.449 . . . . 74.24 112.752 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -64.47 110.73 2.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.94 0.4 . . . . 64.11 111.079 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.11 0.68 25.33 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.224 -0.444 . . . . 65.25 113.257 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.79 153.18 30.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.258 0.551 . . . . 73.01 112.027 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -122.86 116.21 23.27 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.076 -0.511 . . . . 74.53 111.543 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HG ' HD11 ' A' ' 15' ' ' LEU . 82.6 mt -92.64 138.42 31.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.981 0.419 . . . . 61.31 111.87 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.1 ttt -92.09 112.07 23.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.529 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HD23 ' A' ' 54' ' ' LEU . 35.3 tp -106.69 113.24 26.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.208 0.528 . . . . 73.32 111.298 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.8 ttt -90.7 104.43 17.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.271 -0.422 . . . . 63.41 110.76 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.99 151.1 50.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.287 -0.415 . . . . 60.14 110.824 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -71.37 -37.38 71.61 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.817 0.303 . . . . 73.23 111.817 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -97.92 151.26 20.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.82 0.343 . . . . 75.43 111.103 176.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.325 0 CA-C-O 118.842 -0.976 . . . . 37.83 113.197 -177.666 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.786 0.327 . . . . 61.12 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.28 -122.8 1.46 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.912 -0.661 . . . . 45.23 113.199 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -140.25 120.09 13.48 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.361 -0.493 . . . . 72.23 111.651 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -121.53 107.17 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.782 0.325 . . . . 74.24 111.16 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -86.32 136.02 33.31 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.057 0.456 . . . . 71.32 111.52 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -83.13 23.61 0.85 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.259 0.552 . . . . 64.24 110.717 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -68.48 84.49 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.737 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -118.87 -16.31 9.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.139 0.495 . . . . 71.1 110.957 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 t -86.26 133.57 33.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.258 -0.428 . . . . 45.44 111.454 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -109.3 -49.15 3.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.416 -0.357 . . . . 75.01 111.213 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -142.46 27.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.19 0.441 . . . . 55.14 112.19 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 p -97.96 142.48 29.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.791 -0.568 . . . . 61.43 111.981 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' SER . 22.1 pt -111.78 142.66 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.997 -0.547 . . . . 62.44 110.165 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 57.4 mtmt -93.43 111.48 23.16 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.612 0.597 . . . . 73.32 112.612 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 78' ' ' LEU . 6.0 mp -97.38 155.72 16.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.638 -0.71 . . . . 74.22 111.11 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 m -127.49 97.22 4.8 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.406 -0.361 . . . . 65.12 110.992 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 59.2 t -80.87 123.95 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.04 0.448 . . . . 71.21 111.08 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -99.5 103.81 15.59 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.451 0.537 . . . . 53.33 112.451 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 45' ' ' THR . 8.8 m-85 -99.61 106.37 18.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.73 0.3 . . . . 75.55 110.922 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.0 -87.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.318 -0.468 . . . . 73.42 112.659 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.33 10.56 4.4 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.39 -0.433 . . . . 63.0 112.721 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.4 161.61 13.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.894 0.378 . . . . 72.41 111.503 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -118.67 119.42 34.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.943 0.402 . . . . 72.13 111.811 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 17' ' ' VAL . 42.8 mm -103.92 100.96 22.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 64.45 110.69 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.32 107.39 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.62 2.214 . . . . 75.22 113.082 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 24' ' ' ILE . 84.4 mt -125.63 120.94 32.12 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.841 0.353 . . . . 73.32 111.233 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.2 p -102.05 93.41 5.23 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.169 0.509 . . . . 62.55 111.4 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.8 m -105.48 -178.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.908 -0.587 . . . . 65.22 111.408 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.2 p -88.19 140.26 30.56 Favored Pre-proline 0 N--CA 1.471 0.591 0 O-C-N 122.235 -0.291 . . . . 73.03 111.036 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.7 -15.08 44.21 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.627 2.218 . . . . 60.1 112.81 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.8 -27.61 65.04 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.218 -0.446 . . . . 60.31 112.105 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.6 m -64.27 150.07 46.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.178 0.513 . . . . 71.25 111.757 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 59.5 p -90.56 159.88 16.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 54.44 110.881 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.42 -21.08 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.153 0.502 . . . . 44.41 110.904 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.9 tttp -68.18 -43.26 78.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 72.21 110.649 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.24 -38.35 73.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.295 0.569 . . . . 63.35 110.464 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 67' ' ' LEU . 73.4 mt -61.67 -52.08 65.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.034 -0.53 . . . . 63.44 112.07 175.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -58.21 -26.79 63.27 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.978 0.418 . . . . 52.14 111.36 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.4 m -74.73 -40.08 61.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.425 -0.352 . . . . 60.33 111.008 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.85 -38.51 70.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.363 0.505 . . . . 72.12 112.363 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.69 -29.81 63.7 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.682 0.623 . . . . 72.22 112.682 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 62.8 tt0 -56.36 -52.08 75.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 113.173 0.805 . . . . 73.33 113.173 -175.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 28.2 Cg_endo -61.4 -15.05 38.27 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.813 1.675 . . . . 74.34 112.872 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -83.43 -55.32 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.985 0.421 . . . . 72.13 111.474 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 19' ' ' PHE . 75.2 p -107.57 -4.14 18.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.099 0.777 . . . . 73.25 113.099 -173.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 64.36 24.29 13.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.65 0.611 . . . . 63.52 112.65 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.33 139.38 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.779 0.324 . . . . 60.11 111.118 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.61 136.65 90.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-O 120.798 0.332 . . . . 61.51 111.731 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.09 -23.6 73.97 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.611 2.207 . . . . 72.43 112.935 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -71.33 -45.89 61.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.06 0.457 . . . . 74.35 110.852 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.47 78.96 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.229 -0.51 . . . . 64.04 113.083 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -68.51 95.36 0.62 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.113 0.482 . . . . 75.21 111.576 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 54.0 mttm -88.17 94.13 9.72 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.036 -0.529 . . . . 74.1 111.317 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 80' ' ' LEU . 76.4 mt -74.5 100.52 3.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.855 0.359 . . . . 61.04 110.756 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.17 124.18 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.253 -0.43 . . . . 73.32 111.109 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 61' ' ' LEU . 45.1 t80 -130.56 130.43 44.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.452 -0.34 . . . . 74.43 110.111 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 64.78 18.6 11.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.671 0.389 . . . . 74.22 111.542 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.55 79.86 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.278 -0.487 . . . . 51.3 112.621 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -119.37 126.24 50.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.756 0.422 . . . . 73.43 111.315 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.75 127.91 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.956 0.408 . . . . 64.15 110.362 173.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -88.28 139.11 30.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.265 0.555 . . . . 72.02 112.198 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' THR . 43.0 t -73.64 139.01 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.92 -0.582 . . . . 74.03 110.92 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.1 mt-10 -55.54 -28.23 53.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.065 0.765 . . . . 74.44 113.065 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 62' ' ' VAL . 60.0 p -81.05 -1.16 42.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.389 0.514 . . . . 53.31 112.389 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 m -97.46 137.81 35.86 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.015 0.376 . . . . 73.34 112.015 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 44.7 p -82.6 177.27 8.79 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.464 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.656 HD11 HD11 ' A' ' 37' ' ' LEU . 2.9 mm? -63.5 -41.9 98.51 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.988 0.423 . . . . 63.22 110.938 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -61.77 -45.56 93.38 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.113 0.483 . . . . 71.03 111.093 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.21 -28.64 69.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 72.23 111.672 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 p -91.53 4.55 52.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.304 -0.407 . . . . 52.5 111.85 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 70.48 11.82 7.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.199 0.6 . . . . 73.52 112.495 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 76' ' ' ALA . 58.0 t -79.95 107.71 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.828 0.346 . . . . 72.45 111.033 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.05 -158.13 12.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.16 -0.543 . . . . 74.53 113.641 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.2 p -67.9 91.52 0.33 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.317 0.58 . . . . 51.44 111.867 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.63 70.04 0.76 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.073 -0.512 . . . . 72.22 112.358 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 72' ' ' VAL . . . -134.5 127.96 32.43 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.932 0.396 . . . . 74.0 111.609 -178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -88.35 121.22 30.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.853 0.359 . . . . 73.22 111.494 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.635 HD11 HD23 ' A' ' 15' ' ' LEU . 86.3 mt -96.8 117.79 31.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.801 0.334 . . . . 74.05 111.627 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.5 ttm -77.24 86.97 3.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.073 0.463 . . . . 75.22 110.238 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 54' ' ' LEU . 27.1 tp -85.82 99.32 11.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 74.11 110.869 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.1 ttt -82.03 102.29 10.88 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.043 -0.526 . . . . 74.34 110.948 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.29 167.48 17.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 61.42 111.541 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 m -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.481 -0.327 . . . . 72.34 111.548 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.68 -27.81 64.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.081 0.467 . . . . 60.23 111.235 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.924 -0.931 . . . . 64.32 113.013 178.838 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 1' ' ' MET . 11.6 tmm? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.715 0.293 . . . . 74.34 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.44 168.68 35.39 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.216 -0.516 . . . . 23.53 112.677 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -70.48 78.07 0.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.161 0.505 . . . . 73.31 110.847 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -102.03 -14.47 17.13 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.239 -0.437 . . . . 73.34 111.836 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -75.62 126.58 31.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.714 0.292 . . . . 50.2 110.998 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -138.55 135.92 35.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.653 -0.249 . . . . 61.42 110.972 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -149.44 135.88 19.24 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.671 0.272 . . . . 70.5 111.67 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -147.06 151.99 37.8 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.611 0.243 . . . . 54.1 111.082 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.9 m -70.95 159.02 35.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.634 0.254 . . . . 70.51 110.909 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -149.43 157.17 43.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.998 0.428 . . . . 61.3 112.067 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t -98.67 -32.91 11.16 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.115 0.483 . . . . 73.45 112.262 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.6 p -92.19 113.61 25.93 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.733 0.642 . . . . 73.53 112.733 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 30' ' ' PRO . 38.2 pt -80.49 140.77 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.883 0.373 . . . . 71.12 110.696 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.59 112.11 23.68 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 73.13 111.425 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.66 144.41 33.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.906 0.384 . . . . 73.21 111.138 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -112.17 107.88 16.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.736 0.303 . . . . 72.14 111.356 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.68 121.6 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 75.22 111.856 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 79' ' ' MET . 24.4 mtpp -90.75 97.79 11.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.142 0.423 . . . . 73.34 112.142 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -79.57 67.18 5.26 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.462 -0.57 . . . . 73.52 109.462 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.0 -92.28 0.38 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.993 -0.622 . . . . 52.31 112.066 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.06 -28.16 8.37 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.422 -0.418 . . . . 54.33 112.599 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -74.91 139.45 43.08 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.832 0.349 . . . . 71.13 111.682 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.6 p -117.59 105.91 12.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.827 0.346 . . . . 65.41 111.196 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.61 113.98 60.42 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.37 -0.377 . . . . 63.5 111.615 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.28 123.89 8.06 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.84 2.36 . . . . 63.11 112.667 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.34 154.29 46.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.556 0.342 . . . . 64.02 110.805 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 20.9 p -136.7 105.26 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.08 0.467 . . . . 53.23 111.592 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 37' ' ' LEU . 35.1 m -135.35 178.07 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 116.203 -0.453 . . . . 50.32 111.239 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.1 m -87.74 135.71 33.58 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 122.138 -0.351 . . . . 53.22 111.598 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 13' ' ' ILE . 38.8 Cg_endo -65.35 -22.87 59.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.736 2.29 . . . . 73.41 112.921 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.94 -14.96 63.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.977 -0.556 . . . . 65.32 111.95 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 66.5 m -77.92 156.74 30.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.142 0.496 . . . . 44.43 111.722 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 80.6 p -88.93 158.21 18.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.87 0.367 . . . . 74.23 111.822 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 32.8 m -64.65 -21.3 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.158 0.504 . . . . 61.11 110.411 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -64.23 -48.39 75.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.011 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.13 -37.49 74.7 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.746 -0.661 . . . . 74.35 110.36 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 28' ' ' VAL . 32.4 mt -59.61 -49.06 79.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.483 -0.326 . . . . 75.22 111.698 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 52' ' ' GLN . 64.7 mttm -54.49 -45.37 73.21 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.201 0.524 . . . . 72.2 110.66 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -59.22 -31.97 69.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.661 -0.7 . . . . 54.33 111.73 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.424 HE22 HG11 ' A' ' 28' ' ' VAL . 24.6 mt-30 -84.67 -32.84 23.39 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.558 0.577 . . . . 63.11 112.558 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.75 -34.4 66.99 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.47 0.544 . . . . 63.11 112.47 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 50.7 mt-30 -54.16 -47.87 96.0 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.492 0.923 . . . . 63.35 113.492 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 51.7 Cg_endo -69.66 -18.85 37.24 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.848 1.698 . . . . 70.13 113.308 176.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.06 -63.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.912 0.387 . . . . 55.01 112.0 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -100.23 -2.2 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.449 0.536 . . . . 73.12 112.449 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 79.7 m-20 61.38 32.07 19.11 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.592 0.59 . . . . 74.11 112.592 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.6 p -98.11 136.59 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.288 0.565 . . . . 64.14 112.333 -176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.56 141.68 90.83 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.089 -0.505 . . . . 72.33 112.064 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.33 -36.45 93.72 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.829 2.353 . . . . 63.42 112.902 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -64.76 -19.74 65.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.185 0.517 . . . . 63.12 111.186 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' ALA . . . -104.47 -1.95 43.87 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.342 -0.456 . . . . 64.31 112.942 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . 49.5 mt-30 -92.61 77.5 4.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.838 0.351 . . . . 54.52 111.846 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -84.99 90.17 7.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.0 0.429 . . . . 72.1 111.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD23 HD13 ' A' ' 80' ' ' LEU . 96.5 mt -77.08 114.1 15.51 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.156 -0.475 . . . . 72.02 110.75 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.26 132.28 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.307 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -128.29 122.14 30.92 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.363 -0.21 . . . . 75.44 110.471 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.99 24.95 13.23 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.936 0.398 . . . . 54.33 111.976 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -4.98 83.27 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.157 -0.544 . . . . 65.52 112.984 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -92.64 131.61 37.59 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.566 -0.373 . . . . 70.44 111.197 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.16 123.37 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.907 0.384 . . . . 51.32 110.83 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 132.24 35.25 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.176 0.512 . . . . 63.15 112.372 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -87.33 141.45 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.028 -0.533 . . . . 72.43 110.67 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -44.35 -43.88 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.858 1.059 . . . . 75.4 113.858 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.8 p -71.53 -14.72 62.19 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.314 0.857 . . . . 73.55 113.314 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.0 t -82.38 142.87 31.64 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.088 0.471 . . . . 64.45 112.023 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 37.0 p -96.73 156.82 16.18 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.333 -0.394 . . . . 72.24 111.354 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.3 mm? -58.15 -40.86 82.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.235 0.541 . . . . 75.32 110.505 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -61.22 -49.78 75.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.854 -0.612 . . . . 74.43 111.873 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -70.99 -18.97 62.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.802 0.334 . . . . 72.32 111.767 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.7 t -88.64 1.78 54.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.484 -0.325 . . . . 71.42 110.767 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 65.87 18.46 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.228 0.611 . . . . 52.05 112.514 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.58 112.22 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.12 0.486 . . . . 70.43 110.399 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.21 -176.87 26.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 114.453 0.541 . . . . 42.41 114.453 -173.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 76.2 p -65.62 109.79 2.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.877 0.37 . . . . 75.25 111.46 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.29 21.14 11.98 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.332 -0.461 . . . . 41.21 113.16 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.36 140.12 39.88 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.238 0.542 . . . . 75.33 112.156 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.13 103.33 15.26 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.076 -0.511 . . . . 73.21 110.965 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.17 139.28 31.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.326 -0.397 . . . . 72.12 111.444 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.551 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 24.4 ttt -95.9 131.81 41.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.674 0.273 . . . . 75.45 111.023 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 54' ' ' LEU . 39.9 tp -127.54 100.21 5.91 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.382 0.61 . . . . 72.43 111.613 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.0 ttp -90.88 90.67 8.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.026 -0.534 . . . . 71.24 109.761 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' GLY . . . -93.17 139.93 30.06 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.704 0.631 . . . . 74.22 112.704 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -164.75 102.26 0.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.776 -0.647 . . . . 75.13 110.523 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -72.98 91.15 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 120.927 0.394 . . . . 73.32 111.774 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.264 0 CA-C-O 118.783 -1.009 . . . . 53.45 113.225 174.541 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.361 0.124 . . . . 75.31 110.803 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.11 155.3 18.97 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.119 -1.038 . . . . 62.24 114.236 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -63.8 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.053 0.541 . . . . 73.05 111.763 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -52.86 117.55 3.03 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.978 -0.451 . . . . 65.43 110.765 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -79.39 121.72 25.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.86 0.362 . . . . 74.24 111.739 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -89.64 133.71 34.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.46 0.647 . . . . 74.22 111.791 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -84.85 88.41 7.41 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.634 -0.712 . . . . 72.33 111.759 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -129.0 95.51 4.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.129 0.418 . . . . 65.31 112.129 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m 48.83 24.67 0.87 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.586 0.587 . . . . 50.33 112.586 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.432 ' CE1' ' HG ' ' A' ' 29' ' ' SER . 75.1 t60 -106.06 127.22 53.03 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.877 0.37 . . . . 74.31 111.545 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -122.49 -172.52 2.49 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.46 -0.336 . . . . 62.2 110.726 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -116.34 144.22 44.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.95 0.405 . . . . 75.21 111.18 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.471 HD12 HD21 ' A' ' 15' ' ' LEU . 22.5 pt -105.35 134.78 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.119 0.485 . . . . 74.13 111.737 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -86.38 118.43 25.81 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.771 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 76' ' ' ALA . 63.1 mt -115.46 174.68 5.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.353 0.597 . . . . 73.23 112.056 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.6 m -143.41 104.95 4.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.97 -0.559 . . . . 63.23 110.273 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.05 132.17 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.081 0.467 . . . . 32.01 111.999 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -88.1 107.13 18.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.965 0.412 . . . . 72.15 111.917 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HZ ' HG21 ' A' ' 45' ' ' THR . 6.5 m-85 -78.57 90.23 4.52 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 53.51 110.771 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.2 22.73 50.88 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.223 -0.513 . . . . 62.32 113.47 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.41 -30.2 4.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.408 -0.425 . . . . 42.23 113.079 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.95 118.35 25.37 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 122.585 -0.362 . . . . 55.23 111.741 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.7 m -82.43 113.48 20.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.862 0.363 . . . . 72.32 111.838 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.96 118.28 51.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 116.396 -0.366 . . . . 63.25 111.418 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.02 119.12 5.51 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.881 2.387 . . . . 63.05 113.023 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.82 -179.71 3.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 60.54 111.866 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.2 p -153.4 106.68 2.97 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.008 -0.542 . . . . 72.21 110.067 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.81 -177.92 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.81 0.67 . . . . 44.14 112.81 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 33.3 t -87.8 117.74 68.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.282 -0.872 . . . . 60.34 111.508 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.5 Cg_endo -61.19 -28.34 85.07 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.879 2.386 . . . . 72.12 113.555 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.29 4.66 30.02 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.172 0.434 . . . . 61.53 112.172 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 57.8 m -86.39 143.49 27.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.203 -0.311 . . . . 62.32 110.87 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 71.0 p -76.07 153.0 36.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.869 0.366 . . . . 72.44 111.226 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.49 ' HB ' HD12 ' A' ' 54' ' ' LEU . 31.5 m -58.39 -28.74 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.909 0.337 . . . . 74.42 111.909 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -78.3 -34.55 48.69 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.268 -0.27 . . . . 74.34 111.135 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 36.0 t70 -56.83 -40.96 77.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.073 0.463 . . . . 74.1 110.181 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD23 ' NE2' ' A' ' 40' ' ' GLN . 35.8 mt -60.5 -45.58 93.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.014 -0.539 . . . . 71.24 111.505 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 94.2 mttt -53.63 -44.96 69.96 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.842 0.353 . . . . 71.03 111.221 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -68.18 -27.07 66.08 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.899 0.333 . . . . 62.33 111.899 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 36' ' ' ASP . 26.1 mt-30 -81.2 -33.93 32.62 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.883 0.373 . . . . 75.51 111.622 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.54 -34.29 65.13 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.19 0.441 . . . . 74.21 112.19 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mt-30 -47.37 -52.2 37.76 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.705 1.002 . . . . 74.44 113.705 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 23.8 Cg_exo -64.84 -11.54 29.9 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.31 2.006 . . . . 73.14 113.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -113.17 -60.98 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.19 0.519 . . . . 60.01 111.825 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.506 HG21 ' HZ ' ' A' ' 19' ' ' PHE . 34.7 p -79.68 -15.2 58.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.452 0.538 . . . . 73.32 112.452 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 63.25 32.14 15.04 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.33 0.863 . . . . 74.03 113.33 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' OG1' ' A' ' 45' ' ' THR . 3.4 p -115.97 136.94 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.969 -0.457 . . . . 52.41 111.451 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.79 156.93 91.31 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 112.258 0.466 . . . . 62.43 112.258 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.38 -31.57 81.23 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.487 2.125 . . . . 70.1 112.234 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.15 -48.53 78.45 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.026 0.441 . . . . 71.2 110.976 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.77 -42.7 45.34 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.322 -0.466 . . . . 53.14 112.792 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.38 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.911 0.708 . . . . 75.03 112.911 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' CE ' ' SD ' ' A' ' 81' ' ' MET . 31.9 mtmm -99.42 97.52 8.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 75.0 110.714 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 80' ' ' LEU . 94.9 mt -73.38 98.15 2.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.224 0.535 . . . . 70.14 110.459 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 60' ' ' VAL . 64.8 mt -100.42 120.01 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.559 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 61' ' ' LEU . 36.9 t80 -132.35 129.12 39.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.395 -0.366 . . . . 72.03 110.044 176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.6 23.46 12.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.846 0.355 . . . . 61.02 111.811 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.84 5.54 66.29 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.264 0.466 . . . . 61.14 114.264 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -122.91 140.67 52.73 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.429 0.614 . . . . 75.32 112.201 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 55' ' ' ILE . 61.2 t -82.48 108.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.635 -0.506 . . . . 65.13 109.635 171.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 56' ' ' PHE . 3.0 mm? -61.73 143.31 56.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.526 0.679 . . . . 62.54 112.708 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.19 142.66 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.312 -0.858 . . . . 74.25 112.054 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' THR . 41.3 mt-10 -52.05 -47.0 65.3 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.495 0.924 . . . . 75.21 113.495 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -81.93 5.2 19.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.036 0.754 . . . . 63.05 113.036 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -90.79 131.15 36.62 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.822 0.344 . . . . 71.03 111.33 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 30.0 p -87.69 165.08 15.65 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.799 0.333 . . . . 72.42 111.297 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 67' ' ' LEU . 3.2 mm? -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.154 0.502 . . . . 75.1 110.834 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 34.4 ttpt -66.21 -28.51 68.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.951 -0.568 . . . . 70.31 111.443 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.46 -19.39 38.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.096 0.474 . . . . 64.0 111.198 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -96.08 16.54 17.73 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.204 0.446 . . . . 54.3 112.204 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.7 19.19 11.21 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.204 0.526 . . . . 54.42 111.899 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.11 122.24 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.3 -0.409 . . . . 65.23 110.892 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.22 -158.14 7.95 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.817 -0.706 . . . . 45.53 113.64 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.3 p -53.71 112.34 0.91 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.141 0.496 . . . . 62.24 112.154 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.67 30.04 27.88 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.08 -0.509 . . . . 73.41 113.421 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -82.99 120.17 25.38 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.273 -0.545 . . . . 53.02 111.818 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 9.9 mtmp? -82.57 93.63 7.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.047 -0.524 . . . . 63.31 111.205 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.84 154.56 19.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.02 0.438 . . . . 73.21 111.832 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 48.6 ttm -122.66 120.45 33.73 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.415 -0.357 . . . . 72.53 110.714 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD13 HD23 ' A' ' 54' ' ' LEU . 49.0 tp -119.82 114.09 21.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.083 0.468 . . . . 55.5 111.582 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.427 ' SD ' ' CE ' ' A' ' 53' ' ' LYS . 26.1 ttt -78.61 83.3 4.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.065 0.46 . . . . 71.23 110.832 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -115.21 106.2 13.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.224 -0.444 . . . . 73.3 110.454 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -141.01 168.02 20.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.194 0.521 . . . . 73.42 111.894 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.76 -9.65 22.76 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.052 -0.522 . . . . 40.2 111.503 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.813 -0.993 . . . . 35.05 113.112 -178.834 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.615 0.245 . . . . 60.43 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.5 112.09 2.41 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.399 -0.429 . . . . 72.43 113.713 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -69.64 122.67 19.57 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.518 -0.401 . . . . 72.23 111.263 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -105.35 179.3 4.31 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.798 0.332 . . . . 72.15 111.33 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -131.2 134.96 46.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.212 0.53 . . . . 72.13 111.6 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -77.94 137.45 38.34 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.204 -0.453 . . . . 74.23 112.118 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -161.4 156.74 24.16 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.07 -0.514 . . . . 74.32 110.768 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -62.62 136.96 58.14 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.688 0.28 . . . . 72.34 110.947 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -116.67 101.48 8.62 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.826 0.346 . . . . 74.2 111.238 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -73.41 94.67 2.1 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.086 0.469 . . . . 73.23 111.684 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 p -139.52 -176.67 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.96 0.409 . . . . 73.5 111.329 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.2 p -87.54 127.08 35.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.072 0.463 . . . . 54.02 111.835 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.22 134.84 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 74.32 111.953 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.81 115.95 25.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.047 0.451 . . . . 62.51 111.36 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -108.02 147.11 31.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.025 -0.534 . . . . 73.42 110.756 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -116.91 103.97 10.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.956 0.407 . . . . 74.33 111.062 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.39 137.23 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.19 0.519 . . . . 62.23 112.099 -175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -89.99 115.03 26.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.293 -0.412 . . . . 73.02 110.826 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.59 166.89 21.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.257 -0.429 . . . . 74.31 110.065 177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -45.97 -32.21 4.59 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 121.21 -0.519 . . . . 55.23 113.727 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.94 -44.1 0.22 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.331 -0.461 . . . . 72.34 113.572 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -98.97 -179.0 4.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.584 0.587 . . . . 73.44 112.584 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.9 p -126.57 115.27 19.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.476 -0.329 . . . . 73.42 110.712 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.1 117.95 53.76 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 112.642 0.608 . . . . 63.31 112.642 -172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.21 114.88 1.91 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.19 2.594 . . . . 63.12 112.307 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.56 167.58 10.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.12 0.486 . . . . 62.24 111.779 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 p -141.31 109.78 5.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.201 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.79 175.25 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.86 0.362 . . . . 70.11 111.403 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.0 p -100.44 136.03 20.07 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 120.739 0.305 . . . . 70.24 110.832 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.2 Cg_endo -62.09 -12.28 25.71 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.88 2.387 . . . . 63.5 113.662 -176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.54 -12.48 60.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.456 0.539 . . . . 73.1 112.456 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.6 m -86.92 143.54 27.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.842 0.354 . . . . 72.33 111.774 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 38.1 p -79.09 147.61 32.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.712 0.291 . . . . 72.44 110.465 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 61' ' ' LEU . 33.4 m -59.91 -28.43 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.993 0.425 . . . . 75.4 111.515 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 28.6 ttpp -66.11 -47.61 73.57 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.023 0.44 . . . . 62.33 110.576 174.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.97 -41.46 82.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.076 -0.511 . . . . 64.32 111.033 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 67' ' ' LEU . 29.8 mt -59.85 -50.32 74.24 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.246 0.461 . . . . 62.25 112.246 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 34' ' ' VAL . 48.8 mtmt -52.98 -32.83 48.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.92 0.39 . . . . 72.4 111.247 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 29.8 t -77.52 -38.76 48.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.422 -0.354 . . . . 72.45 111.532 177.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -67.69 -27.85 67.18 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.923 0.392 . . . . 70.11 111.189 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.69 -22.75 59.83 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.428 0.529 . . . . 52.12 112.428 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 39' ' ' SER . 45.7 mt-30 -50.52 -52.29 56.83 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 113.23 0.826 . . . . 72.23 113.23 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.61 -5.25 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.983 1.789 . . . . 75.22 113.415 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.5 mt -107.74 -64.14 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.169 0.509 . . . . 71.43 111.736 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG12 ' A' ' 47' ' ' VAL . 68.9 p -75.53 -22.75 56.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.157 -0.474 . . . . 74.15 112.144 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.88 28.78 3.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.981 0.513 . . . . 75.5 112.295 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG12 ' OG1' ' A' ' 45' ' ' THR . 7.3 p -126.17 148.6 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.018 0.437 . . . . 42.21 111.394 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.4 144.64 96.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 112.623 0.601 . . . . 74.51 112.623 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.97 -15.65 47.5 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.0 2.466 . . . . 62.35 113.12 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -67.95 -49.87 59.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.137 0.494 . . . . 71.21 111.082 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.81 -28.73 58.52 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.948 -0.569 . . . . 73.03 113.654 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.1 91.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.155 0.503 . . . . 72.24 112.125 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 60.0 mtpt -92.2 98.9 11.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.232 -0.44 . . . . 73.04 111.27 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD23 HD13 ' A' ' 80' ' ' LEU . 90.8 mt -76.43 109.91 10.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.519 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -115.58 118.52 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.262 0.467 . . . . 74.04 112.262 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.84 124.07 44.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.547 0.339 . . . . 70.34 110.744 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt 60.98 17.34 7.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.321 0.489 . . . . 55.5 112.321 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.94 -6.16 58.33 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.138 -0.553 . . . . 52.22 113.403 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -107.27 132.9 52.58 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.547 -0.384 . . . . 63.21 111.133 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 HG12 ' A' ' 55' ' ' ILE . 59.5 t -72.88 127.3 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 110.018 -0.364 . . . . 74.51 110.018 172.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HB3' HG11 ' A' ' 34' ' ' VAL . 3.9 mm? -58.7 135.74 57.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.141 0.496 . . . . 73.24 111.498 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 64' ' ' THR . 41.5 t -79.16 130.77 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.254 -0.43 . . . . 61.43 111.168 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 47.0 mt-10 -62.12 -27.5 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.132 0.419 . . . . 74.45 112.132 -175.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' HG12 ' A' ' 62' ' ' VAL . 67.6 p -81.41 4.32 21.33 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.252 0.464 . . . . 73.23 112.252 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.4 p -127.04 138.12 53.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.145 0.498 . . . . 74.14 112.14 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 41.2 p -81.32 179.36 7.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.074 -0.512 . . . . 70.31 111.347 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.2 mm? -62.58 -46.03 90.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.928 0.394 . . . . 63.22 110.277 174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.5 tttp -60.41 -44.31 95.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.197 -0.456 . . . . 71.21 111.182 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -64.11 -25.49 68.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.442 -0.345 . . . . 64.31 111.678 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.1 m -93.82 3.65 55.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.608 -0.269 . . . . 70.43 111.649 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.39 23.41 13.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.904 0.482 . . . . 74.3 112.275 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.92 128.14 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.826 0.346 . . . . 61.24 110.476 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -132.27 -174.34 13.6 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.943 -0.646 . . . . 72.45 113.711 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 p -60.86 118.84 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.149 0.5 . . . . 71.41 111.878 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.29 35.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.179 -0.534 . . . . 73.34 113.127 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB3' HD22 ' A' ' 15' ' ' LEU . . . -75.97 144.15 41.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.319 0.581 . . . . 64.11 111.748 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.16 113.4 23.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 73.35 111.549 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.67 177.94 4.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.38 0.61 . . . . 51.13 111.948 -173.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.565 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -128.95 149.25 50.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.882 -0.599 . . . . 74.02 109.868 171.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.561 HD13 HD23 ' A' ' 54' ' ' LEU . 36.4 tp -134.45 101.94 5.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.202 0.525 . . . . 73.52 111.302 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 24.6 ttt -75.47 94.66 3.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.009 -0.541 . . . . 74.24 110.72 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.71 174.2 12.42 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.037 0.446 . . . . 50.13 111.645 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -114.3 162.94 15.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.267 -0.424 . . . . 71.34 111.424 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 67.22 16.09 10.12 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.334 0.494 . . . . 65.11 112.334 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.371 0 CA-C-O 118.895 -0.947 . . . . 72.22 113.004 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.784 0.326 . . . . 70.34 111.555 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.48 -162.1 31.31 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.322 -0.399 . . . . 31.33 112.46 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -137.07 109.92 7.62 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.346 0.593 . . . . 70.13 110.794 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -70.37 -33.48 71.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.152 -0.476 . . . . 73.01 111.608 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -85.82 165.09 17.13 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.863 0.363 . . . . 74.5 111.338 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.92 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.989 0.737 . . . . 73.02 112.989 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.623 ' NE2' ' HB2' ' A' ' 9' ' ' SER . 83.1 t60 -56.7 109.33 0.61 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.122 -0.944 . . . . 74.23 110.751 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -59.79 -37.47 79.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.478 . . . . 74.45 112.292 -173.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.623 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 50.7 m -64.02 133.91 54.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.612 -0.514 . . . . 74.13 109.612 173.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -52.69 140.09 24.46 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.357 0.873 . . . . 70.24 113.357 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -111.57 -168.07 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.825 -0.625 . . . . 70.22 111.571 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.5 p -106.44 163.13 13.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.154 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' SER . 16.5 pt -137.73 150.28 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.242 0.544 . . . . 74.44 112.124 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 74' ' ' SER . 62.8 mttm -80.88 113.15 18.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.86 -0.609 . . . . 74.32 111.829 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.59 127.74 56.18 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.046 0.45 . . . . 73.42 111.792 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 38.1 m -95.9 91.07 5.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.455 -0.339 . . . . 74.12 110.134 172.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -86.49 105.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 72.5 111.171 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.1 104.56 17.12 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.421 0.526 . . . . 73.5 112.421 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 38.9 m-85 -78.21 82.59 4.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.64 0.257 . . . . 71.23 110.761 173.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.74 45.72 18.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 116.208 -0.451 . . . . 43.1 113.675 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.46 -32.85 5.68 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.232 -0.508 . . . . 71.51 112.872 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 48.5 mmtm -76.39 98.86 4.67 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.075 0.464 . . . . 72.4 110.993 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.3 p -75.08 103.46 5.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.892 0.377 . . . . 62.11 111.592 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -98.06 104.67 23.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.434 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.55 111.39 2.56 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.619 2.212 . . . . 71.32 112.98 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.98 173.37 7.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.043 0.449 . . . . 71.14 111.689 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 49.3 m -143.27 96.47 2.92 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.695 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 34.2 m -117.1 176.54 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.072 0.397 . . . . 73.22 112.072 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -86.86 131.25 45.68 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.502 -0.317 . . . . 72.44 111.171 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 32.6 Cg_endo -63.69 -22.88 69.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.583 2.188 . . . . 70.14 112.867 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.67 -23.37 67.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.211 -0.45 . . . . 64.32 111.732 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.07 160.25 31.52 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.022 0.439 . . . . 74.13 111.736 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 58.6 p -91.11 157.54 17.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.128 0.489 . . . . 70.03 111.579 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 54' ' ' LEU . 32.0 m -61.88 -25.38 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.016 0.436 . . . . 73.42 111.015 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 37.8 ttpt -70.79 -42.11 70.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.367 -0.379 . . . . 70.13 110.865 173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 34.3 t70 -55.32 -41.21 72.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.187 0.518 . . . . 73.34 110.124 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 28' ' ' VAL . 39.0 mt -61.5 -56.9 14.96 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.893 -0.594 . . . . 71.42 111.824 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 7.5 mtmp? -58.27 -24.06 58.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.672 0.272 . . . . 71.33 111.654 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 t -76.81 -43.54 36.17 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.854 0.359 . . . . 52.43 111.17 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 26.1 mt-30 -68.3 -34.62 76.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 74.03 111.759 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.39 -18.61 64.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.715 0.635 . . . . 64.42 112.715 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.59 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 52.5 mt-30 -59.47 -52.33 75.0 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.856 0.687 . . . . 75.45 112.856 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 40' ' ' GLN . 16.9 Cg_exo -69.12 -24.58 32.47 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.87 1.713 . . . . 71.23 112.598 174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -78.19 -33.35 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.528 0.566 . . . . 74.53 112.528 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -129.37 -10.28 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.738 0.644 . . . . 55.21 112.738 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 61.32 85.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.23 0.538 . . . . 73.02 111.186 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.527 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 7.5 p -165.22 146.91 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.992 -0.549 . . . . 70.44 111.189 -175.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.2 149.23 58.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.204 0.446 . . . . 75.51 112.204 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' NE2' ' A' ' 42' ' ' GLN . 18.3 Cg_endo -60.27 -27.23 84.46 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.781 2.321 . . . . 63.11 112.249 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.5 ttt-85 -64.51 -49.57 70.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.376 0.607 . . . . 64.23 110.488 170.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.65 -43.96 98.57 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.456 -0.793 . . . . 73.24 112.893 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' HD11 ' A' ' 80' ' ' LEU . 49.8 mt-30 -71.21 115.38 10.29 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.628 0.603 . . . . 63.34 112.628 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -120.72 104.27 9.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.112 -0.494 . . . . 73.51 111.29 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.582 HD12 ' HB ' ' A' ' 34' ' ' VAL . 76.2 mt -76.58 114.22 15.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.953 0.406 . . . . 72.24 111.495 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 60' ' ' VAL . 60.6 mt -118.48 107.82 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.238 0.542 . . . . 72.33 111.547 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' A' ' 61' ' ' LEU . 63.8 t80 -110.07 127.26 54.75 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.918 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 56.21 27.04 11.08 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.029 0.442 . . . . 75.2 111.874 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.01 6.13 79.66 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.296 -0.478 . . . . 45.24 113.892 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.29 137.8 52.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.156 0.478 . . . . 74.02 111.521 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG22 HG12 ' A' ' 55' ' ' ILE . 45.4 t -81.1 132.48 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.674 0.273 . . . . 65.14 111.018 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 56' ' ' PHE . 2.9 mm? -91.97 126.99 37.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.129 0.49 . . . . 62.53 111.749 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.54 142.47 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.31 -0.405 . . . . 73.03 110.821 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 46.8 mt-10 -55.38 -26.27 40.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.086 0.773 . . . . 52.21 113.086 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.8 p -76.95 -7.92 56.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.518 0.562 . . . . 75.02 112.518 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 m -89.13 140.28 29.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.899 0.38 . . . . 75.15 111.977 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 24.6 p -95.75 159.89 14.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.902 0.382 . . . . 74.13 110.884 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mm? -61.74 -35.76 79.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.181 0.515 . . . . 73.35 110.547 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 29.3 ttpp -66.47 -31.43 72.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.9 -0.591 . . . . 72.31 111.5 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.1 -32.56 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.96 0.356 . . . . 63.34 111.96 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -92.92 22.68 4.7 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.98 0.733 . . . . 73.2 112.98 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.87 18.45 10.78 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.66 0.615 . . . . 73.03 112.66 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 67' ' ' LEU . 66.9 t -81.96 125.66 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.072 0.463 . . . . 71.45 110.924 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -167.45 12.12 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.994 -0.622 . . . . 55.44 113.528 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' A' ' 14' ' ' LYS . 35.2 t -58.98 104.93 0.27 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.954 0.407 . . . . 32.04 111.737 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.45 7.5 30.05 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.336 -0.459 . . . . 53.1 113.239 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.01 138.61 38.9 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.095 0.474 . . . . 73.14 111.508 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 65.7 mttm -117.34 123.12 45.72 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.108 0.48 . . . . 60.13 111.331 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.2 mt -109.48 115.6 30.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.833 -0.622 . . . . 71.34 111.769 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 43.7 ttm -74.33 100.91 3.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.82 0.343 . . . . 72.44 110.097 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 52' ' ' GLN . 27.3 tp -95.35 101.85 13.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 73.22 111.695 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.8 ttt -77.53 88.77 3.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.94 -0.573 . . . . 71.31 110.089 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 47' ' ' VAL . . . -97.45 96.32 8.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.878 0.371 . . . . 64.41 111.785 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.4 m -115.47 119.95 37.9 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.388 -0.369 . . . . 74.12 111.109 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -80.0 -73.93 0.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.417 0.525 . . . . 73.24 112.417 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.782 -1.01 . . . . 55.33 114.185 -175.386 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.809 0.337 . . . . 24.33 111.098 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.56 -26.58 14.97 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 114.736 0.654 . . . . 35.02 114.736 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.05 45.53 0.84 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.672 0.736 . . . . 73.25 112.44 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.45 154.26 50.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.662 0.268 . . . . 74.42 111.226 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 53.76 81.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.129 0.572 . . . . 71.13 112.535 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -73.48 -29.23 62.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.262 0.553 . . . . 74.11 110.326 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -116.83 93.76 4.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 64.25 110.776 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -78.06 123.23 26.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 110.218 -0.29 . . . . 74.24 110.218 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -68.09 136.27 53.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.458 0.647 . . . . 63.35 112.74 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -160.03 20.54 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.319 -0.855 . . . . 75.1 109.576 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -88.45 -174.71 4.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.566 -0.743 . . . . 74.05 112.604 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -92.58 175.41 6.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.807 -0.633 . . . . 44.32 112.297 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -120.72 131.07 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.759 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -78.88 101.95 7.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.762 0.315 . . . . 64.2 111.109 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.24 173.87 6.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 72.3 111.481 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -141.16 110.72 6.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.775 0.322 . . . . 64.32 110.806 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.94 133.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.753 0.311 . . . . 64.3 111.102 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' HG3' ' A' ' 79' ' ' MET . 11.1 ptmm? -94.46 117.69 30.51 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.639 0.607 . . . . 72.32 112.639 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -96.92 107.66 20.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.384 -0.371 . . . . 75.1 110.178 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.06 -98.31 0.13 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.156 -0.545 . . . . 55.44 112.527 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.15 -6.29 20.57 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.304 -0.474 . . . . 73.11 112.919 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.2 129.5 38.14 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.49 -0.418 . . . . 73.42 112.013 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m -92.59 115.39 28.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.169 -0.468 . . . . 61.13 110.759 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mm -107.67 101.71 41.34 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.867 0.321 . . . . 71.33 111.867 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.64 116.93 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.9 2.4 . . . . 73.25 112.69 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -129.42 133.32 47.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.915 0.388 . . . . 65.51 111.472 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.8 p -96.47 91.06 5.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.082 0.467 . . . . 75.43 110.802 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.77 166.95 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 72.33 112.204 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.867 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.4 m -72.29 128.27 89.1 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.746 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 27.1 Cg_endo -60.06 -37.8 81.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.824 2.349 . . . . 45.43 113.825 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.49 30.46 1.73 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.3 0.571 . . . . 71.2 112.298 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 29' ' ' SER . 92.0 m -97.22 130.17 44.47 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.101 170.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 72.0 p -70.03 152.12 44.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.173 0.511 . . . . 62.34 111.769 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.8 -10.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.2 0.524 . . . . 72.34 111.497 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 62.4 tttm -75.98 -43.76 42.97 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.541 -0.541 . . . . 75.21 109.541 169.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.54 -42.85 93.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.743 -0.662 . . . . 62.25 110.463 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 67' ' ' LEU . 59.4 mt -54.85 -48.76 72.48 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.348 -0.387 . . . . 70.43 111.827 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 36.2 mtmm -58.2 -21.08 46.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.549 -0.296 . . . . 72.31 111.772 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 t -84.82 -42.87 14.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.731 0.3 . . . . 62.4 111.019 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.39 -38.64 91.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.69 0.626 . . . . 54.21 112.69 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.88 -24.77 65.27 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.719 0.637 . . . . 73.01 112.719 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 57.8 mt-30 -59.8 -54.98 50.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 112.884 0.698 . . . . 75.34 112.884 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' GLN . 74.3 Cg_endo -73.68 9.94 1.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.12 1.88 . . . . 71.51 113.202 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.79 -65.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.948 0.404 . . . . 63.2 111.347 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HA2' ' A' ' 85' ' ' GLY . 45.4 p -102.23 1.19 35.59 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.575 0.583 . . . . 32.42 112.575 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 66.33 25.04 10.48 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.196 0.443 . . . . 62.11 112.196 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 9.1 p -93.77 131.81 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.207 0.527 . . . . 72.51 111.764 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.31 146.48 44.95 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 74.53 111.578 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.65 -38.39 28.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.329 2.686 . . . . 74.45 113.678 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -51.57 -40.57 60.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.919 0.39 . . . . 74.34 111.763 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.66 73.97 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.967 -0.635 . . . . 55.11 113.422 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 51.2 mt-30 -94.25 85.77 4.74 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.273 0.558 . . . . 64.4 112.123 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 29.1 mtpp -91.95 90.8 7.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.036 -0.529 . . . . 74.02 110.508 174.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HD13 ' A' ' 80' ' ' LEU . 97.8 mt -77.05 106.76 8.95 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.99 0.424 . . . . 70.14 111.596 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.36 135.84 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.192 -0.458 . . . . 71.23 111.261 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -136.26 125.15 24.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.618 0.247 . . . . 74.23 110.747 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 57.28 21.76 7.02 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.844 0.457 . . . . 72.13 112.223 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.4 57.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.118 -0.563 . . . . 74.42 113.65 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -122.61 131.31 53.76 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.386 -0.479 . . . . 72.34 111.563 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.07 127.37 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.192 -0.299 . . . . 74.51 110.192 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.76 126.0 30.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.438 0.533 . . . . 64.21 112.438 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.01 132.82 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.898 -0.592 . . . . 63.13 111.057 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 40.7 mt-10 -53.14 -36.46 60.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.218 0.822 . . . . 71.24 113.218 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.2 p -84.06 5.99 23.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.71 0.633 . . . . 75.35 112.71 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -106.74 141.97 37.13 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 65.32 111.14 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 16.5 p -94.59 172.68 8.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.614 -0.266 . . . . 74.33 110.864 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 37' ' ' LEU . 3.1 mm? -60.31 -52.42 65.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.127 0.489 . . . . 75.4 110.433 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 51.7 tttm -64.16 -34.81 78.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.117 -0.492 . . . . 71.54 111.845 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.29 -25.36 63.3 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.106 -0.371 . . . . 74.4 111.113 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 m -91.02 14.36 14.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.285 -0.416 . . . . 63.34 110.974 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 66.68 17.7 10.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.361 0.665 . . . . 75.23 112.42 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.84 110.56 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.894 0.378 . . . . 73.43 111.102 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.32 -174.49 26.22 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.264 -0.493 . . . . 65.42 113.159 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.3 p -70.3 124.94 25.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.425 -0.456 . . . . 73.02 111.354 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.09 -6.95 27.16 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.257 -0.429 . . . . 65.33 112.525 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.8 152.41 25.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.026 0.441 . . . . 35.25 111.251 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -126.39 125.77 42.76 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.047 0.451 . . . . 73.13 111.226 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.28 132.52 36.62 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.147 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.575 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 47.4 ttm -91.82 94.47 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.125 -0.489 . . . . 62.4 110.845 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.651 HD13 HD23 ' A' ' 54' ' ' LEU . 35.0 tp -93.55 120.2 33.53 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.924 0.392 . . . . 73.34 111.379 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 27.9 ttt -84.66 76.98 10.14 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.497 0.665 . . . . 75.11 110.333 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.87 140.0 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.661 -0.7 . . . . 62.54 110.459 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.7 p -87.71 -66.1 0.95 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.982 0.42 . . . . 65.34 112.053 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 115.87 15.53 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.224 -0.444 . . . . 64.35 111.006 -178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 119.195 -0.78 . . . . 37.5 113.105 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.775 0.321 . . . . 65.45 110.992 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.76 87.15 0.5 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.027 -0.606 . . . . 42.12 113.539 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -73.0 80.26 1.19 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.374 0.607 . . . . 63.42 110.195 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -52.83 145.41 12.54 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.399 -0.819 . . . . 74.44 113.014 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.99 150.05 28.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 60.14 111.845 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -100.46 -22.83 14.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.008 0.432 . . . . 74.01 110.884 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -166.63 168.73 14.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.477 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -80.33 134.45 36.06 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.23 -0.294 . . . . 41.03 110.462 173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -108.01 176.36 5.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.001 0.429 . . . . 71.31 111.379 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.95 122.8 39.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.828 0.347 . . . . 71.11 111.437 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 34.3 t -72.92 103.19 3.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.808 -0.441 . . . . 64.03 109.808 173.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 p -115.66 142.9 46.12 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 74.24 112.501 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -105.19 125.57 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.689 -0.687 . . . . 74.45 110.5 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -72.55 98.57 2.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.188 0.518 . . . . 72.41 111.532 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -101.63 163.22 12.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.3 0.572 . . . . 75.11 111.665 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.557 ' HB ' ' HG2' ' A' ' 77' ' ' LYS . 26.6 m -126.37 97.19 4.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.292 -0.413 . . . . 63.33 110.701 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.17 124.93 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.071 0.462 . . . . 73.4 111.185 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 45.6 mtpt -100.14 114.38 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.625 0.602 . . . . 64.43 112.625 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -79.3 84.13 5.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.661 -0.496 . . . . 71.1 109.661 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.14 -98.76 0.28 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.057 -0.592 . . . . 52.45 112.117 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.4 -19.07 31.18 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.223 -0.513 . . . . 71.21 113.051 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -79.57 102.34 8.81 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.402 0.519 . . . . 70.34 112.402 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 58.8 p -80.9 101.0 9.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.827 0.346 . . . . 72.21 111.205 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' A' ' 26' ' ' LEU . 25.5 mm -99.01 113.86 64.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 111.947 0.351 . . . . 62.31 111.947 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.82 111.55 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.793 2.329 . . . . 41.22 112.494 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' HG22 ' A' ' 24' ' ' ILE . 95.9 mt -133.05 132.61 41.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.964 0.411 . . . . 74.22 111.544 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -106.03 108.03 19.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.942 0.401 . . . . 62.54 111.438 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.39 172.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.432 -0.349 . . . . 63.13 111.425 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -79.69 128.98 72.81 Favored Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 122.188 -0.32 . . . . 72.02 111.111 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 35.0 Cg_endo -63.08 -17.12 58.58 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.881 2.388 . . . . 71.43 113.554 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -88.99 -2.91 58.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.202 0.445 . . . . 63.34 112.202 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.2 m -83.22 145.84 28.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.905 0.384 . . . . 75.42 111.043 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 60.9 p -81.8 154.34 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.064 0.459 . . . . 75.42 111.937 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 m -65.93 -11.47 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.326 0.584 . . . . 74.45 110.787 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 44.9 tttp -71.67 -56.16 6.35 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.554 0.693 . . . . 73.4 109.705 170.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.25 -35.02 71.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.18 -0.918 . . . . 71.0 111.536 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 67' ' ' LEU . 30.2 mt -51.41 -45.98 62.74 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.943 0.349 . . . . 75.31 111.943 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -65.82 -29.75 70.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.13 0.49 . . . . 73.24 110.949 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -73.41 -31.83 64.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.948 -0.569 . . . . 62.12 111.203 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -77.12 -42.14 39.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.444 -0.343 . . . . 72.51 111.51 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.91 -26.17 63.09 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.303 0.483 . . . . 74.52 112.303 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.24 -53.97 55.82 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 112.496 0.554 . . . . 73.41 112.496 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -24.78 33.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.868 1.712 . . . . 74.53 113.235 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.15 -53.74 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.253 0.464 . . . . 72.21 112.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -99.15 -12.84 20.1 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.888 0.375 . . . . 71.21 111.783 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 64.98 63.06 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.687 0.756 . . . . 74.43 111.139 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.39 128.98 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.272 -0.876 . . . . 74.05 110.354 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.29 144.0 65.75 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 112.082 0.401 . . . . 52.12 112.082 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.4 -28.62 44.76 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.339 2.693 . . . . 71.44 113.472 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -58.41 -32.74 68.92 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.754 0.312 . . . . 74.51 111.642 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.36 -4.11 55.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.29 -0.481 . . . . 64.31 113.498 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -87.59 88.67 7.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.234 0.54 . . . . 64.35 111.914 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 59.9 mttp -85.04 96.84 9.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.087 -0.506 . . . . 75.14 111.49 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -79.17 112.87 16.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.401 -0.363 . . . . 73.23 111.119 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 61.3 mt -122.41 125.81 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.985 0.422 . . . . 74.3 111.315 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -119.93 113.59 20.79 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.802 0.334 . . . . 75.42 111.18 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 60.86 11.94 3.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.708 0.632 . . . . 61.24 112.708 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.0 -16.91 15.45 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.099 -0.572 . . . . 61.11 113.466 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -100.02 131.48 45.96 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.395 -0.473 . . . . 71.5 111.5 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 55' ' ' ILE . 55.0 t -78.23 133.22 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 74.31 110.492 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.81 127.69 33.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.556 0.576 . . . . 64.05 112.556 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.88 137.38 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.987 -0.551 . . . . 74.42 110.97 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 45.4 mt-10 -53.72 -37.5 63.35 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.587 0.588 . . . . 72.43 112.587 -173.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.0 p -71.5 -11.86 61.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.832 0.678 . . . . 61.52 112.832 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.1 t -90.91 142.56 27.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.053 0.454 . . . . 75.54 111.927 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 28.5 p -94.57 170.75 9.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.387 -0.37 . . . . 71.03 110.692 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 37' ' ' LEU . 3.2 mm? -58.26 -54.04 51.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.238 0.542 . . . . 62.34 110.779 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 37.7 ttpt -60.01 -36.78 77.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.859 -0.61 . . . . 74.02 111.767 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -68.43 -37.87 80.66 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.195 -0.315 . . . . 72.32 111.724 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 t -90.82 20.5 4.72 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.972 0.36 . . . . 61.31 111.972 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 68.85 12.64 8.7 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.036 0.754 . . . . 74.4 113.036 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.64 96.86 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.759 0.314 . . . . 74.4 110.296 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.77 -170.38 15.97 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.13 -0.557 . . . . 72.14 113.73 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.9 p -52.42 114.13 1.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.79 0.329 . . . . 74.15 111.861 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.48 -13.31 39.46 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.536 . . . . 72.44 113.671 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.73 53.83 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.318 0.58 . . . . 71.12 112.374 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 9.7 mtmp? -108.4 125.79 52.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.396 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.81 135.76 44.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.676 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.9 ttm -97.61 106.38 18.69 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 74.25 110.714 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 54' ' ' LEU . 28.6 tp -100.5 102.03 13.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.058 0.456 . . . . 72.55 111.145 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.2 ttt -78.86 79.57 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.467 0.651 . . . . 74.02 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.11 51.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.508 -0.769 . . . . 75.31 110.662 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.3 p -156.71 169.26 25.12 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.972 0.415 . . . . 72.31 111.506 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.4 -44.66 51.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.996 0.427 . . . . 72.23 111.118 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.259 0 CA-C-O 118.94 -0.922 . . . . 61.35 113.002 -179.347 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.736 0.303 . . . . 72.04 111.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.78 153.68 25.03 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.738 -0.545 . . . . 72.33 111.738 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -78.96 52.47 1.26 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 117.473 0.637 . . . . 72.43 112.718 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t60 70.36 -32.23 0.23 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.654 1.353 . . . . 70.23 114.654 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.99 122.14 12.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.816 0.672 . . . . 73.43 112.816 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -66.17 134.87 53.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.793 -0.64 . . . . 74.44 110.926 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -135.23 155.38 50.76 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.112 -0.367 . . . . 73.33 111.29 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -68.92 142.18 54.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.749 -0.205 . . . . 72.03 110.853 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -168.16 167.51 12.3 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.294 0.569 . . . . 52.21 112.236 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -111.78 8.22 20.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.742 -0.663 . . . . 73.33 110.822 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 m -56.62 155.7 7.16 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.699 0.629 . . . . 75.4 112.699 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.7 p -87.18 126.14 34.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.335 0.588 . . . . 74.24 111.039 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' SER . 21.2 pt -103.15 149.87 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.939 -0.573 . . . . 64.33 111.891 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 54.6 mtmt -92.18 109.27 20.63 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.973 0.415 . . . . 64.55 111.566 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 15' ' ' LEU . 5.2 mp -90.62 142.13 28.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.02 -0.536 . . . . 55.34 110.721 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -109.43 90.56 3.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.531 0.205 . . . . 72.33 110.727 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 24' ' ' ILE . 12.1 p -88.68 145.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.213 0.53 . . . . 70.43 111.292 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -113.3 111.45 22.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.153 0.797 . . . . 74.53 113.153 -168.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 6.2 m-85 -82.35 166.06 19.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.469 -0.567 . . . . 71.31 109.469 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.4 84.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 120.832 -0.699 . . . . 72.32 113.054 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' PHE . . . 92.68 8.13 62.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.694 -0.289 . . . . 60.54 113.719 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 19' ' ' PHE . 30.5 mmtp -130.15 137.59 50.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 117.295 0.547 . . . . 74.22 111.238 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -107.16 126.72 52.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.039 0.447 . . . . 31.23 111.157 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 34.6 mm -117.49 108.82 42.75 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.553 -0.294 . . . . 73.24 111.15 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 98.6 Cg_endo -90.3 115.36 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.9 2.4 . . . . 62.34 113.382 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.131 0.419 . . . . 74.32 112.131 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 34.5 p -91.69 100.77 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.658 0.266 . . . . 74.24 111.066 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.409 HG22 HD13 ' A' ' 15' ' ' LEU . 34.3 m -128.22 172.21 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.148 0.499 . . . . 74.34 111.902 -177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.8 m -84.72 127.68 64.21 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.236 -0.438 . . . . 75.11 111.164 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 32.5 Cg_endo -62.46 -18.56 63.84 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.77 2.313 . . . . 62.11 113.272 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.51 -19.28 62.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.0 m -75.43 157.92 33.41 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.381 . . . . 34.15 111.673 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 p -91.13 155.26 18.76 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.066 0.46 . . . . 70.31 111.666 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 63' ' ' GLU . 34.3 m -65.31 -18.57 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.888 0.375 . . . . 64.41 111.612 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 63.5 tttm -79.43 -38.69 34.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.967 0.413 . . . . 61.31 110.659 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.98 -42.15 84.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.143 0.497 . . . . 64.42 109.911 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 28' ' ' VAL . 51.0 mt -53.3 -39.42 63.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.898 -0.592 . . . . 63.34 111.711 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 89.0 mttt -57.93 -41.48 82.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.059 0.457 . . . . 72.23 111.486 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.4 t -67.95 -23.86 65.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.028 -0.533 . . . . 44.34 111.418 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -91.52 -33.02 15.34 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.22 -0.445 . . . . 75.3 111.533 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.77 -41.67 74.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.599 0.592 . . . . 70.33 112.599 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -52.14 -52.99 57.04 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.216 0.821 . . . . 72.42 113.216 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -11.98 33.63 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.82 1.68 . . . . 65.24 113.575 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.96 -60.25 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.889 0.376 . . . . 73.04 111.99 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -92.07 4.69 52.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.322 0.49 . . . . 72.04 112.322 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.93 24.19 14.41 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.443 0.534 . . . . 75.32 112.443 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 10.6 p -99.9 143.68 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.063 0.459 . . . . 75.31 112.051 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.17 135.71 47.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.538 -0.301 . . . . 61.11 111.675 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -55.28 -40.09 87.5 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.927 2.418 . . . . 74.03 113.409 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.68 -36.99 85.24 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.69 0.281 . . . . 71.32 111.462 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.25 -14.97 73.05 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 74.24 113.089 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' HG22 ' A' ' 47' ' ' VAL . 39.8 mt-30 -69.5 102.78 1.88 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.348 0.594 . . . . 74.24 112.244 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 68.3 mttm -105.36 95.74 6.03 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.922 -0.581 . . . . 74.02 110.824 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 34' ' ' VAL . 94.4 mt -79.26 120.76 24.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.99 0.424 . . . . 74.23 110.734 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.547 HG12 HG22 ' A' ' 60' ' ' VAL . 43.6 mt -127.22 119.03 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.935 0.398 . . . . 74.53 112.033 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' HD21 ' A' ' 61' ' ' LEU . 39.2 t80 -108.54 121.3 44.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.568 0.347 . . . . 74.12 111.094 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 63.01 20.21 12.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.755 0.422 . . . . 73.43 111.721 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.44 -0.28 74.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.018 -0.611 . . . . 42.53 112.893 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -112.87 122.41 47.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.837 0.351 . . . . 72.14 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 55' ' ' ILE . 39.6 t -65.47 135.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 111.989 0.366 . . . . 44.11 111.989 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 56' ' ' PHE . 2.6 mm? -81.41 144.57 31.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.882 0.372 . . . . 43.22 110.98 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 64' ' ' THR . 39.5 t -77.9 128.62 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.575 -0.284 . . . . 62.04 110.704 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 34' ' ' VAL . 43.5 mt-10 -57.05 -25.52 58.78 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.834 0.679 . . . . 65.44 112.834 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . 70.3 p -89.43 11.82 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.904 0.335 . . . . 71.12 111.904 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -113.61 158.0 21.39 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.834 0.35 . . . . 74.23 111.314 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 23.3 p -97.79 173.55 7.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.066 0.46 . . . . 74.43 111.598 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -70.73 -40.49 72.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.919 0.39 . . . . 74.45 110.367 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 64.6 tttm -63.83 -37.75 88.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.172 -0.467 . . . . 73.41 111.624 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -67.02 -24.69 66.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.892 0.377 . . . . 72.43 111.391 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 m -97.6 10.01 41.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.27 -0.423 . . . . 75.4 111.713 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 63.88 15.47 9.14 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.7 0.63 . . . . 73.53 112.7 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.74 107.96 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.643 0.259 . . . . 61.14 110.929 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.22 -165.43 18.44 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.344 -0.455 . . . . 23.33 113.605 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -65.98 119.93 12.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.998 0.428 . . . . 34.32 111.569 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.51 67.19 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.188 -0.529 . . . . 73.44 113.003 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.84 128.8 36.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.094 0.473 . . . . 52.34 111.258 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -93.5 126.33 38.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.162 0.505 . . . . 73.51 112.257 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 15' ' ' LEU . 85.4 mt -113.69 159.17 19.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.84 -0.618 . . . . 65.33 110.929 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 46.1 ttm -116.03 122.97 46.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.768 -0.196 . . . . 65.32 110.53 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD13 HD23 ' A' ' 54' ' ' LEU . 26.3 tp -103.7 99.96 9.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.42 0.628 . . . . 65.21 110.556 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.591 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 28.0 ttt -77.27 78.31 3.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.329 0.585 . . . . 62.35 111.047 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.49 132.38 17.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.704 -0.68 . . . . 52.42 110.842 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.5 p -80.02 30.33 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.245 0.461 . . . . 71.12 112.245 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 13.7 mm100 -99.53 -163.38 1.03 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.868 0.366 . . . . 71.34 111.669 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.767 -1.018 . . . . 51.11 112.646 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 2' ' ' GLY . 21.1 ttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 110.677 -0.12 . . . . 71.11 110.677 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . 140.22 -144.17 14.57 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.599 -0.81 . . . . 73.14 113.628 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -98.84 -174.74 2.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.788 0.435 . . . . 64.2 109.898 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -55.83 147.61 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.011 -0.676 . . . . 71.23 109.862 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 67.21 38.82 3.24 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.919 0.866 . . . . 72.12 108.955 -165.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -52.27 156.19 1.77 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.94 -1.027 . . . . 64.32 112.58 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -149.54 159.1 44.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.119 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -92.31 137.56 32.26 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.46 -0.336 . . . . 74.04 110.775 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -64.31 94.6 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.212 0.529 . . . . 74.01 111.702 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -117.56 155.91 28.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.609 -0.723 . . . . 71.01 109.809 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.8 t -53.67 102.48 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.002 0.429 . . . . 63.21 111.751 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.6 p -117.39 114.54 23.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.153 0.501 . . . . 75.4 110.987 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 15' ' ' LEU . 32.8 pt -82.32 148.64 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.643 -0.708 . . . . 45.14 111.945 -175.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -101.07 106.83 18.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.989 -0.551 . . . . 73.24 110.892 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HG13 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -104.75 167.24 9.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.239 0.542 . . . . 62.35 111.475 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -129.11 100.79 5.76 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.089 -0.505 . . . . 62.12 109.963 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.57 106.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.016 0.436 . . . . 74.0 111.49 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -71.26 85.39 0.78 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.585 0.707 . . . . 75.23 110.737 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 84' ' ' GLN . 4.0 t80 -79.8 92.9 5.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.448 -0.796 . . . . 72.23 110.911 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.46 29.1 52.76 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 121.161 -0.543 . . . . 74.22 113.151 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.69 13.21 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.541 -0.362 . . . . 63.01 112.616 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -70.79 110.63 5.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.534 0.334 . . . . 74.35 111.207 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 76.6 p -71.82 94.62 1.43 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.712 0.292 . . . . 72.32 111.099 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.2 mm -97.72 106.43 33.46 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 111.988 0.366 . . . . 73.43 111.988 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' SER . 7.1 Cg_exo -74.98 125.78 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.913 2.409 . . . . 72.44 112.374 176.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.7 158.95 39.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.916 0.389 . . . . 64.32 111.636 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 83.3 p -134.88 103.36 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.933 0.397 . . . . 73.24 111.135 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.8 168.13 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.754 0.311 . . . . 50.22 111.186 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.7 p -91.35 132.72 33.0 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 122.2 -0.312 . . . . 64.34 111.508 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 28.3 Cg_endo -60.78 -15.94 40.93 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.017 2.478 . . . . 70.44 113.523 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.52 -5.99 40.8 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.298 0.481 . . . . 70.15 112.298 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.34 146.43 25.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.784 0.326 . . . . 64.14 111.404 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 67.5 p -78.39 151.41 32.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.807 0.337 . . . . 65.15 111.077 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 m -63.34 -23.9 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.223 0.535 . . . . 75.13 111.01 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 24.9 ttpp -67.35 -37.19 82.84 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.014 0.435 . . . . 74.31 110.173 171.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.66 -30.2 69.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.79 0.328 . . . . 71.2 110.412 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 67' ' ' LEU . 64.1 mt -60.42 -38.9 85.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.599 -0.273 . . . . 45.34 110.773 170.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 53.2 mttm -58.86 -40.26 83.78 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.367 0.603 . . . . 72.24 109.98 171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -71.37 -26.1 62.65 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.675 -0.693 . . . . 74.01 112.029 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -88.93 -36.51 15.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.802 0.297 . . . . 74.51 111.802 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -81.89 -25.08 35.31 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.567 0.58 . . . . 71.31 112.567 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.9 tt0 -58.46 -47.92 97.89 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.64 0.607 . . . . 75.54 112.64 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 46.0 Cg_endo -68.51 -11.86 33.14 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.802 1.668 . . . . 71.41 112.972 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.8 mt -93.13 -46.22 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 73.32 111.481 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.586 ' OG1' HG12 ' A' ' 47' ' ' VAL . 82.0 p -102.14 -16.69 16.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.64 0.607 . . . . 74.11 112.64 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.42 20.13 12.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.838 0.681 . . . . 72.14 112.838 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' OG1' ' A' ' 45' ' ' THR . 13.2 p -101.56 150.82 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.024 0.44 . . . . 70.45 111.032 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.8 mt -69.8 148.16 96.43 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.092 0.404 . . . . 74.55 112.092 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.98 -24.24 31.32 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.895 2.397 . . . . 32.34 112.714 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.36 -45.06 81.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.207 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.46 -28.09 64.3 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.135 -0.555 . . . . 64.54 112.447 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.71 80.86 0.28 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.311 0.577 . . . . 75.43 111.823 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -96.72 103.15 15.04 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.058 -0.519 . . . . 62.21 111.594 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.473 HD23 HD13 ' A' ' 80' ' ' LEU . 83.4 mt -83.43 119.02 24.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 74.24 111.066 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.0 mt -128.45 131.26 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.09 0.472 . . . . 72.34 111.683 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -132.77 130.02 39.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.745 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 59.64 19.84 8.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.213 0.449 . . . . 72.13 112.213 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.33 10.25 77.87 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.878 -0.677 . . . . 53.3 112.815 -176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -111.48 121.63 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.811 0.444 . . . . 72.22 110.892 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.55 127.0 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.935 0.398 . . . . 74.42 110.569 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.52 134.23 38.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.162 0.506 . . . . 74.31 112.163 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.9 128.66 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.009 -0.541 . . . . 64.3 111.305 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' HE3' ' A' ' 38' ' ' LYS . 45.0 mt-10 -52.04 -34.08 41.72 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.26 0.837 . . . . 74.21 113.26 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.2 p -80.52 -12.18 59.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.64 0.607 . . . . 74.41 112.64 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -85.09 153.64 22.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.132 0.491 . . . . 64.43 111.93 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 34.5 p -102.03 169.43 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.406 -0.361 . . . . 64.4 111.229 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 3.3 mm? -62.44 -39.14 92.38 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 44.41 110.245 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.15 -42.14 94.26 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.026 -0.534 . . . . 73.3 111.024 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.99 -34.61 78.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.984 0.421 . . . . 62.31 111.296 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 m -83.05 -5.47 59.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.085 -0.507 . . . . 71.25 111.841 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 65.49 26.2 11.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.257 0.466 . . . . 70.45 112.257 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.76 122.84 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.716 0.293 . . . . 62.41 110.939 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 -173.95 13.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.044 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -55.64 122.83 12.25 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.979 0.419 . . . . 65.13 111.428 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.4 -14.9 42.93 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.13 -0.486 . . . . 51.31 112.859 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.81 110.9 13.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.137 0.494 . . . . 63.43 111.02 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -91.15 109.43 20.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.193 0.52 . . . . 64.34 110.688 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 mt -85.95 177.9 7.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.144 -0.48 . . . . 75.23 111.752 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 60.4 ttp -136.43 126.75 26.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.445 -0.343 . . . . 74.05 110.855 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 54' ' ' LEU . 31.9 tp -105.38 108.02 19.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.027 0.442 . . . . 61.13 110.835 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.7 ttm -90.12 98.33 11.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 73.23 111.209 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HB3' ' HE1' ' A' ' 19' ' ' PHE . . . -144.04 -177.54 5.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.313 -0.403 . . . . 73.13 111.484 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -92.11 16.86 10.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.888 0.375 . . . . 70.3 111.998 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 19' ' ' PHE . 81.5 mm-40 -128.54 164.25 23.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.797 0.332 . . . . 71.35 111.562 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.422 0 CA-C-O 118.909 -0.939 . . . . 65.43 113.414 179.746 . . . . . . . . 0 0 . 1 stop_ save_